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SUMMARY 
 
In the modern day lifestyle, two factors have been primarily associated with the rising 
prevalence of obesity, the increasing consumption of energy dense food and the 
decline in physical activity (Varo et al. 2003). With an estimated 500 million adults 
thought to be obese worldwide (WHO 2013), it is clear we need to stem this 
epidemic. Much emphasis on research has already been placed on developing 
strategies to manipulate these two factors and reduce the incidence of obesity but at 
present an effective and sustainable solution seems elusive.  
 
One thing that is clear, with the increase in the cases of obesity, there has also been a 
concomitant rise in our intake of high refined carbohydrates and sugars. Moreover, 
the consumption of sugar-sweetened beverages (SSB) has increased over the past four 
decades (ERS 2004) and consequently, their association with obesity has been well 
documented (Nissinen et al. 2009, Olsen, Heitmann 2009, Hu, Malik 2010). To undo 
the damage of diets high in refined carbohydrates and sugars, exercise has been 
thought to be the answer by many but as yet this has not yielded convincing success in 
promoting weight loss and repairing the alterations to metabolism associated with 
chronic hyperglycaemia and obesity.  
 
In the first experimental chapter, an in vivo and in vitro approach was used to 
investigate the effects of high glucose availability on skeletal muscle metabolism. In 
our in vivo study the effects of 4 weeks sugar-sweetened beverage (SSB) 
supplementation was investigated on lean, healthy, lightly active individuals with very 
little or no previous consumption of SSB. Muscle biopsies were taken from each 
participant pre and post 4 week intervention and through western blotting and real 
time reverse-transcriptase polymerase chain reaction (RT-PCR), protein and gene 
expression of several metabolic markers and glucose regulating factors was measured. 
In the in vitro study, primary human muscle cell cultures were exposed to chronic 
hyperglycaemia and compared to cultures with normal glucose concentrations for 7 
days. Analyses revealed both the in vivo and in vitro studies demonstrated a shift 
towards increased glycolytic activity and reduced oxidative activity, similar to that 
found in type 2 diabetes mellitus patients. Furthermore, in both studies an increase in 
MondoA expression was observed and in the in vitro cell cultures TXNIP expression 
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was also increased. The fact that the findings from in vivo study are comparable to 
those in the in vitro study, demonstrates the potency of high glucose availability on 
skeletal muscle. The results are even more alarming as the participants were young 
healthy individuals, not overweight or obese and with very little previous history of 
SSB consumption, highlighting just how damaging the effects of SSBs can be and the 
significant role they play in the development of obesity.  
 
In chapter 3 and 4, long term exercise interventions were used to investigate the 
effects of chronic exercise on metabolism, body composition and energy balance of 
lean and overweight or obese (Ov/Ob) sedentary women. The aim of these studies 
was to investigate the compensatory mechanisms in Ov/Ob individuals preventing 
adaptations to exercise. A novel approach to long term exercise with ad libitum 
energy intake was used in both of these studies, where participants were not recruited 
with a desire to lose weight and they were also naïve to the true aims of the study. In 
chapter 3 a 4 week exercise training intervention was used and in chapter 4 an 8 week 
training intervention was used. Both studies utilized a group based circuit training 
format 3 days per week, the 4 week intervention was at a moderate intensity and the 8 
week intervention had both a high and low intensity exercise group. Dual-energy x-
ray absorptiometry (DXA) and indirect calorimetry, at rest and during exercise, were 
used to give and overview of participants’ anthropometric and metabolic profiles, 
before and after inventions. Blood samples were collected for analysis of several key 
hormones regulating metabolic adaptations and energy homeostasis in response to 
exercise. Diet records were also collected from participants to measure any alterations 
in energy and macronutrient intake. 
 
Neither the 4 week nor the 8 week exercise intervention demonstrated significant 
weight loss of either the lean or Ov/Ob individuals. However, in both the 
interventions lean participants displayed losses in percentage body fat, even though no 
weight loss was seen overall. These findings reaffirm those reported in previous 
literature that during an increase in exercise induced energy expenditure, Ov/Ob 
individuals with respond with a concomitant increase in energy intake, negating any 
possible weight or fat loss and possibly even promote weight gain. On the contrary 
lean individuals do not display the same over-compensation to the increased energy 
expenditure and there energy intake is unchanged. It is hypothesized that the lean 
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participants were able to display a reduction in body fat through the ability to exercise 
at a higher absolute intensity. Based on analysis of blood samples, it was possible to 
further investigate possible regulators that may control a homeostatic mechanism, 
preventing weight/fat loss in obese individuals. In the 8 week study a significant drop 
in amylin concentrations was observed in the Ov/Ob participants, compared to no 
change in the lean subjects. It was proposed that Ov/Ob individuals, who also 
displayed heightened insulin resistance and hyperleptinemia, have developed an 
overreliance on amylin for satiety signalling. Moreover, in conjunction with the 
inability to achieve an absolute intensity high enough to induce adaptive responses to 
exercise, Ov/Ob individuals with reduced amylin secretion, increase energy intake 
after exercise and prevent any possible weight or fat loss. 
 
Additionally, adaptive responses to exercise were seen in both the 4 week and 8 week 
exercise studies, Ov/Ob participants displayed a positive movement away from a 
preference to rely on anaerobic metabolism at a low exercise intensity pre-
intervention, towards more anaerobic metabolism post-intervention. In addition, 
following the 8 week exercise intervention, the inter-individual variability in response 
to exercise was investigated. Participants were separated based on their heart rate 
response, into responders and non-responders and it was revealed that those who 
clearly demonstrated adaptations, also tended to lose more weight, maintain a 
negative energy balance, and avoid the maladaptive decrease in amylin 
concentrations. Suggesting these individuals do not develop the hypothesized leptin 
resistance, and overreliance on amylin signal, meaning they do not overcompensate 
for increased exercise induced energy expenditure and can lose weight. 
 
In conclusion, it is clear that an exercise only or a one size fits all approach is not the 
answer in the treatment of obesity. A more multi-dimensional approach is necessary 
and in order to reduce many of the associated lifestyle disease markers, both diet and 
levels of physical activity must be addressed in the obese. Recommendations for 
future intervention studies must address this and combine a diet low in refined 
carbohydrates and sugars, with high intensity interval training and resistance exercise. 
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Introduction to obesity 
 
The rise in the prevalence of obesity is a worldwide problem, no longer just for high 
income countries but obesity is now rising in low and middle income countries also, 
with an estimated 1.4 billion adults thought to be overweight and of those 200 million 
men and 300 million women were obese (WHO 2013). Furthermore, in England alone 
over 60 % of people are overweight or obese and 28% of children aged between 2 and 
15, with the associated health problems costing the National Health Service (NHS) 
more than £5 billion every year (Department of Health 2013). In addition, obesity has 
been identified as a risk factor for a wide range of co-morbidities including, type 2 
diabetes mellitus, hypertension, coronary heart disease, osteoarthritis, respiratory 
problems and some forms of cancer (Neary, Goldstone & Bloom 2004). Two key 
factors in our modern day lifestyle have been associated with this epidemic, the first is 
an increase in the consumption of energy dense food and the second is a decline in 
physical activity (Varo et al. 2003). Naturally, these two variables have been the focus 
of research attempting to outline the causes, treatment and prevention of obesity and a 
greater understanding of how these contributing factors influence metabolism is 
required, to ensure progress in the fight against the ever increasing prevalence of 
obesity. Moreover, with a more complete understanding it will be more possible to 
develop effective strategies for weight loss, significantly reducing the morbidity and 
mortality associated with obesity (Murphy, Bloom 2004).  
 
To date intervention studies have investigated how either restricting energy intake, 
manipulating energy expenditure or both simultaneously affect weight loss and so far 
have produced no clear intervention that has been able to achieve long-term 
sustainable weight loss or curb the increasing incidence of obesity, more research 
needs to focus on the dysregulation of homeostatic mechanisms regulating energy 
balance (Hafekost et al. 2013). In Hafekost et al’s review (2013) all intervention 
studies investigating weight loss through energy manipulation with follow up tests 
post-intervention, demonstrated significant weight regain and in Jakicic et al’s 
(Jakicic et al. 2008) study after 6 months of lifestyle alteration and weight loss, an 18 
month follow up was conducted, 72% had regained weight and a further 31% 
regained weight over and above their previous baseline. The issue with these previous 
intervention studies is that by way of approach they do not take into account 
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compensatory mechanisms that may exist and assume that energy intake and 
expenditure can be altered independently from one another (Stubbs et al. 2002). The 
mechanisms causing these compensatory changes and the coinciding alterations in 
metabolic factors need further investigation, in order to develop more successful and 
effective strategies to promote and maintain weight loss in the growing overweight 
and obese population. 
 
The role of high refined carbohydrates and sugars, and the incidence of obesity 
 
In recent years, one thing is clear that with the increase in the cases of obesity 
worldwide, there has been a concomitant rise in our intake of high refined 
carbohydrates and sugars. Since industrialisation, the availability of sugar and refined 
carbohydrates has increased significantly and in modern times, corn syrup has become 
the leading source of added sugar in our diets (Bray 2008). Corn syrups can be 
fructose, combination of fructose and glucose or glucose (100% glucose) based but 
whatever their make-up they are the main sweetener used in sugar sweetened 
beverages (SSB) today and it is the consumption of these which this thesis is 
specifically concerned with. Furthermore, the consumption of SSBs has increased 
over the past four decades, with the percentage of adults drinking SSBs in the US 
rising from 58% between 1988 and 1994 to 63% between 1999 and 2004 (ERS 2004). 
Subsequently, the association between obesity and refined carbohydrate and SSB 
consumption has been reported in many investigations recently (Nissinen et al. 2009, 
Olsen, Heitmann 2009, Hu, Malik 2010, Ludwig, Peterson & Gortmaker 2001, 
Ebbeling, Pawlak & Ludwig 2002, Schulz et al. 2002, St-Onge, Keller & Heymsfield 
2003, Berkey et al. 2004, Bray, Nielsen & Popkin 2004, Gross et al. 2004, James, 
Kerr 2005, Bes-Rastrollo et al. 2006, Malik, Schulze & Hu 2006, Dhingra et al. 2007, 
Vartanian, Schwartz & Brownell 2007, Palmer et al. 2008, Bleich et al. 2009, Fung et 
al. 2009). Not all of the evidence surrounding SSB consumption and obesity is 
damning however, there are studies with conflicting evidence (Drewnowski, Bellisle 
2007, Gaesser 2007, Forshee, Anderson & Storey 2008, Gibson 2008, Gomez-
Martinez et al. 2009, van Baak, Astrup 2009). Although as recognized by a recent 
review (Vartanian, Schwartz & Brownell 2007) these articles which try to discredit 
the association between obesity and SSBs are food industry funded and adjust the 
energy intake when supplementing SSBs to reduce the relationship with weight gain. 
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Nonetheless, more evidence is needed to prove that increasing SSB consumption is 
directly associated with obesity (Mattes et al. 2011). Moreover, obesity is greatly 
associated with type 2 diabetes mellitus and insulin resistance (Wannamethee, Shaper 
1999) and consequently a diet high in refined carbohydrates and sugars has been seen 
shown to be related to the development of this condition (Hu, Malik 2010, Gross et al. 
2004, Vartanian, Schwartz & Brownell 2007, Palmer et al. 2008, Bleich et al. 2009, 
Liu 2002, Yoshida et al. 2007, Mohan et al. 2009, Stanhope et al. 2009).  
 
Additionally, offering further support for the negative effects of diets high in refined 
carbohydrates, low carbohydrate diets have been proven to promote weight loss in 
overweight and obese (Ov/Ob) individuals (Brehm et al. 2003, Foster et al. 2003, 
Boden et al. 2005, Dansinger et al. 2005, Westman et al. 2006, Ebbeling et al. 2007). 
They have also been demonstrated to lessen the symptoms of insulin resistance in 
Ov/Ob people, reducing both plasma glucose and insulin concentrations (Foster et al. 
2003, Dansinger et al. 2005). The same has also been reported in patients with type 2 
diabetes mellitus (Boden et al. 2005, Samaha et al. 2003, Yancy et al. 2005).  
 
Regulation of blood glucose 
 
In healthy individuals, blood glucose levels are tightly regulated, primarily by insulin 
and glucagon, as part of a hormonal regulatory system. During postprandial 
hyperglycaemia after carbohydrate ingestion, glucose is absorbed in the gut 
promoting high intracellular glucose availability in the pancreatic β-cells; as a result 
insulin secretion is stimulated to decrease circulating blood glucose levels. Under 
normal conditions, insulin then stimulates glucose uptake of the peripheral tissues and 
blood glucose levels are reduced. In contrast, under hypoglycaemic conditions, 
glucagon is secreted by the α-cells of the Langerhans; in the liver it stimulates the 
release of glucose through glycogenolysis and gluconeogenesis.  
 
In skeletal muscle, during hyperglycaemia glucose uptake is facilitated by insulin-
dependent active transport (GLUT4) (Klip, Paquet 1990). In order for this to happen, 
first insulin must bind to the insulin receptors at specific sites of the muscle cells 
(Burant et al. 1986). This binding of insulin induces the phosphorylation of tyrosine 
(Hubbard et al. 1994) and in turn the phosphorylation of insulin-receptor substrate 
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(IRS-1) (Gual, Le Marchand-Brustel & Tanti 2005). This activates 
phosphatidylinositol- 3-kinase (PI3-K) (Gual, Le Marchand-Brustel & Tanti 2005) 
which interacts with the IRS-1 docking site, phosphorylating phosphatidylinositol-
4,5-biphosphate (PIP2), subsequently generating phosphatidylinositol-3,4,5-
triphosphate (PIP3) (Saltiel, Pessin 2002). PIP3 binds to Akt (also known as protein 
kinase B; PKB) and after phosphorylation by 3-phosphoinositide-dependent protein 
kinase (PDK-1) (Corvera, Czech 1998), Akt activates its substrate AS160 which 
induces the translocation of GLUT4 to the plasma membrane (Sano et al. 2003), 
increasing glucose uptake. Simultaneously, Akt while promoting the translocation of 
GLUT4 to the membrane for glucose uptake, also inhibits glycogen synthase kinase-3 
(GSK-3) (Cross et al. 1995) which allows glycogen synthase to direct much of the 
glucose entering the cell towards storage through glycogen synthesis. 
 
Fig. 1.1 Regulation of insulin stimulated glucose transport and glycogen synthesis in 
skeletal muscle. 
 
After ingestion, most glucose is disposed of in skeletal muscle tissue through insulin 
dependent glucose uptake. It has previously been demonstrated that 67% enters 
glycolysis and 33% is stored as glycogen, of the 67% glycolysis, 65% goes through 
oxidative glycolysis and the rest non-oxidative glycolysis (Woerle et al. 2003). 
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Additionally, the existing levels of glycogen stores, depending on diet and physical 
activity, can also influence the amount of glycogen synthesis (Fery, Plat & Balasse 
2003). Furthermore, glycogen has been demonstrated to influence more than just 
glucose storage it has also been shown to regulate glucose flux also (Jensen et al. 
2006). Subsequently, high glycogen levels have been shown to reduce glycogen 
synthase activity (Danforth 1965) and glucose uptake into the muscle (Derave et al. 
2000, Aslesen et al. 2001). It is possible that under conditions of high glucose 
availability, the function of glycogen synthase may be reduced, leading to increased 
glucose metabolites, lipogenesis and finally insulin resistance. 
 
Glucose sensing 
 
After refined carbohydrate and sugar ingestion, glucose is absorbed by the gut and 
there is an increase in blood glucose levels, through insulin action this glucose is 
taken up by skeletal muscle and used in any one of numerous cellular processes. 
Recently, new evidence has demonstrated that glucose and its metabolites are sensed 
in the muscle cell by specific molecules stimulating regulatory gene expression 
(Desvergne, Michalik & Wahli 2006). Inside the muscle, hexokinase (HK) converts 
glucose into glucose-6-phosphate (G6P). G6P is important in the regulation of L-
pyruvate kinase (L-PK) in the hepatic and adipose tissues (Desvergne, Michalik & 
Wahli 2006). A region on the L-PK gene has been shown to interact with glucose 
(Diaz Guerra et al. 1993), as in other genes and these have been termed carbohydrate 
response elements. ChREBP or MondoB as it’s also known, has since been identified 
as a protein which binds to the ChoRE of the L-PK gene (Yamashita et al. 2001) but 
only in the liver. Under hyperglycaemic conditions MondoB translocates to the 
nucleus of hepatic cells and activates acetyl-CoA carboxylase (ACC) and L-PK, 
promoting lipogenesis (Ma, Tsatsos & Towle 2005). The paralog of MondoB, 
MondoA is expressed in skeletal muscle (Billin et al. 2000), it has been found to 
translocate from the mitochondrial membrane to the nucleus (Sans et al. 2006) and 
here it accumulates, like MondoB, through G6P activity (Peterson et al. 2010). In the 
muscle cell, MondoA and its heterodimerisation partner max-like protein x (Mlx) 
form a complex (Billin et al. 2000) which activates the transcription of lactate 
dehydrogenase-A (LDH-A), phosphofructosekinase 2-fructose biphosphatase 2 
(PFK2-FBPase2) and HK genes, highlighting its importance in the regulation of 
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glucose in and out of the muscle cell (Sans et al. 2006). Moreover, MondoA has been 
shown to activate thioredoxin-interacting protein (TXNIP) (Stoltzman et al. 2008). 
This is significant because TXNIP inhibits thioredoxin-NADPH-dependent reduction 
of protein disulfides (Nishiyama et al. 1999), making cells more susceptible to 
oxidative stress by reactive oxygen species (Nordberg, Arner 2001). TXNIP has also 
previously been shown to reduce glucose uptake (Parikh et al. 2007). Other glucose 
sensors present in skeletal muscle include, sterol regulatory element binding-protein 
1c (SREBP-1c) and liver X receptor (LXR). During periods high glucose availability 
SREBP-1c up regulates lipogenesis by activating HK, FAS, ATP-citrate lysase and 
ACC (Guillet-Deniau et al. 2004). LXR is also an important regulator of lipid and 
cholesterol metabolism in skeletal muscle (Muscat et al. 2002).  
 
Fig. 1.2 Glucose sensing in skeletal muscle, highlighting the influence of MondoA 
and TXNIP in controlling glucose uptake. 
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High glucose availability and skeletal muscle 
 
The increase in dietary refined carbohydrates and sugars produces a large rise in 
glucose availability (Foster-Powell, Miller 1995) and continuous high energy food 
intake and a lack of energy expenditure, challenge the normal regulation of blood 
glucose levels (Manson et al. 1992), eventually weakening the system so that periods 
of hyperglycaemia following carbohydrate ingestion are extended. In turn this can 
influence several signalling pathways, causing adaptations to skeletal muscle which 
contribute to reduced oxidative capacity and insulin sensitivity. Reduced glucose 
uptake (DeFronzo, Simonson & Ferrannini 1982) and high intracellular glucose levels 
have been observed in diabetic patients during hyperglycaemia and hyperinsulinaemia 
(Bonadonna et al. 1996). This leads to the assumption that high carbohydrate diets 
combined with low physical activity can cause prolonged periods of hyperglycaemia 
even in individuals with normal glucose tolerance and if continued they can lead to 
development of a low oxidative capacity and impaired insulin signalling pathways, 
usually described as a diabetic phenotype. Moreover, high glucose availability has 
been widely recognized as a cause of insulin resistance in skeletal muscle (Fell et al. 
1982, Richter, Hansen & Hansen 1988a, Richter, Hansen & Hansen 1988b, Hansen et 
al. 1992, Davidson et al. 1994, Gulve et al. 1994, Kawanaka et al. 2001, Kawanaka et 
al. 1999, Oku et al. 2001, Han, Chen & Holloszy 2003). Some of the mechanisms, 
through which high glucose availability leads to insulin resistance include, UDP-N-
acetylhexosamine accumulation (Marshall, Bacote & Traxinger 1991b, Marshall, 
Bacote & Traxinger 1991a, Robinson, Sens & Buse 1993, Baron et al. 1995, 
Virkamaki et al. 1997), protein kinase C activation (Pillay, Xiao & Olefsky 1996, 
Filippis, Clark & Proietto 1997, Laybutt et al. 1999) and increased glycogen content 
(Fell et al. 1982, Kawanaka et al. 1999, Jensen et al. 1997). 
 
High glucose availability and gene expression  
 
Based on findings of previous investigations, there is sufficient evidence to suggest 
that high glucose availability, in skeletal muscle, can alter numerous transcription 
factors, including, MondoA, SREBP-1c, LXR, and proliferator-activated receptor 
coactivator 1 alpha (PGC1α), which have all been implicated in the metabolic 
alteration of skeletal muscle towards a diabetic phenotype, through decreasing 
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oxidative capacity and increasing glycolytic capacity (Sans et al. 2006, Guillet-Deniau 
et al. 2004, Mitro et al. 2007, Hanke et al. 2008). Changes in metabolic gene 
expression are also likely to occur very early in the development of this phenotype, as 
previously seen in human muscle cell cultures, changes in glucose uptake and 
glycogen synthesis were seen after just two days of exposure to high glucose 
availability (Aas et al. 2004). Of all of these MondoA has been found to be transcribe 
many of the genes regulating of glucose, one of the most dependent genes is TXNIP 
(Stoltzman et al. 2008). As previously discussed, TXNIP is known to be involved the 
formation of ROS and is important in the regulation of glucose uptake by negative 
feedback (Parikh et al. 2007). For these reasons, it is apparent that MondoA is crucial 
to the regulation of glucose homeostasis and high glucose availability is likely to 
destabilise this relationship. Furthermore, as a result of the inhibition of MondoA 
during chronic high glucose availability, downstream complications include the 
inhibition of glyceradehyde-3-phoshate dehydrogenase (GAPDH), through the ROS 
stimulated mitochondrial dysfunction, having profound effects on glycolytic capacity 
(Bouche et al. 2004). Moreover, it is highly likely that the high glucose availability 
will reduce oxidative capacity of skeletal muscle, as seen in obese and diabetic or 
insulin resistant individuals (Kelley, Mandarino 1990, Kelley et al. 1999). Other 
impairments of skeletal muscle in this population include, decreased mitochondrial 
ATP synthesis, less oxidative fibres compared to glycolytic fibres, decreased 
glycogen synthesis and significantly lower expression of PGC1α (Mootha et al. 2003, 
Patti et al. 2003, Lowell, Shulman 2005). Finally, it should be possible to see these 
alterations in sedentary individuals’ with diets high in refined carbohydrates and 
sugars, typically seen in SSBs, as they will not be able to combat the damage caused 
by periodic high glucose availability with increased glucose clearance through of 
physical activity. 
 
Benefits of physical activity 
 
In order to undo the damage to the regulation of glucose and hence, the metabolic 
profile of the obese population, typically with diets high in refined carbohydrate, 
many investigations have been conducted to find the best cure. As previously 
mentioned low carbohydrate diets have been employed by many and have been 
demonstrated to promote weight loss and lessen the symptoms of insulin resistance 
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associated with obesity (Foster et al. 2003, Dansinger et al. 2005) but to date they 
have been unsuccessful in sustaining long term weight loss and returning glycaemic 
control back to normal function (Boden et al. 2005, Dansinger et al. 2005, Samaha et 
al. 2003, Yancy et al. 2005). 
 
Exercise has been thought to be the answer by many but as yet this has not yielded 
convincing success in promoting weight loss and repairing the alterations to 
metabolism associated with chronic hyperglycaemia and obesity. In many exercise 
studies even with reported weight loss, this is usually lower than expected (King et al. 
2007). In addition, where follow up tests have been conducted after the exercise 
intervention and weight loss was achieved, it is not uncommon to see individuals 
regain some of the weight and regain over and above original pre-intervention weight 
has also been well documented (Hafekost et al. 2013, Jakicic et al. 2008, Wadden et 
al. 1998, Doucet et al. 2011). Moreover, it has previously been demonstrated that 
interventions using exercise alone only show minimal weight loss (2.4 kg), compared 
to diet interventions (4.9 kg) and a combined approach (7.9 kg) (Franz et al. 2007), 
suggesting that exercise may cause a compensatory increase in energy intake in 
response to the added energy expenditure. In addition, previous literature 
demonstrates a large variability in the individual responses to exercise interventions, 
particularly regarding bodyweight and fat mass. Ranges in fat mass change of Ov/Ob 
individuals post intervention, was reported between -9.5 and +2.6 kg in one study, 
after a 12 week programme (King et al. 2007) and weight change varied between -5.3 
and +2.1 kg in another study after 7 weeks training (Barwell et al. 2009). These 
studies clearly demonstrate that responses to long term exercise interventions vary 
greatly between individuals but what is not clear are the underlying mechanisms 
which control this response, more research is needed here. 
 
The question of exercise intensity is also an issue when prescribing exercise, previous 
research demonstrates to produce greater weight loss, increased fat oxidation, as 
opposed to carbohydrate oxidation, is more favourable and this is dependent on 
exercise intensity (Achten, Jeukendrup 2004). Exercise at moderate intensities (55% 
?̇?O2MAX) has been shown to use equal amounts of energy from fat and carbohydrate 
sources, and with increasing intensity (75% ?̇?O2MAX) more energy is derived from 
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carbohydrate oxidation than from fats, with low intensity (40% ?̇?O2MAX) this 
relationship is reversed (van Loon et al. 2001). Furthermore, even though a greater 
percentage of energy is derived from fat oxidation at low intensity (25% ?̇?O2MAX), 
absolute amounts of fat oxidation at the end of exercise is significantly higher using a 
moderate intensity (65% ?̇?O2MAX) during exercise (Romijn et al. 1993), suggesting 
that a moderate intensity exercise intervention may be the most suitable for weight 
and fat loss. However, to increase glycogen depletion through exercise and reduce the 
effects of chronic hyperglycaemia on skeletal muscle, higher intensity exercise may 
be more advantageous. Muscle glycogen depletion has been seen to be greater in high 
intensity (90% ?̇?O2MAX) exercise than low intensity (60% ?̇?O2MAX) exercise 
(Gollnick, Piehl & Saltin 1974, Vollestad, Blom 1985). Finally, high intensity 
exercise has been seen to increase glucose clearance and improve insulin sensitivity of 
both healthy and insulin resistant individuals (Kjaer et al. 1990, Mourier et al. 1997, 
Loimaala et al. 2003, Dela et al. 2004, DiPietro et al. 2006). 
 
Compensatory mechanisms influencing energy balance 
 
The basic principle of energy balance is that, energy storage will only increase if 
energy intake exceeds energy expenditure, where energy expenditure includes 
physical activity, basal metabolism and thermogenesis (Spiegelman, Flier 2001). The 
central nervous system (CNS) controls energy balance and body weight via three 
mechanisms, which are; effects on behaviour, including intake and physical activity; 
effects on autonomic nervous system, which regulates expenditure and metabolism; 
and effects on the neuroendocrine system, including secretion of hormones 
(Spiegelman, Flier 2001). All three of these mechanisms interact and form a complex 
network of pathways regulating energy balance. 
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Fig. 1.3 Peripheral factors contributing to energy balance regulation via the central 
nervous system (CNS). PP – pancreatic polypeptide, PYY – Peptide YY, OXM – 
oxyntomodulin, GLP-1 – glucagon like peptide 1, GIP – gastric inhibitory 
polypeptide and CCK – cholecystokinin.  
 
As previously discussed, recent research using long term exercise interventions to 
promote weight loss in the Ov/Ob, seem to suggest a compensatory mechanism exists 
within this population, causing an increase in energy intake after an initial exercise 
induced energy deficit (Stubbs et al. 2002).  Consequently, this implies energy 
balance may be homeostaticly regulated to maintain a set bodyweight, understanding 
the regulation of this mechanism may be the key to enabling Ov/Ob individuals to 
lose weight. Previous research documenting this compensatory response to increased 
energy expenditure, shows it takes a number of weeks for exercise to stabilise energy 
balance (Doucet et al. 2011, King et al. 2008), explaining why larger discrepancies in 
energy balance may be seen in the earlier stages of exercise interventions. Moreover, 
it is also possible that the type of exercise may influence the compensatory response 
to exercise. As mentioned earlier, obesity is associated with impaired fat oxidation 
and a greater emphasis on carbohydrate oxidation, influenced by the higher blood 
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glucose and muscle glycogen levels. In addition, individuals with high levels of 
carbohydrate oxidation have been shown to have significantly higher energy intake 
post exercise than high fat oxidation levels (Almeras et al. 1995). As high intensity 
exercise also promotes carbohydrate oxidation, it is reasonable to assume high 
intensity exercise will result in a larger compensatory intake following exercise. 
 
Furthermore, even though there is strong evidence to suggest that a compensatory 
mechanism exists in obese individuals preventing response to exercise and weight 
loss; research also shows that not all individuals display this phenomenon. Both 
compensators and non-compensators were identified in a recent study, where energy 
intake was compared after exercise against intake without exercise and compensators 
tended to eat more after exercise and non-compensators consumed the same amount 
of food or less (Finlayson et al. 2009). In this study, the authors attributed this 
variation in compensation of energy expenditure to individual’s hedonic response to 
exercise, indicating this may be an important mediating factor influencing response to 
exercise. 
 
Leptin 
 
It is well documented that leptin plays a key role mediating; fat mass, bodyweight and 
energy balance (Adami et al. 2002). It is also known that leptin is produced and stored 
in adipose tissue and high circulating levels are known to correlate with elevated 
adiposity in obese individuals (Considine et al. 1996). When administered to obese 
leptin deficient mice and humans, it has been shown to induce significant fat loss by 
decreasing appetite and increasing energy expenditure (Zhang et al. 1994, Farooqi et 
al. 2002). Although, in humans the leptin administration only produced modest weight 
loss, it is evident that obese individuals experience a leptin resistance (Munzberg et al. 
2005). It has been suggested that this leptin resistance is caused by impairment in the 
transport of leptin across the blood brain barrier; demonstrating a reduced efficiency 
in brain leptin delivery and CNS leptin uptake (Nam et al. 2001).  
 
To date there is little evidence to suggest that exercise alters leptin concentrations 
independent of changes in body composition; in many studies which have displayed a 
reduction, the findings can be explained by other extraneous variables. Acute leptin 
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concentrations have been reported to decrease after a graded exercise test to 
exhaustion (Elias et al. 2000) but this reduction was attributed to an increase in non-
esterfied fatty acids (NEFA) during exercise which has been negatively associated 
with leptin concentrations previously (Duclos et al. 1999). In a further study, a 
significant decrease in leptin levels was reported after a 30 minute high intensity 
exercise bout however, with the presence of a control group where a significant 
decrease was also observed, meant the reduction was explained by changes brought 
on by circadian rhythms (Kraemer et al. 1999). Moreover, a further explanation of 
decreased leptin concentrations following exercise may be an alteration in 
hemoconcentration which may cause leptin levels to appear greater due to changes in 
plasma volume (Kraemer, Chu & Castracane 2002). After a 9 week exercise 
programme no alterations in leptin concentrations were found, indicating the training 
had no impact on leptin levels although this was unsurprising as no significant 
changes in fat mass were reported (Kraemer et al. 1999). In contrast, a 12 week 
exercise intervention did reveal a significant reduction in leptin but this was 
accompanied by a significant drop in fat mass also (Ozcelik et al. 2004). Both of these 
studies support the notion that changes in leptin levels with exercise are reliant on 
changes with fat mass. Having said that it may be possible to alter leptin 
concentrations with exercise irrespective of fat mass if insulin sensitivity is improved 
(Martins, Robertson & Morgan 2008) 
 
Insulin and leptin 
 
As previously described, insulin is secreted by the pancreatic β-cells in response to 
food intake and in an effort to regulate plasma glucose concentrations. Like leptin, 
increased insulin concentrations are known to decrease appetite and increase energy 
expenditure (Porte, Baskin & Schwartz 2005). Insulin concentrations are also known 
to be higher in obese individuals (Moore, Cooper 1991), often leading to insulin 
resistance. Moreover, suppression of insulin has been shown to reduce leptin 
resistance (Blaak, Saris & van Baak 1993), combined with the associated 
hyperglycaemia and hyperlipidaemia, this suggests that hyperinsulinaemia may be 
one of the key causes of leptin resistance (Lustig 2006). Both, insulin and leptin are 
controlled by the CNS in similar ways, sharing signalling pathways that regulate 
adiposity and energy homeostasis (Niswender, Schwartz 2003) but it is not yet known 
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whether a chronic increase in insulin levels, seen in the obese, can cause a resistance 
here in the same way as leptin.  
 
Amylin 
 
Amylin is co-secreted with insulin by the pancreatic β-cells following food intake, to 
regulate glucose levels (Qi et al. 2010). However, even though amylin and insulin are 
co-secreted together, they have different effects on energy homeostasis. Amylin 
concentrations peak one hour after food ingestion and remain high for up to 4 hours 
(Roth et al. 2009), they are also typically elevated in obese individuals (Moore, 
Cooper 1991). Moreover, amylin receptors are found within the area postrema of the 
brain (Grill, Kaplan 2002) and amylin receptor agonism has been found to suppress 
appetite (Pullman, Darsow & Frias 2006), slow gastric emptying (Smith et al. 2008) 
and reduce postprandial glucagon release (Roth et al. 2008), together these processes 
slow the release of glucose into the blood to improve the effectiveness of insulin. 
Furthermore, when amylin antagonist AC187 was centrally administered to rats it 
increased food intake, glucagon concentrations, gastric emptying, and glycaemia after 
glucose ingestion (Riediger et al. 2004, Gedulin et al. 2006).  
 
At present, few studies have investigated the effect of exercise on amylin response. In 
a study with progressive intermittent exercise from moderate to maximal intensities 
(60%, 75%, 90% and 100% ?̇?O2MAX), well trained men demonstrated no change at the 
moderate intensities but at 90 and 100% amylin was elevated with the peak in amylin 
at 100% (Kraemer, Chu & Castracane 2002). This increase was maintained till one 
hour after exercise and the same changes were observed in glucose and insulin. 
Interestingly, in a further study prescribing resistance exercise no significant increase 
was seen in amylin concentrations but insulin was significantly elevated (Kraemer et 
al. 2004). Furthermore, in a final study by the same authors, a reduction in amylin of 
healthy young men was seen during prolonged moderate intensity exercise for 90 
minutes (Kraemer et al. 2011). To date, no long term exercise interventions have 
investigated the effects on amylin concentrations.  
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Amylin/leptin mechanism 
 
As discussed earlier there is strong evidence to suggest that obese individuals are not 
only insulin resistant but they are also likely to be leptin resistance (Munzberg et al. 
2005). Moreover, it has been suggested that insulin resistance is one of the major 
factors contributing to the development of leptin resistance (Lustig 2006). Therefore, 
it seems logical that amylin is important in this mechanism, as it is co-secreted with 
insulin from the pancreas and both play a pivotal role in energy homeostasis. In a 
study by Roth et al. (Roth et al. 2006), obese leptin resistant rats administered amylin, 
reduced food intake, bodyweight and body fat. The authors postulate this may be 
through improved leptin sensitivity via altered hypothalamic activity and metabolic 
alterations. Complimentary to these findings, in another study by the same authors 
(Roth et al. 2008), obese humans were administered amylin and leptin together for a 
20 week period, these were compared to amylin alone and leptin alone treatment 
groups. The combined amylin and leptin treatment induced a 12.7% loss in 
bodyweight, compared to the amylin and leptin groups where an 8% loss was 
observed. Although the mechanisms for this change are not fully understood it is clear 
amylin is very important in mediating leptin sensitivity and therefore any potential 
weight loss in obese individuals. Possible metabolic mechanisms which may explain 
the amylin/leptin mediated weight loss include; reduced energy intake without the 
concomitant reduction in energy expenditure, improved substrate utilization towards 
preferred fat oxidation and reduced lipid biosynthesis (Trevaskis et al. 2008).  
 
Adiponectin and pro-inflammatory cytokines 
 
Adiponectin is another chemical which has strong links to obesity and may contribute 
to the response to exercise in these individuals. It is produced solely by adipocytes 
(Scherer et al. 1995) and a strong negative correlation has been found between 
adiponectin and BMI, with obese individuals demonstrating significantly lower 
concentrations than their lean counterparts (Arita et al. 1999, Cnop et al. 2003, Weyer 
et al. 2001). Additionally, adiponectin has been repeatedly shown to be negatively 
correlated with insulin resistance (Cnop et al. 2003, Matsubara, Katayose & Maruoka 
2003, Yamamoto et al. 2002) and in support of this increased insulin sensitivity has 
been proven to be associated with high adiponectin levels, independent of adiposity 
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(Baratta et al. 2004, Tschritter et al. 2003).Furthermore, after a 4 week exercise 
intervention sufficient enough to induce weight loss, adiponectin concentrations and 
insulin sensitivity were significantly elevated, this increase in adiponectin was also 
associated with increased glucose uptake and decreased free fatty acid levels (Bluher 
et al. 2006). In further support of this, in exercise studies without weight loss no 
significant alterations in adiponectin concentrations were observed (Hulver et al. 
2002, Boudou et al. 2003). It is suggested that the primary mechanism by which 
adiponectin enhances insulin sensitivity is likely through increased fatty acid 
oxidation and inhibition of hepatic glucose production (Lihn, Pedersen & Richelsen 
2005).  
 
Pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin 6 
(IL-6) have also been shown to be elevated in obese individuals and to influence 
insulin sensitivity (Hotamisligil 1999, Senn et al. 2002, Kern et al. 2001); they have 
also been implicated in the regulation of adiponectin. Under in vitro conditions TNF-α 
has been shown to down regulate and inhibit adiponectin gene expression (Fasshauer 
et al. 2002, Maeda et al. 2001). Additionally, these findings have been replicated in 
vivo with humans (Lihn et al. 2003, Kern et al. 2003) where negative associations 
were observed between adiponectin and TNF-α in plasma concentrations and mRNA 
in adipose tissue. Consequently, this suggests TNF-α and adiponectin act against each 
other in an antagonistic manner, influencing insulin action accordingly and in the case 
of obesity both TNF-α and IL-6 are elevated causing adiponectin to be down 
regulated, reducing insulin sensitivity (Lihn, Pedersen & Richelsen 2005). (Kern et al. 
2003)(Kern et al. 2003)(Kern et al. 2003) 
 
Other mechanisms regulating energy intake 
 
Energy intake is regulated at two levels, both centrally and peripherally, to maintain 
energy homeostasis. The CNS and more specifically, the arcuate nucleus in the 
hypothalamus is responsible for the central control of food intake and the 
gastrointestinal tract, adrenal glands, pancreas and adipose tissue, all combine to 
regulate food intake in the peripheral organs (Neary, Goldstone & Bloom 2004). 
Ghrelin is secreted by the gut and is the only known hormone to stimulate food intake 
(Cummings, Foster 2003). When administered to both lean and obese individuals 
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before an ad libitum buffet test meal, participants ate significantly more and reported 
higher subjective ratings of hunger than controls (Wren et al. 2001, Druce et al. 2005, 
Druce et al. 2006). Furthermore, ghrelin concentrations are thought to be suppressed 
by insulin (Flanagan et al. 2003, Shiiya et al. 2002), suggesting that the associated 
hyperinsulinaemia seen in obesity is responsible for decreased ghrelin in this 
populations and a possible mechanism for bodyweight regulation also (McLaughlin et 
al. 2004). There are two types of ghrelin, acylated and desacylated or unacylated, 
acylated ghrelin is considered to be the more active form and has the greatest 
influence on intake (Asakawa et al. 2005). Acylated ghrelin is thought to control short 
term energy balance as it is reportedly greater in a fasting state and suppressed 
postprandially, in proportion to the size of meal ingested (Callahan et al. 2004).  
 
Moreover, differing effects of exercise have been observed on both acylated and total 
ghrelin. Acute exercise has been seen to lower acylated ghrelin up to one hour post 
exercise (Broom et al. 2007, Broom et al. 2009) but not alter concentrations of total 
ghrelin (Dall et al. 2002, Burns et al. 2007). However, chronic exercise has reported 
no effects on acylated ghrelin (Kim et al. 2008) but increased total ghrelin 
concentrations have been seen after a one year exercise intervention, alongside 
significant weight loss (Foster-Schubert et al. 2005). This suggests that the ghrelin 
concentrations were increased in response to weight loss as part of feedback 
mechanism regulating body weight and without weight loss exercise would have no 
effect on total ghrelin concentrations (Borer 2008).  
 
Peptide YY (PYY) is another hormone that has a significant effect on energy intake 
and homeostasis. It is secreted in the small and large intestine by the L cells of the 
mucosa after food ingestion. Once again there are two forms of PYY, PYY1-36 and 
PYY3-36, PYY3-36 is the most common form found in the gut and circulation (Neary, 
Goldstone & Bloom 2004). PYY3-36 is secreted after food intake and concentrations 
begin to rise 15 minutes after ingestion, with peak concentrations reached up to two 
afters eating (Guo et al. 2006). Increased levels of PYY3-36 have been shown to 
suppress food intake through receptor action in the hypothalamus (Neary, Goldstone 
& Bloom 2004), demonstrated by exogenous infusion (Batterham et al. 2002) where 
food intake was reduced by 33%  when compared to a saline control. Batterham et al. 
(2002) also observed lower fasting total PYY concentrations in obese individuals but 
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no differences have been seen in PYY3-36 concentrations between lean and obese 
participants (Pfluger et al. 2007), suggesting obesity is not characterised by impaired 
PYY action.  
 
Previous investigations have shown that PYY concentrations are significantly 
increased during exercise but this increase is short lived as no differences were seen 
one hour after exercise; both lean (Martins et al. 2007) and obese subjects (Ueda et al. 
2009) displayed this same effect. Additionally, long term exercise interventions have 
revealed significant decreases in PYY concentrations but these studies also showed 
significant weight loss (Roth et al. 2005, Jones et al. 2009). Research investigating the 
effects of exercise on PYY3-36 is limited and at present the findings have been 
contradictory. Previously, 60 minutes of moderate intensity cycling (60% ?̇?O2MAX) 
did not reveal any significant changes in PYY3-36 concentrations (Cheng et al. 2009). 
However, in a another study 90 minutes of running at 70% ?̇?O2MAX increased PYY3-36 
concentrations by as much as 27% (King et al. 2011). The conflicting results here 
could be explained by the differences in either intensity or duration in exercise but the 
findings suggest higher intensity or longer duration exercise is needed to increase 
PYY3-36 levels. To date, the long term effects of exercise on PYY3-36 have not been 
investigated. 
 
Chronic exercise and energy homeostasis 
 
It has previously been stated that energy storage will only increase if energy intake 
exceeds total energy expenditure (Spiegelman, Flier 2001). This assumes that if we 
increase energy expenditure through increasing physical activity we will create an 
energy deficit and reap the much reported benefits of exercise. However, as we have 
discussed in this chapter there are many different factors which can influence both 
sides of the equation, altering the responses to exercise. Research investigating the 
long term effects of exercise on the regulation of energy balance has been limited, 
with many studies employing dietary restriction to achieve weight loss. Based on 
previous findings it is evident that in the case of long term exercise with ad libitum 
energy intake, participants will subsequently increase energy intake to compensate the 
increased expenditure. However, this does not take into account the influence of 
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potential training adaptations which may alter one of the many mechanisms discussed 
and thus their response to exercise. 
 
To date, it seems that chronic exercise has very little effect on leptin concentrations, 
where training effects have been seen, these have been dependent on reduced fat mass 
(Kraemer et al. 1999, Ozcelik et al. 2004). Moreover, training load seems to have no 
effect either, as varying training levels showed no differences in reported leptin 
concentrations (Ishigaki et al. 2005, Desgorces et al. 2004). However, in a yearlong 
training intervention study with overweight men and a combination of resistance and 
aerobic exercise, a significant reduction in leptin was observed (Miyatake et al. 2004). 
This coincided with significant gains in strength and decreases in weight, fasting 
insulin and fat mass, indicating significant metabolic and endocrine responses to 
training may be dependent on training modality. 
 
Furthermore, from the long term exercise interventions with significant metabolic and 
endocrine alterations post training, it seems evident that resistant training has been 
key to achieving these outcomes (Miyatake et al. 2004, Brooks et al. 2006). Studies 
utilising aerobic exercise interventions have been shown to improve insulin sensitivity 
but these have implemented some kind of dietary restriction (van der Heijden et al. 
2012) making it difficult to attribute these findings to exercise and not diet. In a 
further study, investigating exercise modality and insulin resistance (Davidson et al. 
2009)(Davidson et al. 1994)(Davidson et al. 1994)(Davidson et al. 1994), to isolate 
the effect of exercise, sedentary obese men and women were prescribed a minimum 
energy diet to maintain baseline bodyweight and participants were encouraged to eat 
healthily with 4 weeks familiarisation. Participants were split into aerobic training, 
resistance training and combined training groups and after 6 months the combined 
training group saw the greatest improvements in insulin resistance, the aerobic group 
also improved but the resistance group did not. It has been suggested that the 
contractile activity during exercise is the significant driver behind the improved 
insulin sensitivity and not just the increase in lean mass (Holloszy 2005).  
 
The effect of chronic exercise on amylin concentrations is yet to be examined but 2 
weeks of exercise and diet restriction did bring about a 36% reduction in amylin post 
intervention (Izadpanah et al. 2012). It seems logical that the effects of a long term 
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exercise intervention would be similar to those observed in insulin. In support of this, 
the findings after acute exercise in amylin concentrations follow those seen in insulin; 
moderate intensity (<75% ?̇?O2MAX) exercise had no effect on either amylin (Kraemer 
et al. 2004) or insulin (Kreisman et al. 2000) but high intensity (>85% ?̇?O2MAX) 
exercise increased both amylin (Kraemer et al. 2004) and insulin levels (Kraemer, 
Chu & Castracane 2002). Evidently, more research is needed to understand the role of 
amylin in the regulation of energy balance during chronic exercise.  
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Aim of thesis 
 
Worldwide we our suffering from an obesity epidemic and this can be primarily 
attributed to an increased consumption of refined carbohydrates and sugars, as well as 
an ever increasing sedentary population. Now more than ever, we need to understand 
how and why this is happening in order to reduce the considerable negative effects on 
our society. 
 
The general aim of this thesis is to improve the current knowledge of the mechanistic 
pathways involved in the development of obesity. More specifically, to investigate the 
damaging effects of high glucose availability on skeletal muscle metabolism, typically 
seen in sedentary individuals with a diet high in refined carbohydrates and sugars. In 
particular, this thesis will focus on the contribution of high sugar-sweetened beverage 
consumption and their role in the growing prevalence of obesity. Gene expression 
analysis has been used to identify alterations in metabolic enzyme expression and 
transcription factors important in the regulation of glucose. In vivo and in vitro studies 
have been used to identify both the periodic and chronic effects of high glucose 
availability on metabolism. 
 
Furthermore, it is also the aim of this thesis to investigate the influence of chronic 
exercise on metabolism of lean and obese sedentary populations. Experiments have 
been designed to improve the understanding of how lean and obese individuals 
respond to exercise and how they differ in key regulatory processes of whole body 
and cell metabolism. A novel approach to long-term exercise interventions has been 
utilised, where participants are naïve to nature of the experiments and its end goals, 
this has been combined with ad libitum energy intake to gain a more accurate view of 
the mechanisms controlling energy homeostasis in both populations.  
 
Research questions 
 
Chapter 2: How does 4 weeks periodic high glucose availability (sugar-sweetened 
beverage consumption) alter metabolism of young, healthy, lightly active individuals? 
How does chronic hyperglycaemia affect the cell metabolism of human primary 
skeletal muscle cells? 
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Chapter 3: How does 4 weeks moderate intensity exercise training, with ad libitum 
energy intake, affect the body composition, metabolism and energy balance, of lean 
and obese sedentary women? 
 
Chapter 4: How does 8 weeks high and low intensity exercise training, with ad 
libitum energy intake, affect the body composition, metabolism and energy balance, 
of lean and obese sedentary women?  
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CHAPTER II 
 
METABOLIC ALTERATIONS IN RESPONSE TO 4 WEEKS SUGAR-
SWEETENED BEVERAGE CONSUMPTION IN HEALTHY, LIGHTLY 
ACTIVE INDIVIDUALS AND CHRONIC HIGH GLUCOSE AVAILABILITY 
IN PRIMARY HUMAN MUSCLE CELLS 
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Introduction 
 
The consumption of SSBs has increased over the past four decades, with the 
percentage of adults drinking SSBs in the US rising from 58% between 1988 and 
1994 to 63% between 1999 and 2004 (ERS 2004) and the association between obesity 
and SSB consumption has been well documented (Nissinen et al. 2009, Olsen, 
Heitmann 2009, Hu, Malik 2010, Ludwig, Peterson & Gortmaker 2001, Ebbeling, 
Pawlak & Ludwig 2002, Schulz et al. 2002, St-Onge, Keller & Heymsfield 2003, 
Berkey et al. 2004, Bray, Nielsen & Popkin 2004, Gross et al. 2004, James, Kerr 
2005, Bes-Rastrollo et al. 2006, Malik, Schulze & Hu 2006, Dhingra et al. 2007, 
Vartanian, Schwartz & Brownell 2007, Palmer et al. 2008, Bleich et al. 2009, Fung et 
al. 2009). Moreover, obesity is greatly associated with type 2 diabetes mellitus and 
insulin resistance (Wannamethee, Shaper 1999) and consequently a diet high in 
refined carbohydrates and sugars has been seen shown to be related to the 
development of this condition (Hu, Malik 2010, Gross et al. 2004, Vartanian, 
Schwartz & Brownell 2007, Palmer et al. 2008, Bleich et al. 2009, Liu 2002, Yoshida 
et al. 2007, Mohan et al. 2009, Stanhope et al. 2009).  
 
The increase in dietary refined carbohydrates and sugars such as those in SSBs, 
produces a large rise in glucose availability (Foster-Powell, Miller 1995) and 
continuous high energy food intake and a lack of energy expenditure, challenge the 
normal regulation of blood glucose levels (Manson et al. 1992), eventually weakening 
the system so that periods of hyperglycaemia following carbohydrate ingestion are 
extended. In turn this can influence several signalling pathways, causing adaptations 
to skeletal muscle which contribute to reduced oxidative capacity and insulin 
sensitivity. This leads to the assumption that high carbohydrate diets combined with 
low physical activity can cause prolonged periods of hyperglycaemia even in 
individuals with normal glucose tolerance and if continued they can lead to 
development of a low oxidative capacity and impaired insulin signalling pathways, 
usually described as a diabetic phenotype. Moreover, high glucose availability has 
been widely recognized as a cause of insulin resistance in skeletal muscle (Fell et al. 
1982, Richter, Hansen & Hansen 1988a, Richter, Hansen & Hansen 1988b, Hansen et 
al. 1992, Davidson et al. 1994, Gulve et al. 1994, Kawanaka et al. 2001, Kawanaka et 
al. 1999, Oku et al. 2001, Han, Chen & Holloszy 2003).  
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After refined carbohydrate and sugar ingestion, glucose is absorbed by the gut and 
there is an increase in blood glucose levels, through insulin action this glucose is 
taken up by skeletal muscle and used in anyone of numerous cellular processes. 
Recently, new evidence has demonstrated that glucose and its metabolites are sensed 
in the muscle cell by specific molecules stimulating regulatory gene expression 
(Desvergne, Michalik & Wahli 2006). One of these molecules, the transcription factor 
MondoA, has been demonstrated to be a master regulator of glycolytic genes, 
activating the transcription of many genes encoding metabolic enzymes (Sans et al. 
2006).  In the muscle cell, MondoA and its heterodimerisation partner max-like 
protein x (Mlx) form a complex under high glucose conditions (Billin et al. 2000), 
which up regulates glycolytic gene expression. Moreover, the MondoA:Mlx complex 
has been shown to activate thioredoxin-interacting protein (TXNIP) (Stoltzman et al. 
2008), which has previously been shown to reduce glucose uptake (Parikh et al. 
2007). TXNIP mRNA has also been shown to be expressed more highly in pre-
diabetic and diabetic patients (Parikh et al. 2007). This suggests, chronic high glucose 
availability leads to metabolic alterations in skeletal muscle through the promotion of 
MondoA activity. These alterations may include the inhibition of glyceradehyde-3-
phoshate dehydrogenase (GAPDH), causing profound effects on glycolytic capacity 
(Bouche et al. 2004). Moreover, it is highly likely that the high glucose availability 
will reduce oxidative capacity of skeletal muscle, as seen in obese and diabetic or 
insulin resistant individuals (Kelley, Mandarino 1990, Kelley et al. 1999). Other 
impairments of skeletal muscle in this population include, decreased mitochondrial 
ATP synthesis, less oxidative fibres compared to glycolytic fibres, decreased 
glycogen synthesis and significantly lower expression of PGC1α (Mootha et al. 2003, 
Patti et al. 2003, Lowell, Shulman 2005). Finally, it should be possible to see these 
alterations in sedentary individuals’ with diets high in refined carbohydrates and 
sugars, typically seen in SSBs, as they will not be able to combat the damage caused 
by periodic high glucose availability with increased glucose clearance through of 
physical activity. In this chapter, both in vitro and in vivo studies have been 
conducted to analyses the impact of chronic and periodic high glucose availability on 
skeletal muscle metabolism. 
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In vitro study 
 
The effects of chronic hyperglycaemia were examined on primary muscle cell 
cultures for 7 days and compared to control conditions. The in vitro effects of the high 
glucose conditions on metabolic gene expression were measured using real-time RT-
PCR. Additionally, western blot analyses were used to scrutinize the impact of the 
chronic hyperglycaemia on protein expression of the same markers. It was assumed 
that the in vitro chronic hyperglycaemia would display similar metabolic alterations 
seen in type 2 diabetes patients; elevated glycolytic and lipogenic activity and reduced 
oxidative activity. Finally, it was also hypothesised that the chronic hyperglycaemic 
conditions would increase MondoA and TXNIP expression.  
 
Methods 
 
Muscle biopsies 
 
Muscle biopsies were taken with a 14-gauge needle (14ga x 10cm, Tru∙Core® II 
Biopsy instrument, Angiotech, Gainesville, FL, USA). Following local anaesthesia 
(1% lignocaine), 2 needle muscle biopsies were collected from the vastus lateralis of 
the left leg, at a mid-distance between the greater trochanter and the femorotibial 
joint. Upon collection biopsies were snap-frozen and stored in liquid nitrogen until 
later use. 
 
Primary cell cultures 
 
Satellite cells were isolated from four muscle biopsies of healthy male subjects (age 
38 ± 13 yrs, height 1.79 ± 0.06 m, weight 72 ± 6 kg). After collection, biopsies were 
immediately transferred to RT skeletal muscle growth medium (SMGM) with 5% 
foetal calf serum (FCS), 1% L-glutamine with pencillin/streptomycin plus 
supplements (PromoCell, Heidelberg, Germany), and washed twice in medium. 
Disintegration was then performed with surgical blades and 0.05% trypsin (PAA, 
Pasching, Austria) in PBS for 30 minutes, trypsination was stopped by trypsin 
inhibitor (Sigma-Aldrich, St. Louis, MO, USA) to give a final concentration of 0.14 
mg/ml. Cells were centrifuged at 800 x g for 5 minutes at 10oC, pellets were then re-
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suspended in accutase (PAA, Pasching, Austria) and incubated for 20 minutes at 
37oC. Following sedimentation, the cell suspension was centrifuged once more at 800 
x g for a further 5 minutes at 10oC, cell pellets were then re-suspended in SMGM with 
5% FCS, and 1% L-glutamine with pencillin/streptomycin plus supplements 
(PromoCell, Heidelberg, Germany). This cell suspension was then transferred into 75 
cm2 tissue culture flasks (Greiner, Frickenhausen, Germany) and incubated at 37oC, 
with 5% CO2 and 95% humidity until passage. Half-medium change was performed 
every 2nd day and 3 passages were completed before the initiation of differentiation. 
After initiation of differentiation in Dulbecco’s modified eagle medium (DMEM; 
PAA, Pasching, Austria) with 2% FCS for 4 days, the primary myotubes were tested 
for creatine kinase activity. For the cultivation of differentiated myocytes, grown on 
microcarriers, 5 x 106 cells per 10 ml medium were seeded on microcarriers in 
suspension (0.015g microcarriers, CultiSpher- GL; Percell Biolytica, Astorp, Sweden) 
using 25 cm2 flasks. To guarantee sufficient O2 supply to the cells and to prevent the 
cells and microcarriers from settling down, flasks were kept on a circular shaker at 
53rpm. After 12 days of differentiation myotubes were exposed to high glucose, 
DMEM with 2% FCS , 15 mM D-glucose (Sigma-Aldrich, St. Louis, MO, USA) and 
10 µg/ml insulin (Actrapid, Novo Nordisk A/S, Bagsvaerd, Denmark). Control 
myotubes were cultivated in DMEM with 2% FCS, 5 mM D-glucose and 10 µg/ml 
insulin. Exposure time for both conditions was 7 days.  
 
Cell harvest and western blotting 
 
Myotubes on microcarriers were washed with PBS, lysed and denatured using SDS-
PAGE sample buffer at 95oC for 3 minutes and then cooled on ice. Samples were 
cleared by centrifugation at 16000 x g in QIAshredder columns (Qiagen, Hilden, 
Germany) and the eluates were frozen in liquid nitrogen and stored at -80oC until later 
use. Nuclear and cytoplasmic fractions of myotubes, from both high glucose and 
control conditions, were prepared using a nuclear extraction kit, according to the 
manufacturer’s protocol (Nuclear extraction kit (No400010/No40410), Active-Motif, 
Rixensart, Belgium). Protein content of samples was assessed by Lowry protein assay 
(Sigma-Aldrich, St. Louis, MO, USA). 5 or 10% SDS-PAGE was used to separate 
equal amounts of protein per lane; these were then transferred to nitrocellulose 
membrane (Hybond ECL 6 x 8cm, GE Healthcare, Amersham, Slough, UK). India 
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ink staining of membranes was used for loading control. Once membranes were 
blocked in PBS (containing, 0.2% tween, and 5% low-fat dry milk), blots were probed 
with primary antibodies for 4 hours, for ACC (H-76; sc-30212) with a 1:250 dilution, 
FUM (J-13; sc-100743) at 1:2000, and GAPDH (0411; sc-47724) at 1:10000 
(Antibodies provided by Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA). 
MondoA (Sans et al., 2006) at at1:500 and TXNIP (MBL, Nakaku Nagoya, Japan) at 
1:1000 were incubated overnight. Goat anti-rabbit, IgG-HRP, 1:15000 (Sigma-
Aldrich, St. Louis, MO, USA) and goat anti mouse, IgG-HRP, 1:5000 (Santa Cruz 
Biotechnology Inc, Santa Cruz, CA, USA) were used. ECL (Amersham Hyperfilm 
ECL, 18 x 24cm, GE Healthcare Life Sciences, Little Chalfront, UK) detection was 
performed using SuperSignal West Pico and Femto ECL kits (Pierce, Rockford, IL, 
USA). For re-probing membranes were stripped for 45 minutes at 50oC in striping 
buffer (10% SDS, 0.5M Tris, pH 6.8, and 0.8% β-mercaptoethanol),  and washed for 
1 hour. Protein bands were quantified using densitometry (Gel Doc 2000 and software 
Quantity One 4.6.3, Bio-Rad, Hercules, CA, USA). 
 
Real-time RT-PCR 
 
Total RNA was isolated from frozen muscle biopsies using RNeasy kit (Qiagen Ltd, 
Crawley, West Sussex, UK). RNA concentration was measured at 260nm and 280nm 
using spectrophotometry (Double-Beam Spectrophotometer (U-2800A), Hitachi 
High-Technologies Pte Ltd, Singapore) and purity of RNA was assessed using a ratio 
of 260/280nm. cDNA was synthesised from 50ng RNA using sensiscript reverse 
transcription kit (Qiagen) and thermal cycler (Auto Q Server Gradient Thermal 
Cycler, Quanta Biotech, Byfleet, Surrey, UK) at 37oC for 60 minutes, after heating  
for 5 minutes at 65oC. cDNA was stored at -80oC until use. Real-time RT-PCR was 
performed using Applied Biosystems 7900HT fast real-time PCR system (Applied 
Biosystems, Carlsbad, California, USA) and 2x Quantitect SYBR green PCR master 
mix (Qiagen). Primers for each gene were selected from published sources or 
designed using reference mRNA sequences (National Center for Biotechnology 
Information, National Library of Medicine, Bethesda, MD, USA) and Primer3 
software (http://frodo.wi.mit.edu/primer3/). All primers were confirmed for 
homologous binding to desired mRNA targets by conducting a BLAST search 
(http://blast.ncbi.nlm.nih.gov/), once chosen primers were synthesised (Eurofins 
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MWG Operon, Ebersberg, Germany). Table 2.2, shows details of each primer set. 
Each gene was measured in all samples simultaneously, and all samples were 
measured in duplicate. 18s rRNA was used as an endogenous control to normalise 
gene expression. Each reaction contained PCR master mix, forward and reverse 
primers (0.3 µM), RNase free water and 2.5 µl cDNA in 25 µl final volume. Thermal 
cycling conditions were as follows: PCR initial activation step 15 min at 95oC, then 3 
step cycling of 15 s denaturation at 94oC, 30 s annealing 50-60oC (varies with primer) 
and 30 s extension at 72oC for 45 cycles. Melting curves performed after all runs 
showed single products in each case. Critical threshold (CT) values were recorded for 
target gene and endogenous control and used to quantify mRNA expression. Standard 
curve method was used to quantify relative amounts of mRNA for each gene, this was 
done by preparing a 10x dilution series of template cDNA for both target gene and 
endogenous control and run simultaneously with all samples.  
 
Gene Accession 
No. 
Primer Sequence Product 
Size (bp) 
MondoA NM_014938 F: TGACTTTGGCCTACAGTGGG 
R: TTGCGCTTCTCCAGATACTGC 
139 
TXNIP NM_006472 F: CTGGCGTAAGCTTTTCAAGG 
R: AGTGCACAAAGGGGAAACAC 
185 
PGC1α NM_013261 F: CCTGCATGAGTGTGTGCTCT 
R: GCAAAGAGGCTGGTCTTCAC 
164 
ACC α NM_198834 F: AGTGAGGATGGCAGCTCTGGA 
R: TGAGATGTGGGCAGCATGAAC 
132 
GAPDH NM_002046 F: GAAGGTGAAGGTCGGAGT 
R: GAAGATGGTGATGGGATTTC 
226 
Citrate 
Synthase 
NM_004077 F: CCATCCACAGTGACCATGAG 
R: CTTTGCCAACTTCCTTCTGC 
186 
18s NR_003286 F: GTAACCCGTTGAACCCCATT 
R: CCATCCAATCGGTAGTAGCG 
151 
Table 2.2. Primer pairs for each gene analysed in the present study including, forward 
and reverse primer sequences, accession numbers and product sizes for each gene. 
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Statistical Analysis 
 
All statistical analyses were performed using IBM SPSS Statistics 20. Differences 
between conditions were analysed by non-parametric Mann-Whitney U tests. 
Pearson’s correlations were used to analyse relationships between variables. All data 
are reported as means ± SD unless otherwise stated. Statistical significance was set 
at P<0.05.  
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Results 
 
Primary human myotubes were isolated from biopsies of healthy male subjects and 
grown on microcarriers. After 12 days of differentiation, cells were exposed to either 
high glucose (15mM glucose, 10µg/ml insulin) or control conditions (5mM Glucose, 
10µg/ml insulin) for 7 days. Cell harvest was performed and western blotting and real 
time RT-PCR was used to assess any potential metabolic alterations at protein and 
gene level. 
 
Fig. 2.5. Primary human myotubes grown on microcarriers in culture (A) and seeded 
in culture flasks (B). Image captured with light inverted microscope (Eclipse TS100, 
Nikon, Kawasaki, Japan) 20x magnification. 
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Protein expression in primary human myotubes 
 
Western blot analysis of cell homogenates showed that seven days of high glucose 
availability significantly increased protein levels of glycolytic marker GAPDH and 
lipogenic marker ACC when compared to control conditions (173 ± 32 % and 177 ± 
18 % of control, P = <0.05, respectively). Oxidative marker FUM levels were 
unaffected by the 7 days hyperglycaemia (91 ± 30 % of controls, P = 0.44). Both 
MondoA and TXNIP expression levels were also elevated in the cells under high 
glucose conditions (190 ± 30 % and 352 ± 47 % of control, P = < 0.05, respectively). 
A significant positive correlation between protein levels of MondoA and TXNIP was 
also observed (r = 0.87, P = 0.011).  
 
 
Fig. 2.6 A. Western blot analysis of MondoA in primary muscle cell cultures, under 
conditions of normal glucose (N-Gluc (5mM)) and high glucose (H-Gluc (15mM)) 
with loading control alpha-actin. B. Quantification of MondoA and TXNIP western 
blots under normal and high glucose conditions, expressed as percentage of control 
(Sartor et al. 2013). Data are presented as means ± SEMs. * P = < 0.05 for differences 
between conditions. 
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Gene expression in primary human myotubes 
 
Real time RT-PCR analysis of cell homogenates revealed no significant difference in 
either MondoA or TXNIP gene expression between high and normal glucose 
conditions (83 ± 8 % and 111± 16 % of controls, respectively). Further analysis of 
metabolic enzyme gene expression under differing glucose concentrations also 
displayed no significant differences between measurements of GAPDH and ACC 
(129 ± 27 % and 128 ± 41 % of controls, respectively), although a decrease in the 
marker of mitochondrial gene expression PGC1α was observed under high glucose 
availability (70 ± 14 % of control, P = 0.05).  
 
 
Fig. 2.7 MondoA and TXNIP gene expression under conditions of normal glucose (N-
Gluc (5mM)) and high glucose (H-Gluc (15mM)). Data are presented as means ± 
SEMs. 
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Fig. 2.8 Metabolic gene expression under conditions of normal glucose (N-Gluc 
(5mM)) and high glucose (H-Gluc (15mM)). GAPDH glyceraldehyde-3-phosphate 
dehydrogenase, ACC acetyl-CoA carboxylase α, PGC1α peroxisome proliferator-
activated receptor-gamma coactivator 1 α,. Data are presented as means ± SEMs. * P 
= < 0.05 for differences pre and post between conditions. 
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In vivo 
 
In this chapter, the effects of periodic high glucose availability in the form of a 4 
weeks sugar-sweetened beverage (SSB) consumption was investigated on the 
metabolism of healthy, lightly active, normal weight individuals, with very little or no 
history of previous soft drink consumption. To analyse the effects of the SSB 
intervention in vivo, muscle biopsies were taken from vastus lateralis of participants 
and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was 
conducted to measure metabolic gene expression. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and acetyl-CoA carboxylase (ACC) were used as markers 
of glycolytic and lipogenic markers respectively, citrate synthase (CS) and 
peroxisome proliferator-activated receptor-gamma coactivator 1α (PGC1α) were used 
to reflect mitochondrial activity. Additionally, glucose sensing transcription factors 
MondoA and thioredoxin-interacting protein (TXNIP) gene expression was also 
analysed to measure the impact of SSB consumption on glucose metabolism and 
regulation. It was expected that the periodic high glucose availability would shift the 
participants’ metabolism towards more carbohydrate use, promoting an elevation in 
glycolytic and lipogenic gene expression, GAPDH and ACC. Subsequently, it was 
hypothesised that mitochondrial gene expression, CS and PGC1α, would reduce 
during the SSB consumption and it was also expected that MondoA and TXNIP 
expression would be elevated following the intervention. Finally, the effects of the 
SSB consumption on whole body metabolism and protein expression in skeletal 
muscle were also investigated. 
 
Methods 
 
Participants and study design 
 
Eleven (5 male and 6 female) healthy subjects with low physical activity were 
recruited to take part in the study after an initial screening for lifestyle and (sugar-
sweetened beverage) SSB consumption via qualitative questionnaire. Only people 
consuming less than 500ml of SSB per week were considered eligible to take part in 
the study (32 out of 213 people who completed the questionnaire). Baseline 
anthropometric characteristics for participants are presented in table 2.1. Participants 
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were informed they would receive £100 for compensation of their time upon 
completion of the study. All subjects in the study underwent a 4-week SSB 
supplementation period and various pre and post anthropometric, metabolic, blood 
and muscle biopsy measures were carried out. Tests were conducted across two visits 
to the laboratory and before each test participants were asked to refrain from any 
exercise for a 24 hour period. All post-tests were completed at least 36 hours after the 
last SSB supplementation.  
 
Parameters (units) Baseline Post-intervention 
Age (yr) 26 ± 7  
Weight (kg) 65.9 ±10 66.8 ± 11 
BMI (kg/m2) 
DXA 
21.6 ± 1.5 22.0 ± 1.8# 
Fat mass (kg) 15.2 ± 5.1 16.2 ± 4.7* 
Lean mass (kg) 
Blood Lipids 
48.1 ± 12.6 48.0 ± 13.0 
 
Total Cholesterol 
(mmol/L) 
4.27 ± 0.89 4.42 ± 0.73 
Triglycerides (mmol/L) 1.01 ± 0.36 1.02 ± 0.33 
HDL (mmol/L) 1.30 ± 0.21 1.29 ± 0.22 
LDL (mmol/L) 2.52 ± 0.75 2.67 ± 0.64 
 
Table 2.1.  Anthropometric data of all participants before and after the 4 weeks SSB 
supplementation. Data are presented as means ± standard deviation. * P < 0.05, # P 
< 0.10. 
 
Study intervention 
 
Lucozade Energy (Lucozade energy, GlaxoSmithKline plc, Harlow, UK; Ingredients: 
carbonated water, glucose syrup, orange juice from concentrate, citric acid, 
preservatives (sodium benzoate, sodium bisulphate, flavourings (including caffeine), 
stabiliser (acacia gum), antioxidant (ascorbic acid) and colour (beta carotene)) was the 
chosen SSB for the 4 weeks SSB supplementation, this was provided to participants 
by the experimenters on top of their habitual diet. Supplementation was calculated on 
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the basis of 2 grams per kilogram bodyweight carbohydrate intake per day. On 
average this equated to 760 ml SSB per subject per day.  
 
Anthropometry 
 
Body mass was measured to using a beam balance scale (Seca, Hamberg, Germany), 
participants were instructed to wear minimal clothing, remove footwear and empty 
their pockets whilst being weighed. Height was measured using a wall mounted 
stadiometer (Bodycare products, Southam, United Kingdom). Body composition (lean 
mass, fat mass and percentage body fat) bone mineral density were measured using 
dual-energy x-ray absorptiometry (DEXA; QDR 4500, Hologic, Bedford, MA, USA). 
 
Indirect calorimetry 
 
Participants were instructed to arrive at the laboratory after a 12 hour overnight fast 
and well rested, having refrained from any exercise for 48 hours prior to 
measurement. The meal prior to indirect calorimetry and blood and muscle sampling 
was controlled according the World Health Organisation (WHO 2006) 
recommendations for oral glucose tolerance tests. Respiratory exchange ratio (RER; 
?̇?CO2/?̇?O2) was measured by indirect calorimetry (Metalyzer 3B, Cortex Biophysik, 
GMBH, Leipzig, Germany) following published guidelines (da Rocha, Alves & da 
Fonseca 2006) as participants lay awake in a supine position for 30 minutes. Substrate 
oxidation rates were also calculated based on indirect calorimetry (Frayn 1983). 
Ambient temperature (20oC) and humidity (40%) were kept constant during 
measurement through use of a climate chamber.  
 
Energy and macronutrient intake  
 
Participants were asked to maintain their normal diet and complete a 7 day diet diary 
before and after the 4 weeks SSB supplementation, using food record sheets provided 
by the researchers. Additionally, a 14 day diet diary was completed during the 4 
weeks supplementation. Participants were instructed to complete the diet diaries using 
standardised instructions (Gibson 1993) and the importance of accuracy and precision 
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when reporting was emphasised. The United States Department of Agriculture, 
National Nutrient Database for Standard Reference (http://ndb.nal.usda.gov/) and the 
Tesco Supermarket online database (http://www.tesco.com/groceries/) were used to 
assess energy intake and macronutrient composition.  
 
Blood sampling and analysis 
 
Overnight fasting venous blood (4ml) was collected from the antecubital vein of each 
participant in heparinised vacutainers, a 75g oral glucose load was then administered 
and precisely 1 hour after consumption a second venous blood sample was collected. 
Following collection whole blood was centrifuged at 3000rpm for 10 minutes at 4oC 
and plasma was separated. Plasma glucose (YSI 2300 STAT, Incorporated Life 
Sciences, Yellow Springs, OH, USA) and lipid profile (Reflotron®, Roche 
Diagnostics, Mannheim, Germany) were measured in fasting plasma. Plasma samples 
were then stored at -40oC for later insulin analysis by ELISA (Ultrasensitive human 
insulin ELISA, Mercodia, Uppsala, Sweden). The Homeostasis Model Assessment 
(HOMA) was used to calculate beta cell function (%B), insulin resistance (IR) and 
insulin sensitivity (%S) from fasting plasma insulin and glucose (Wallace, Levy & 
Matthews 2004).  
 
Muscle biopsies 
 
Muscle biopsies were taken one hour after glucose load with a 14-gauge needle (14ga 
x 10cm, Tru∙Core® II Biopsy instrument, Angiotech, Gainesville, FL, USA). 
Following local anaesthesia (1% lignocaine), 2 needle muscle biopsies were collected 
from the vastus lateralis of the left leg, at a mid-distance between the greater 
trochanter and the femorotibial joint. Post-test biopsies were taken 0.5-1cm from the 
pre-test biopsies. Upon collection biopsies were snap-frozen and stored in liquid 
nitrogen until later use. 
 
Real-time RT-PCR 
 
Frozen muscle biopsies (15.6 ± 0.3 mg) were pulverized (1900 rpm for 15 seconds) at 
liquid nitrogen temperature using a micro-dismembrator (Sartorius-Stedim Biothec, 
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Goettingen, Germany).  Total RNA was isolated from frozen muscle biopsies using 
RNeasy fibrous tissue kit (Qiagen Ltd, Crawley, West Sussex, UK). RNA 
concentration was measured at 260nm and 280nm using spectrophotometry (Double-
Beam Spectrophotometer (U-2800A), Hitachi High-Technologies Pte Ltd, Singapore) 
and purity of RNA was assessed using a ratio of 260/280nm, total RNA 
concentrations averaged 108 ± 37 µg/ml. Following RNA extraction the same 
protocol for real-time RT-PCR from the cell culture experiments was replicated as 
stated earlier in the chapter 
 
Western blotting and myosin heavy chain (MHC) analysis  
 
Frozen muscle biopsies and 150µl frozen buffer containing, 10% PBS, 5% protein 
phosphatase inhibitors, 0.1% 1M DTT, 0.05% protease inhibitor and 0.1% detergent 
(Nuclear Extraction Kit, Acrivemotif, Rixensart, Belgium) were pulverized (1900 rpm 
for 15 seconds) using a micro-dismembrator (Mikro-Dismembrator S, Sartorius-
Stedin Biotech, Goettingen, Germany), all equipment was cooled to liquid nitrogen 
temperature. Pulverized muscle and buffer was thawed on ice and centrifuged at 
20000 x g at 4oC for 5 minutes and the resulting supernatant was used to measure 
ACC, FUM, GAPDH and TXNIP expression levels. Pellets were extracted using an 
ultrasonic processor (VCX 130, Sonics & Materials INC, Newton, CT, USA) with 
myosin extraction buffer (0.6M KCL, 1mM EGTA, 10mM sodium phosphatedibasic, 
1mM PMSF, pH 6.8) on ice at 0oC. Following this extracts were centrifuged at 20000 
x g for 20 minutes at 4oC, crude nuclear membrane fractions were then re-suspended 
in SDS sample buffer, these were used to measure MondoA expression levels. As per 
real-time RT-PCR, western blotting procedure was replicated using the same 
procedures from the in vitro study. Furthermore, MHC extraction and electrophoresis 
was carried out as previously described in (Sartor et al. 2010). 
 
Statistical Analysis 
 
All statistical analyses were performed using IBM SPSS Statistics 20. Differences pre 
and post intervention of the in vivo study were analysed by paired samples t-tests. 
Differences between male and female participants were analysed at baseline by 
independent samples t-tests before pooling genders. Pearson’s correlations were used 
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to analyse relationships between variables. All data are reported as means 
± SD. Statistical significance was set at P<0.05. Due to a viral infection one 
participant in the in vivo study was unable to attend the post-test oral glucose 
tolerance test and muscle biopsy, because of this only body composition, energy and 
macronutrient intake data were used for this participant in the statistical analysis.  
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Results 
 
11 healthy, lightly active, normal weight individuals, with very little or no previous 
soft drink use, consumed SSBs for 4 weeks (2 grams of carbohydrate per kilogram 
bodyweight), on top of their habitual diet. DXA scans, indirect calorimetry, venous 
blood and muscle biopsies were collected to assess any potential metabolic 
alterations. 
 
Body composition, diet diary analysis and indirect calorimetry 
 
The analysis of the body composition by DXA revealed a significant increase in fat 
mass post SSB supplementation but lean mass and weight remained unchanged (Table 
2.1). Diet diary analysis showed no alteration in energy intake during the SSB 
supplementation however, a significant increase in carbohydrate (pre, 264 ± 72 g/d, 
post, 347 ± 65 g/d, P = 0.005) and sugar intake (pre, 98.6 ± 40.2 g/d, post, 183.9 ± 
32.1 g/d, P = <0.001) were reported, this coincided with a significant decrease in 
protein (pre, 83.4 ± 21.1 g/d, post, 71.0 ± 23.2 g/d, P = 0.008), total fat (pre, 93.1 ± 
33.5 g/d, post, 72.5 ± 34.8 g/d, P = 0.05) and PUFA (pre, 10.7 ± 5.1 g/d, post, 7.4 ± 
4.6 g/d, P = 0.04). SFA showed a trend towards a decrease (pre, 41.8 ± 19.0 g/d, post, 
31.7 ± 16.9, P = 0.08) and MUFA and dietary fibre remained unchanged (pre, 40.6 ± 
15.7 g/d, post, 33.3 ± 17.6 g/d, P = 0.12; pre, 19.6 ± 5.9 g/d, post, 18.5 ± 5.8 g/d, P = 
0.29, respectively). Analysis of resting substrate metabolism by indirect calorimetry 
showed a significant increase in RER (pre, 0.75 ± 0.09 AU, post, 0.87 ± 0.08 AU, P = 
0.039) (Fig. 2.1 B) and further analysis of substrate oxidation rates revealed a shift in 
metabolism of preferred substrate, from a high level of fat oxidation at baseline to an 
altered high level of carbohydrate oxidation after the SSB supplementation period 
(Fat: pre, 67.5 ± 48.9 %, post, 22.7 ± 23.8 %; Carbohydrate: pre, 32.5 ± 48.9 %, post, 
77.3 ± 23.8 %) (Fig. 2.1 A).  
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Glucose levels and insulin sensitivity 
 
The 4 weeks SSB supplementation significantly increased fasting plasma glucose 
levels and a trend towards increased plasma insulin levels was also observed (pre, 
4.83 ± 0.43 mmol/L, post, 5.13 ± 0.38 mmol/L, P < 0.05; pre, 4.95 ± 1,90 mU/L, post, 
6.40 ± 1.62 mU/L, P = 0.09, respectively) (Fig. 2.2). In addition, HOMA 2 
calculations demonstrated a trend towards a decrease in %S and an increase in IR 
(pre, 158 ± 47, post, 126 ± 32, P = 0.06; pre, 0.68 ±0.19, post, 0.84 ± 0.20, P = 0.08, 
respectively), %B remained unchanged (pre, 76.6 ± 28.4, post, 81.3 ± 21.8, P = 0.57). 
Blood lipids were unaffected by the SSB intervention (Table 2.1). 
 
Fig. 2.1 A. Substrate oxidation rate derived from RER during indirect calorimetry 
after an overnight fast, pre and post 4 week SSB intervention. B. RER (VCO2/VO2) 
pre and post 4 week SSB intervention measured by indirect calorimetry after an 
overnight fast (Sartor et al. 2013). Data are presented as means ± SEMs. * P = < 0.05 
for differences pre and post intervention. 
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Fig. 2.2 A. Plasma glucose levels after an overnight fast pre and post 4 week SSB 
intervention. B. Plasma insulin levels after an overnight fast pre and post 4 week SSB 
intervention (Sartor et al. 2013). Data are presented as means ± SEMs. * P = < 0.05 
and # P = < 0.10 for differences pre and post intervention. 
 
Myosin heavy chains and protein expression in skeletal muscle biopsies 
 
Western blot analysis of metabolic markers, GAPDH, ACC and FUM  showed no 
significant changes post supplementation (pre, 1.00 ± 0.24 AU, post, 0.93 ± 0.37 AU, 
P = 0.393; pre, 1.00 ± 0.55 AU, post, 0.84 ± 0.47 AU, P = 0.328; pre, 1.00 ± 0.35 AU, 
post, 0.79 ± 0.41 AU, P = 0.179, respectively). The transcription factor MondoA, in 
the crude nuclei membrane fraction of the muscle, demonstrated a clear trend towards 
an increase in protein content (pre, 1.00 ± 1.08 AU, post, 2.58 ± 2.46 AU, P = 0.08) 
(Fig. 2.3 A, B). Conversely, no significant alteration in TXNIP protein expression was 
observed (pre, 1.00 ± 0.38 AU, post, 1.24 ± 0.49 AU, P = 0.21) (Fig. 2.3 C, D). 
However, there was a positive correlation between changes of TXNIP and MondoA at 
the protein level (r = 0.88, P < 0.01). MHC analysis by electrophoresis did not show 
any difference in fibre type composition pre to post SSB supplementation (MHC I: 
pre, 52.2 ±17.0 %, post, 50.4 ± 15.5 %; MHC II: pre, 45.4 ± 19.3 %, post, 46.8 ± 17.6 
%; MHC IIx: pre, 2.4 ± 7.6 %, post, 2.8 ± 8.9 %), it can therefore be assumed the 
origin of muscle biopsies did not affect the outcomes of the study. 
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Gene expression in skeletal muscle biopsies 
 
Real time RT-PCR analysis pre and post SSB intervention revealed a significant 
alteration in metabolic gene expression of the muscle. GAPDH gene expression, 
which was used as a glycolytic marker, increased significantly (pre, 1.00 ± 0.74 AU, 
post, 1.94 ± 1.52 AU, P = 0.03) and a trend towards an increase in the lipogenic 
marker ACC was also observed (pre, 0.99 ± 0.52 AU, post, 1.21 ± 0.78 AU, P = 
0.09). The co-transcription factor and marker of mitochondrial gene expression 
PGC1α, decreased significantly (pre, 0.96 ± 0.44 AU, post, 0.79 ± 0.53 AU, P = 0.04) 
and no change in CS expression was seen (pre, 1.00 ± 0.38 AU, post, 0.98 ± 0.66 AU, 
P = 0.94). A strong trend towards increased MondoA mRNA transcription was also 
observed after the 4 week SSB intervention (pre, 0.36 ± 0.25 AU, post, 0.44 ± 0.34 
AU, P = 0.06) but no alteration in TXNIP mRNA was seen (pre, 0.51 ± 0.55 AU, 
post, 0.31 ± 0.41 AU, P = 0.37). 
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Fig. 2.3 A. Western blot analysis of MondoA in muscle biopsies pre and post 4 week 
SSB intervention with loading control alpha-actin. B. Quantification of MondoA 
western blots pre and post intervention for all participants. C. Western blot analysis of 
TXNIP in muscle biopsies pre and post 4 week SSB intervention with loading control 
alpha-actin. D. Quantification of TXNIP western blots pre and post intervention 
(Sartor et al. 2013). Data are presented as means ± SEMs. # P = < 0.10 for differences 
pre and post intervention. 
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Fig. 2.4 A. MondoA and TXNIP gene expression pre and post 4 week SSB 
intervention. Data are presented as means ± SEMs. # P = < 0.10 for differences pre 
and post intervention. 
Fig. 2.4 Metabolic gene expression pre and post 4 week SSB intervention. GAPDH 
glyceraldehyde-3-phosphate dehydrogenase, ACC acetyl-CoA carboxylase α, PGC1α 
peroxisome proliferator-activated receptor-gamma coactivator 1 α, CS citrate 
synthase. Data are presented as means ± SEMs. * P = < 0.05 and # P = < 0.10 for 
differences pre and post intervention. 
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Discussion 
 
From the findings of these studies, it is evident that 4 weeks of high glucose 
availability through regular SSB consumption is sufficient to bring about metabolic 
alterations similar to those, in muscle cells under chronic hyperglycaemic conditions. 
These findings were seen in vivo mainly at gene expression level but under in vitro 
conditions alterations at the protein level were also visible.  
 
After the 4 weeks SSB intervention and in line with previous research (Reiser et al. 
1981, Reiser et al. 1979), a significant increase in plasma glucose levels and a trend 
towards increase plasma insulin levels was observed. This was also accompanied by a 
trend towards decreased insulin sensitivity and increased insulin resistance of 
participants, which were lean and healthy with very little previous exposure to SSB 
(less than 500 ml per week). A further alteration caused by the SSB intervention was a 
significant increase in fat mass; this is most likely attributed to the changes in the 
insulin sensitivity, although alterations in insulin sensitivity have been reported 
without the concomitant changes in fat mass (Black et al. 2005). Furthermore, 
previous investigations have shown that high glucose intake or consumption of high 
glycaemic index foods at night does not increase overnight fasting levels of blood 
glucose or insulin (Nilsson et al. 2006, Stevenson, Williams & Nute 2005, Wolever et 
al. 1988). Consequently, this demonstrates that the alterations we have observed can 
be attributed to consistently altered glucose homeostasis and metabolism caused by 
the 4 week SSB intervention. Additionally, changes to glycogen storage during the 
periods of high glucose availability may be responsible for these alterations, as 
glycogen storage reached capacity, to compensate the high intracellular glucose, 
glycolysis, glucose oxidation and lipogenesis would have been enhanced (Acheson et 
al. 1988). The increase in resting RER after an overnight fast also supports this 
explanation, after the 4 week intervention lipid oxidation reduced and conversely 
carbohydrate oxidation increased by 40%. This increase in RER following high 
carbohydrate intake has been shown in previous research (Aitken, Thompson 1989). 
Furthermore, it has also previously been proven that carbohydrate ingestion during 
exercise inhibits lipid oxidation (Horowitz et al. 1997, Trenell et al. 2008). These 
findings have also been replicated in animal studies using rodents, after only 3 weeks 
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of a high glycaemic index diet, later preceding to obesity, fat oxidation was lowered 
significantly. 
 
One of the major outcomes of this study was influence of the SSB consumption on 
skeletal muscle metabolic gene expression. Increases in the glycolytic marker 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and a trend towards increased 
lipogenic enzyme acetyl Co-A carboxylase (ACC) gene expression were both 
reported, in line with previous findings seen in individuals with type 2 diabetes 
mellitus (He, Kelley 2004). Reduced expression of peroxisome proliferator-activated 
receptor-gamma coactivator-1 alpha (PGC1α), the oxidative marker and metabolic 
regulator was also observed as expected (Puigserver, Spiegelman 2003). This ratio of 
increased glycolytic to oxidative enzyme activity has also been reported in insulin-
resistant and type 2 diabetes mellitus skeletal muscle (Simoneau, Kelley 1997). 
Although, no change in citrate synthase (CS) gene expression was seen, this may be 
caused by the low level of physical activity in our participants, in turn resulting in 
calcium transients and calcium-dependent signal transduction (Kubis et al. 2003) 
which has previously been shown to limit the impact of glucose signalling on CS 
activity (Hanke et al. 2011). Our in vitro study also showed similar results with a shift 
towards increased GAPDH and ACC levels at a protein level, although no differences 
were observed in gene expression of these, a significant reduction in PGC1α was seen 
under hyperglycaemic conditions, in line with findings from results seen in rabbit 
primary muscle cell cultures (Hanke et al. 2011). 
 
This shift in the metabolic gene expression of skeletal muscle towards that found in 
type 2 diabetes mellitus may be helped by alterations in glucose dependent signalling, 
such as the transcription factor MondoA. MondoA has recently been recognized to be 
important in regulating glycolytic gene expression and further metabolic responses to 
high glucose availability (Sans et al. 2006, Stoltzman et al. 2008). In our vivo study a 
trend towards increased MondoA protein expression was observed in skeletal muscle 
after the 4 weeks SSB consumption. Furthermore, this trend was amplified under 
hyperglycaemic conditions in the primary muscle cell cultures of the in vitro study, 
providing convincing evidence that MondoA plays an important role in the metabolic 
adaptations of hyperglycaemia. Further support for this explanation is seen in the 
expression of thioredoxin interacting protein (TXNIP) which has been shown to be 
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upregulated by MondoA (Stoltzman et al. 2008).TXNIP is in involved in the 
inhibition of peripheral glucose uptake of skeletal muscle (Parikh et al. 2007) and has 
been found to be important in the regulation of glucose production in the liver also 
(Chutkow et al. 2008). Furthermore, TXNIP transcription has been demonstrated to be 
heightened in pre-diabetic and type 2 diabetes mellitus patients, suggesting it may 
play a role in the development of this condition (Parikh et al. 2007, Muoio 2007). In 
the in vivo study, the change in MondoA protein expression was significantly 
correlated with the changes in TXNIP although no significant change in expression 
was reported, a significant increase in TXNIP expression was however seen under 
hyperglycaemic conditions in the in vitro study.  A significant increase in TXNIP 
expression in the in vivo study may have been prevented by the nature of SSB 
intervention which only exposed participants to short periods of high glucose 
availability. In addition, the increase in insulin levels during the intervention may 
have led to increased glutamine in the muscle (Rennie et al. 1996) which in turn has 
been shown to influence the activity of MondoA and consequently inhibit TXNIP 
(Kaadige et al. 2009). Moreover, the amplified alterations present in the in vitro study 
compared to the in vivo study are expected as the exposure of the high glucose 
conditions to cell cultures was continuous and at a greater concentration than the in 
vivo study which was lower and periodic in contrast. Glucose in the in vitro study was 
comparable to those reported in post-prandial type 2 diabetes mellitus patients 
(Matsuda, DeFronzo 1999, Monnier et al. 2006) and in the vivo study; SSB 
supplementation was chosen to be similar to daily amounts consumed by the average 
individual in the UK, in 2010 (BSDA 2011). Therefore, we can assume that the 
results of the in vitro study are more comparable to what may result from long term 
exposure to SSB. However, it is important to note that after only 4 weeks of SSB 
consumption in otherwise healthy individuals, with a history of very minimal soft 
drink consumption, significant changes can begin to be seen in metabolic alterations 
experienced in the development of type 2 diabetes mellitus. 
 
In summary, the findings from the present study provide further evidence for the 
important role SSBs play in the development of obesity and type 2 diabetes mellitus 
(Hu, Malik 2010, Malik et al. 2010a, Malik et al. 2010b). The chronic and periodic 
exposure of hyperglycaemia was enough to influence metabolic phenotype and alter 
substrate preference which could lead to alterations in metabolism of skeletal muscle 
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similar to those in type 2 diabetes mellitus. Finally, it is suggested that MondoA and 
TXNIP are important mediators in these adaptations of skeletal muscle to high 
glucose availability but more research is needed to fully understand their role. 
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CHAPTER III 
 
EFFECTS OF 4 WEEKS MODERATE INTENSITY EXERCISE ON BODY 
COMPOSITION, METABOLISM AND ENERGY BALANCE OF LEAN AND 
OVERWEIGHT/OBESE SEDENTARY WOMEN 
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Introduction 
 
To overcome the prevalence of obesity and undo much of the damage to the 
regulation of glucose and the metabolic profile of the obese population, many 
investigations have suggested exercise as the answer but as yet this has not yielded 
convincing success in promoting weight loss and repairing the alterations to 
metabolism associated with obesity. In many exercise studies even with reported 
weight loss, this is usually lower than expected (King et al. 2007). Moreover, it has 
previously been demonstrated that interventions using exercise alone only show 
minimal weight loss (2.4 kg), compared to diet interventions (4.9 kg) and a combined 
approach (7.9 kg) (Franz et al. 2007), suggesting that exercise may cause a 
compensatory increase in energy intake in response to the exercise induced energy 
expenditure but what is not clear are the underlying mechanisms which control this 
response. 
 
The suggestion of a compensatory mechanism implies energy balance may be 
homeostaticly regulated to maintain a set bodyweight and understanding the 
regulation of this mechanism may be the key to enabling Ov/Ob individuals to lose 
weight. Previous research and opinion documenting this compensatory response to 
increased energy expenditure, shows it takes a number of weeks for exercise to 
stabilise energy balance (Doucet et al. 2011, King et al. 2008), explaining why larger 
discrepancies in energy balance may be seen in the earlier stages of exercise 
interventions. Moreover, it is also possible that the type of exercise may influence the 
compensatory response to exercise. One of the many characteristics of obesity is an 
impaired fat oxidation and a greater emphasis on carbohydrate oxidation, influenced 
by the higher blood glucose and muscle glycogen levels. In addition, individuals with 
high levels of carbohydrate oxidation have been shown to have significantly higher 
energy intake post exercise than high fat oxidation levels (Almeras et al. 1995). As 
high intensity exercise also promotes carbohydrate oxidation, it is reasonable to 
assume high intensity exercise will result in a larger compensatory intake following 
exercise, suggesting that a high intensity intervention may not be the best approach to 
exercise with this population. 
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Leptin is likely to play a key role in mediating a compensatory mechanism as it is 
well known to regulate fat mass, bodyweight and energy balance (Adami et al. 2002). 
It is also known that leptin is produced and stored in adipose tissue and high 
circulating levels are known to correlate with elevated adiposity in obese individuals 
(Considine et al. 1996). When administered to obese individuals, leptin administration 
only produced modest weight loss, suggesting its effects have been dampened in these 
individuals causing a leptin resistance (Munzberg et al. 2005). This leptin resistance is 
likely to be central to obese individuals’ inability to lose weight through exercise with 
ad libitum energy intake. 
 
In further support of this, there is little evidence to suggest that exercise alters leptin 
concentrations independent of changes in body composition. After a 9 week exercise 
programme no alterations in leptin concentrations were found, indicating the training 
had no impact on leptin levels, although this was unsurprising as no significant 
changes in fat mass were reported (Kraemer et al. 1999). In contrast, a 12 week 
exercise intervention did reveal a significant reduction in leptin but this was 
accompanied by a significant drop in fat mass also (Ozcelik et al. 2004). Both of these 
studies support the notion that changes in leptin levels with exercise are reliant on 
changes with fat mass. However, there is evidence to suggest that it may be possible 
to alter leptin concentrations with exercise irrespective of fat mass if insulin 
sensitivity is improved (Martins, Robertson & Morgan 2008). 
 
Adiponectin may also contribute to the lack of response to exercise in obese 
individuals. Obese individuals have been shown to have significantly lower 
concentrations than their lean counterparts (Arita et al. 1999, Cnop et al. 2003, Weyer 
et al. 2001). Additionally, adiponectin has been repeatedly shown to be negatively 
correlated with insulin resistance (Cnop et al. 2003, Matsubara, Katayose & Maruoka 
2003, Yamamoto et al. 2002). Previously, a 4 week exercise intervention 
demonstrating significant weight loss, also showed adiponectin concentrations and 
insulin sensitivity were significantly elevated (Bluher et al. 2006). Moreover, exercise 
studies without weight loss have shown no significant alterations in adiponectin 
concentrations (Hulver et al. 2002, Boudou et al. 2003).  
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In this chapter, a 4 weeks moderate intensity (70-80% heart rate max) exercise 
training intervention (60 min/day, 3 days/week), in the form of group based circuit 
training was used to investigate the effects of chronic exercise with ad libitum energy 
intake on body composition, metabolism and energy balance of previously sedentary 
lean and overweight or obese (Ov/Ob) women. A female only sample was chosen as 
hormonal responses have been shown to vary with gender (Hickey et al. 1997). 
Participants were recruited after expressing no desire to lose weight and during the 
study participants were naïve to the true purpose of the study and informed only that 
the study aimed to investigate the effect of exercise on metabolism and reaction time. 
Lean and Ov/Ob individuals were then assigned to either exercise or control groups. 
Dual-energy X-ray absorptiometry (DXA) was used to assess body composition at 
baseline and post intervention, and incremental exercise testing with indirect 
calorimetry was used to assess cardiovascular fitness, metabolism and exercise 
tolerance. Moreover, diet records were collected across the intervention to monitor 
energy intake and capillary blood samples were collected to analyse plasma leptin and 
adiponectin concentration, before and after the exercise intervention.  
 
It was anticipated that Ov/Ob participants would respond to the increase in energy 
expenditure from exercise by adapting energy intake and therefore compensating for 
any possible weight loss from exercise induced energy expenditure. This 
compensatory mechanism would also be supported by no changes in the 
concentrations of leptin and adiponectin, responsible for regulating this mechanism 
and maintenance of bodyweight. Furthermore, it was expected the lean exercise group 
would not display this mechanism and this would be reflected by positive alterations 
in body composition following the 4 week program. Significant differences in the 
regulatory hormones and metabolic data of lean and Ov/Ob participants would also 
offer further support for this argument. Finally, although significant alterations in 
bodyweight or fat mass were not expected from exercise in the Ov/Ob subjects, it was 
hoped that analysis of metabolic data would shed more light on the regulation of 
compensatory mechanisms, explaining how and why these populations differ in their 
response to exercise. 
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Methods 
 
Ethical approval 
 
The study design was approved by the School of Sport, Health and Exercise Sciences, 
Bangor University ethics committee. Before taking part in the study all participants 
were given an information sheet describing all procedures and any potential risks 
involved in experiments. As well as this all procedures were explained verbally and 
once satisfied all participants provided written informed consent. 
 
Participants and study design 
 
Twenty-nine healthy and sedentary women were recruited for this study through an 
advertising campaign which included emails and posters placed around Bangor 
University and the surrounding area.  During the recruitment process and throughout 
testing participants were informed that the aim of the study was to investigate the 
effects of exercise on metabolism and cognitive performance (reaction time), they 
were not aware that weight loss was being investigated. Participants were also asked 
during the screening process if they wished to lose weight and those which did were 
excluded. This was necessary to prevent participants from consciously altering their 
diet in any way. Upon completion of the study participants were debriefed and 
informed the true purpose of the study.  
 
Following initial interest potential participants were selected to take part in the study 
based on their responses to a pre-screening questionnaire. All subjects were; aged 
between 18 and 35 years; BMI between 18 and 24.9 kg/m2 (lean) or 27 and 39.9 
kg/m2 (overweight/obese); in good health; sedentary; not pregnant or breast feeding; 
and not consuming any type of specialised diet. In good health was defined as having 
no chronic health complaints, currently not receiving any medication other than the 
oral contraceptive pill, and non-smoking (Martins et al. 2010). Sedentary lifestyle was 
defined as not engaged in regular strenuous physical activity more than once a week 
or light exercise more than 20 minutes a day on 3 days per week (Martins et al. 2010).  
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In this study there were three experimental conditions; lean exercise (LEx), 
overweight/obese exercise (OEx) and lean control (LC). An overweight/obese 
(Ov/Ob) control group was intended but due to a smaller number of willing Ov/Ob 
recruits, it was not possible. Participants in both exercise groups completed a 
supervised 4 week exercise training intervention and participants in the control group 
remained sedentary, only maintaining their current level of physical activity. Twenty 
lean women were randomly assigned to either LEx (n=10) or LC (n=10) and 7 
overweight/obese women made up the OEx (n=7) group. Baseline anthropometric 
characteristics for each group are presented in table 3.1. All participants went through 
a 2 week pre-testing period prior to the training intervention during which several 
measurements were taken including, anthropometrical measures, maximal oxygen 
consumption and blood sampling. All of these measures were repeated after the 
intervention during a 2 week post-testing period.  
 
Parameter (units) 
 
Lean Control 
(n=10) 
Lean Exercise 
(n=10) 
Ov/Ob Exercise 
(n=7) 
    
Age (yr) 22.5 ± 2.2 22.4 ± 4.6 26.9 ± 3.9 
Weight (kg) 57.3 ± 9.8 58.1 ± 6.3 77.0 ± 9.9 
BMI (kg/m2) 21.2 ± 2.5 22.7 ± 2.1 31.1 ± 5.6 
Fat mass (kg) 17.5 ± 4.5 19.3 ± 4.8 34.5 ± 8.1 
Lean mass (kg) 38.6 ± 6.1 37.5 ± 3.7 42.3 ± 4.4 
Fat Percentage (%) 29.9 ± 4.1 32.6 ± 5.9 42.6 ± 6.9 
VO2PEAK (ml/kg/min) 30.5 ± 5.6 32.5 ± 8.3 26.6 ± 7.2 
Leptin (ng/ml) 29.7 ± 25.1 57.6 ± 44.1 85.0 ± 31.5 
Adiponectin (µg/ml) 11.3 ± 3.9 15.5 ± 7.2 7.6 ± 3.7 
    
 
Table 3.1. Anthropometric, oxygen uptake and hormonal data of participants in all 
conditions pre training intervention. Data are presented as means ± standard deviation. 
 
Study intervention 
 
Those participants assigned to LEx and OEx groups underwent a 4 week supervised 
exercise training intervention (60 min/day, 3 days/week). Exercise training was 
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performed in groups and a circuit based exercise intervention was used. Training 
intensity was set at 70-80% maximal heart rate, obtained during ?̇?O2MAX assessment 
pre intervention. Heart rate was kept within range using heart rate monitors (Polar F1, 
Polar Electro Oy, Kempele, Finland) fitted to all participants during each exercise 
session; monitors were assigned and programmed to individual participants and 
alarmed to notified researchers if heart rate was outside of set range. 
 
Anthropometry 
 
Body mass was measured to using a beam balance scale (Seca, Hamberg, Germany), 
participants were instructed to wear minimal clothing and remove footwear. Height 
was measured using a wall mounted stadiometer (Bodycare products, Southam, 
United Kingdom). Body composition (lean mass, fat mass and percentage body fat) 
bone mineral density were measured using dual-energy x-ray absorptiometry (DXA; 
QDR 4500, Hologic, Bedford, MA, USA). 
 
Peak oxygen consumption 
 
To determine peak oxygen uptake (?̇?O2PEAK; ml.kg-1.min-1) a progressive exercise test 
was performed on an electronically braked cycle ergometer (Corival 400, Lode, 
Groningen, Netherlands). After a 3 minute seated measurement, participants began a 
graded exercise test with 1 minute stages, starting at 25 watts (w), then increasing to 
50w and plus 20w every minute following, until the point of volitional exhaustion. 
Expired gas fractions of oxygen and carbon dioxide were measured breath by breath 
via online spirometry analysis (Metalyzer 3B, Cortex Biophysik, GMBH, Leipzig, 
Germany; Zan 600 CPET, Meβeräte, Germany). Respiratory exchange ratio (RER) 
and energy expenditure (Kcal.min-1) were also obtained via metabolic cart. Energy 
expenditure was calculated using the Weir equation. Resting energy expenditure was 
also calculated using the Mifflin equation for women (Frankenfield et al. 2003). These 
were used in conjunction with energy intake data to produce two ratios for energy 
balance across the intervention, energy intake and measured total energy expenditure 
(EIEE) and secondly, energy intake and theoretical total energy expenditure (EITEE). 
Heart rate (Polar F1, Polar Electro Oy, Kempele, Finland) and ratings of perceived 
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exertion (RPE; Borg, 1973) were collected at the end of every stage and at the point 
of exhaustion. ?̇?O2PEAK was achieved when one of three criteria was met: RER greater 
than 1.1, RPE of 20 or cadence less than 60rpm.  
 
Energy and macronutrient intake 
 
During the 8 week duration of the study (2 weeks pre-testing period, 4 weeks training 
intervention and 2 weeks post-testing period) all participants were asked to maintain 
their normal diet and report 3 days (2 week days and 1 weekend day, chosen at 
random) diet each week using food record sheets. Participants were instructed to 
complete the diet diaries using standardised instructions (Gibson 1993) and the 
importance of accuracy and precision when reporting was emphasised. Each 
participant was provided with a set of cup measures to improve the estimation of 
portion sizes. The United States Department of Agriculture, National Nutrient 
Database for Standard Reference (http://ndb.nal.usda.gov/) and the Tesco 
Supermarket online database (http://www.tesco.com/groceries/) were used to assess 
energy intake and macronutrient composition. 
 
Blood sampling and analysis 
 
Capillary blood was collected from the earlobe of participants following a 4 hour fast 
and mixed with 3.4% sodium citrate solution (using a 1:4 dilution factor). Samples 
were centrifuged at 3400rpm for 10 minutes at 4oC; plasma was separated and stored 
at -80oC for hormone measurement at a later date. Plasma leptin and adiponectin were 
assessed by enzyme-linked immunosorbent assay (ELISA; BioVendor Research and 
Diagnostic Products, BioVendor – Laboratorni medicina a.s., Czech Republic). All 
samples were batch analysed and assayed in duplicate using the same microplate 
reader (Opsys MR, Dynex Technologies, Chantilly (VA), USA). Hormone 
concentrations are reported for 17 participants (3 LEx, 5 LC, and 7 OEx) as blood 
samples were not obtained from 12 participants (7 LEx and 5 LC). 
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Statistical analysis 
 
All statistical analyses were performed using IBM SPSS Statistics 20. Differences pre 
and post intervention were analysed by two-factor mixed model ANOVA with 
repeated measures, after all relevant assumptions had been met and outliers removed. 
Due to the difficulty obtaining blood samples, means and standard deviations for 
concentrations are presented in the results section below but due to the low sample 
size, these results should not be considered representative of the population. 
Bonferroni Post hoc tests were conducted where appropriate. Pearson’s correlations 
were used to analyse relationships between variables. All data are reported as means 
± SD. Statistical significance was set at P<0.05.  
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Results 
 
To recap, lean and overweight or obese individuals were selected to take part in the 
present study, after having already expressed no desire to lose weight. Participants 
were also not informed about the aims of the study, to prevent them from consciously 
altering energy intake. Furthermore, lean participants were randomly assigned to 
either an exercise or control group, those in the exercising group completed 4 weeks 
of circuit training based exercise, at a moderate intensity and controls were informed 
to keep to their normal habitual levels of physical activity. The effects of the exercise 
intervention with ad libitum energy intake on body composition were measured by 
DXA and ?̇?O2PEAK, leptin and adiponectin plasma concentrations were also obtained 
pre and post intervention. Finally, diet records were collected before during and after 
the intervention to analyse participants’ energy and macronutrient intake.  
 
Anthropometry and plasma concentrations of leptin and adiponectin 
 
Comparison of anthropometric measurements at baseline showed significant 
differences in weight, BMI, fat mass and fat percentage between lean participants in 
both groups and obese participants as expected (See table 3.2, P < 0.05). When 
comparing differences pre and post training intervention by two factor mixed model 
ANOVA no significant differences in bodyweight, BMI or fat mass of either lean 
exercise (LEx) or overweight/obese exercise (OEx) groups were reported. However, 
although no change in body weight was seen, a significant reduction of body fat 
percentage and increase in lean mass of LEx was observed post intervention (Table 
3.2, P < 0.05); this was not repeated in OEx. Both plasma leptin and adiponectin 
concentrations were found to be significantly different between lean and obese groups 
as expected, overweight/obese participants were found to have significantly higher 
plasma leptin concentrations and significantly lower plasma adiponectin levels than 
their lean counterparts (Table 3.2, P < 0.05). However, no significant alterations were 
observed after the 4 week training intervention in either of the exercise groups plasma 
leptin or adiponectin levels. Total energy expenditure during the 4 week training 
intervention was not significantly different between both exercise groups (LEx, 
1769.89 ± 616.6 kcal, OEx, 1431.34 ± 620.5 kcal, P = 0.764). 
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 Lean Exercise (n = 10) Obese Exercise (n = 7) Lean Control (n = 10) 
Parameter (units) Pre Post Pre Post Pre Post 
       
Weight (kg) 58.13±6.27 58.66±5.73 77.00±9.85† 77.2±10.95 57.34±9.78 58.22±10.10 
BMI (kg/m2) 22.70±2.14 22.92±2.09 31.12±5.60† 31.21±5.99 21.22±2.46 21.55±2.70 
Fat mass (kg) 19.30±4.83 18.71±4.56 35.22±8.61† 33.74±9.83 17.52±4.51 17.75±4.95 
Fat Percentage (%) 32.60±5.91 31.39±5.84* 43.93±6.43† 42.54±7.05 29.90±4.09 29.80±4.54 
Lean mass (kg) 37.49±3.67 38.56±3.85* 42.30±4.81 42.51±4.67 38.59±6.08 39.19±6.26 
VO2PEAK (L/min) 1.87±0.47 1.87±0.36 2.07±0.65 1.99±0.51 1.77±0.49 1.69±0.57 
VO2PEAK (ml/kg/min) 32.47±8.34 31.85±6.33 26.63±7.15 25.31±6.26 30.49±5.64 28.77±7.21 
Leptin (ng/ml) 57.55±44.08 58.77±44.18 84.98±31.52† 64.30±39.06 29.71±25.07 51.52±48.86 
Adiponectin (µg/ml) 15.53±7.18 11.49±3.42 7.58±3.68† 7.06±3.10 11.34±3.87 13.39±3.43 
       
Table 3.2. Anthropometric, oxygen uptake and hormonal data of participants in all conditions pre and post 4 week 
training intervention. Data are presented as means ± standard deviation. * P = < 0.05 for differences pre and post 
intervention. † P = < 0.05 for differences between lean and obese subjects. 
 
 ?̇?O2PEAK, and individual stage analysis of ?̇?O2PEAK assessment 
 
The 4 week training intervention had no significant effect on absolute or relative 
?̇?O2PEAK (Table 3.2) of participants in either of the exercise groups, nor were any 
differences seen between groups. Nevertheless, significant alterations were observed 
in certain parameters at the individual stages of V̇O2PEAK assessment after the exercise 
intervention. Heart rate was significantly reduced post intervention in exercise groups 
during loaded stages of 25, 50, 70, 90 and 110 watts (Table 3.3, all P’s < 0.05) but 
again no differences were reported between groups. RER during the exercise test was 
unaffected by the training intervention but overweight/obese subjects were found to 
display significantly higher values during 50, 70 and 110 watt stages (Table 3.3, all 
P’s < 0.05), this trend was also seen at 90 watts and during rest but these were not 
significantly different. Both groups displayed improved cycling efficiency post 
training, evident through a decline in energy expenditure during the ?̇?O2PEAK 
assessment but this was only found to be significant during the 70 and 130 watt stages 
(Table 3.3, all P’s < 0.05). Perhaps more interestingly, OEx and LEx groups were 
seen to respond differently during the early stages of the exercise test, the LEx group 
had significantly higher energy expenditure than OEx pre intervention at the 25 watt 
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stage but after the intervention no between group differences were seen. This shows a 
normalisation and improvement of the OEx energy expenditure towards the LEx 
group post intervention. RPE was also measured during each stage of the ?̇?O2PEAK 
measurement, this was seen to be significantly reduced post training in the later stages 
of the exercise test, the 110 watt stage, of the LEx group (pre, 15.89 ± 1.62, post, 
14.00 ± 1.41, P = 0.004). Additionally, participants RPE in the LEx group was 
significantly greater than those in the OEx and LC groups across the 25, 50, and 70 
stages (all P’s < 0.05).  
 
 Lean Exercise Obese Exercise Lean Control 
Parameter (units) Pre Post Pre Post Pre Post 
HR (bpm)       
Rest 89.20±12.30 85.20±12.76 86.83±8.18 91.86±13.01 86.00±10.90 86.60±12.22 
25 w 112.00±13.44 106.80±12.50* 119.17±17.39 111.86±11.44* 105.80±10.70 105.30±12.26 
50 w 122.50±13.70 115.11±15.72* 129.67±19.37 121.57±14.06* 116.20±10.57 114.80±14.47 
70 w 135.90±12.62 129.33±15.26* 139.67±20.91 134.14±13.66* 132.20±15.07 130.50±16.17 
90 w 151.22±14.73 142.00±17.05* 152.67±19.89 146.57±14.33* 144.80±17.97 145.20±17.43 
110 w 162.67±15.58 153.75±17.30* 160.83±17.90 157.29±15.96* 158.50±17.66 156.50±17.78 
130 w 171.89±14.30 163.38±16.86 163.25±2.63 170.29±13.40 169.22±18.16 167.33±17.43 
RER (VCO2/VO2)       
Rest 0.84±0.05 0.84±0.05 0.85±0.04‡ 0.88±0.04 0.81±0.05 0.82±0.06 
25 w 0.79±0.03 0.77±0.04 0.82±0.05 0.81±0.04 0.79±0.04 0.80±0.07 
50 w 0.77±0.07 0.77±0.06 0.85±0.08† 0.88±0.05 0.76±0.11 0.79±0.08 
70 w 0.82±0.11 0.83±0.08 0.97±0.08† 0.94±0.06 0.80±0.13 0.82±0.09 
90 w 0.91±0.10 0.91±0.07 1.03±0.09‡ 1.00±0.07 0.87±0.14 0.91±0.10 
110 w 0.95±0.10 0.97±0.07 1.12±0.10† 1.07±0.08 0.95±0.10 0.98±0.09 
130 w 1.03±0.11 1.01±0.09 1.11±0.10 1.12±0.11 1.04±0.10 1.01±0.10 
EE (kcal.min-1)       
Rest 1.56±0.30 1.45±0.30 1.14±0.15 1.18±0.20 1.55±0.25 1.53±0.32 
25 w 2.80±0.90 2.78±1.07 2.04±0.67† 2.36±0.84 2.92±0.43 2.38±0.99 
50 w 3.07±0.98 3.09±1.01 2.85±1.31 2.88±0.75 3.24±0.81 2.60±1.22 
70 w 4.20±0.86 4.03±0.64* 4.02±1.22 3.51±0.72* 4.08±0.88 3.50±1.28 
90 w 4.77±0.86 5.07±0.84 4.97±1.16 4.62±1.22 5.09±0.87 4.61±1.51 
110 w 6.14±0.93 6.27±0.97 5.76±2.30 5.47±1.33 6.04±0.99 5.50±1.53 
130 w 7.26±0.73 7.11±1.10* 6.37±2.77 6.02±1.59* 7.04±1.28 6.58±2.00 
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Table 3.3. Heart rate, RER and energy expenditure data during ?̇?O2PEAK assessment pre and post 4 week training 
intervention. Data are presented as means ± standard deviation. * P = < 0.05 for differences pre and post intervention. † 
P = < 0.05 and ‡ P = < 0.10 for differences between lean and obese subjects. 
 
Energy and macronutrient intake 
 
After removal of participants with implausible dietary intake (less than 600 or greater 
than 4000 kcal per day; (Willet 1998)) analysis was conducted on the remaining 
nineteen participants (8 LEx, 7 OEx and 4 LC). Total energy intake was not 
significantly altered across the duration of the study, including when expressed 
relative to body surface area no differences were reported (all P’s > 0.05). When 
macronutrient intake was also compared across the duration of the study  as 
percentage intake per body surface area, carbohydrate, sugar, total fat, and saturated 
fat were not significantly altered (all P’s > 0.05). However, a significant alteration in 
protein intake was observed in both exercise groups during the intervention, 
percentage protein per body surface was significantly lower in week 3, the first week 
of the exercise training, compared to week 6, the last week of the training (Figure 3.1, 
P = 0.013). Furthermore, percentage protein per body surface area was significantly 
different between OEx and LEx groups, with obese participants consuming less 
protein than their lean counterparts (Figure 3.1, P = 0.027). When diet records were 
grouped into 2 week blocks; pre-test (weeks 1 and 2), early exercise (weeks 3 and 4), 
late exercise (weeks 5and 6) and post-test (weeks 7 and 8), again no differences in 
sugar, total fat or saturated fat were observed (Table 3.4, all P’s > 0.05). Total energy 
intake and energy intake per body surface area however, were significantly reduced 
from pre-test to post-test in the OEx group (pre, 1717.63 ± 237 kcal, post, 1361.65 ± 
283 kcal, P = 0.014; pre, 971.51 ± 184 kcal.m-2, post, 771.39 ± 198 kcal.m-2, P = 
0.016), as well as a significant reduction in reported amounts of carbohydrate pre to 
post intervention were also seen in this group only (Table 3.4, P = 0.007).  Protein 
percentage intake per body surface area in all groups tended to be higher during late 
exercise when compared to early exercise but this difference was not significant 
(Table 3.4). Protein percentage intake per body surface area showed further grouped 
differences, even though both exercise groups tended to increase protein intake further 
into the training, LEx consumed significantly more than OEx throughout the study 
(Table 3.4). Pearson’s correlations were used to investigate any potential relationships 
77 
 
between changes (post-test minus pre-test) in energy intake and physiological 
characteristics. Significant trends were noticed between changes in energy intake and 
changes in both leptin and body weight (r = -0.524, P = 0.081; r =-0.410, P =0.081, 
respectively). Furthermore, a significant positive correlation was observed between 
changes in energy intake and percentage body fat (r = 0.578, P = 0.010) and finally a 
significant negative correlation was also reported for lean mass change (r = -0.577, P 
= 0.010). 
 
 
Fig. 3.1. Percentage protein intake relative to body surface area each week of the 8 
week study. Data are presented as mean values. * P < 0.05 when compared to week 3, 
beginning of training intervention. 
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 Pre-test Early Exercise Late Exercise Post-test 
 LEx OEx LC LEx OEx LC LEx OEx LC LEx OEx LC 
             
Energy Intake 
(kcal.day-1.m-2) 
1108.4±259 971.5±184 827.2±148 1111.6±231 887.2±259 888.3±139 1074.4±278 850.5±186 980.2±52 1068.0±300 771.4±198* 838.4±74 
Protein   
(%.day-1.m-2) 
10.1±1.9 8.0±1.2 7.9±1.3 9.3±2.3 7.5±1.1 8.6±1.4 10.7±1.6 8.1±1.0† 9.3±1.4 10.1±1.3 9.1±2.6 9.58±2.1 
Carbohydrate 
(%.day-1.m-2) 
33.1±5.3 29.8±3.6 37.8±6.9 32.1±5.0 31.3±3.2 37.2±3.3 31.4±4.1 30.2±1.8 37.1±7.1 31.5±4.1 32.4±3.4* 37.0±5.3 
Sugar     
(%.day-1.m-2) 
11.31±3.8 10.2±2.8 15.4±4.9 11.6±2.6 11.3±2.3 14.1±3.7 10.4±3.1 9.7±2.7 13.8±3.1 11.1±2.9 13.1±3.4 13.3±4.7 
Fat         
(%.day-1.m-2) 
17.8±4.8 16.7±3.1 19.0±5.2 19.5±3.2 17.0±3.5 19.9±3.5 18.6±2.0 16.7±3.1 18.3±1.5 18.4±3.2 14.9±3.7 17.8±2.1 
Saturated fat 
(%.day-1.m-2) 
6.7±1.5 5.3±0.7 6.3±2.8 7.2±1.5 6.3±1.5 5.8±2.0 6.5±1.1 5.4±1.2 5.2±1.8 6.5±1.1 4.8±1.02 5.8±1.9 
             
Table 3.4. Total energy intake (kcal) and macronutrient intake (%) expressed using body surface area, in two weeks blocks. Data are presented as means ± standard deviation. * P 
< 0.05 when compared to pre-test. † P < 0.1 when compared to early exercise. 
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Energy balance 
 
Energy balance was expressed as the ratio between calculated energy intake and 
energy expenditure (EIEE). EIEE was calculated on a week by week basis and 
compared throughout the study using a two factor mixed model ANOVA. EIEE did 
significantly alter over time, as a significant main effect for time was observed (P = 
0.005) and on closer inspection using Bonferroni post hoc test, EIEE was found to be 
significantly lower in week 6 than week 1 (Figure 3.2, P = 0.006), trends were also 
seen towards lower EIEE in weeks 3 and 4 (Figure 3.2, P = 0.08 and 0.074, 
respectively), all during the exercise intervention. As energy expenditure was not 
measured in a true resting state theoretical energy expenditure was also calculated as 
outlined earlier in the methods section. This was also used to give a new energy 
balance ratio, energy intake and theoretical energy expenditure (EITEE). When 
EITEE was compared a significant interaction between group and time was observed 
(Figure 3.3, P = 0.02), and using a Bonferroni post hoc test once again, trends were 
observed in both OEx and LEx. When compared to week 1 lower EITEE was seen in 
weeks 2, 3, 5, and 6 of LEx, and lower in weeks 2, 4, 5, 6, 7, and 8 of OEx. In spite of 
this, only weeks 1 and 6 in OEx displayed a significant difference after a multiple 
comparisons correction (Figure 3.3, P = 0.004). Moreover, as with energy intake, 
weeks were separated into 2 week blocks and energy balance was analysed once more 
by ANOVA. A significant difference in EIEE over time was observed and after 
further analysis a significant difference between EIEE pre-test and post-test was 
revealed in OEx (pre, 1.01 ± 0.09, post, 0.82 ± 0.13, P = 0.027). EITEE also tended to 
be lower post-test but this difference was not significant (pre, 1.19 ± 0.23, post, 0.94 ± 
0.25, P = 0.062). Finally, changes in EITEE from pre-test to post-test were correlated 
with changes in percentage body fat (r = 0.619, P = 0.005), and lean mass (r = -0.598, 
P = 0.007). 
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Fig. 3.2. The ratio between energy intake and energy expenditure (EIEE) during each 
week of the study. Data are presented as mean values. * P < 0.05 and # P < 0.1 when 
compared to week 1 of the study. 
 
Fig. 3.3. The ratio between energy intake and theoretical energy expenditure (EITEE) 
during each week of the study. Data are presented as mean values. * Trend towards 
lower EITEE than week 1 (P < 0.1) and # trend towards lower EITEE than week 1 (P 
< 0.1). 
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Discussion 
 
The main outcomes of the present study are that a 4 week exercise training 
intervention (3d/wk, 60min/d, 70-80% HRpeak) with ad libitum energy intake, where 
participants were naïve to the purpose of the study, did not results in weight or fat loss 
of Ov/Ob but did lead to a reduction in percentage fat and increase in lean mass of 
lean participants. Although, no improvements were seen in ?̇?O2PEAK after the 4 week 
intervention, significant adaptations to exercise were seen in energy expenditure of 
Ov/Ob at lower intensities, towards those measured in their lean counterparts. 
Furthermore, the 4 week training intervention did seem to improve the coupling of 
energy intake and expenditure in both sets of exercise groups and even though no 
changes were observed in macronutrient composition of participants, protein intake 
was significantly different between lean and Ov/Ob participants, which may support 
the lack of changes in lean mass with exercise in the Ov/Ob participants. 
 
The lack of weight loss and the maintenance of bodyweight in both Ov/Ob and lean as 
a result of completing the 4 week training intervention suggest that both groups 
compensated the increase in energy expenditure from exercise by adjusting their 
energy intake. The significant changes in percentage fat and lean mass of the lean 
group indicates that even though they were able to respond to the exercise with 
improved body composition, their overall body weight remained unaffected in line 
with Ov/Ob subjects. However, the analysis of energy balance across the whole study 
does show a trend towards a reduction in energy balance suggesting that over time, 
exercise did improve the previously sedentary participants’ ability to balance their 
energy intake and expenditure. At the beginning of exercise the Ov/Ob group tended 
to over-compensate their intake and by the end of the exercise there ability to more 
accurately compensate their expenditure was improved. In support of these findings 
regular exercisers have been shown to more accurately compensate a high 
carbohydrate preload when compared to non-exercisers (Long, Hart & Morgan 2002). 
Previous investigations have also shown that increased physical activity in sedentary 
individuals can improve sensitivity to eating behaviour and therefore reduce their 
capacity to overcompensate increased energy expenditure with higher energy intake 
(Martins, Robertson & Morgan 2008, Martins, Truby & Morgan 2007). It has been 
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put forth that this improvement in sensitivity of eating behaviour through exercise is 
caused by an improved satiation in response to food and control of appetite (Martins 
et al. 2010, King et al. 2009).  
 
Although trends were seen towards adjusted energy balance at the end of the exercise 
intervention, little differences were detected in macronutrient intake across the 
intervention. These findings reflect those from further investigations where prolonged 
exercise training of previously sedentary Ov/Ob participants did not affect 
macronutrient composition (Martins, Robertson & Morgan 2008, Donnelly et al. 
2003, Tremblay, Drapeau 1999). However, even though few changes were observed 
over time, significant differences were reported between lean and Ov/Ob participants. 
Both sets of exercise groups tended to consume more protein later on in the 
intervention when compared to the onset of exercise and lean participants consumed 
significantly more protein across the intervention than their Ov/Ob counterparts. 
Ov/Ob participants did consume less carbohydrate post intervention than pre 
intervention; this is likely due to the increase in protein replacing excess 
carbohydrate. Past research has shown that obese individuals consuming a diet high in 
protein resulted in greater weight than those who consumed a high carbohydrate diet 
(Skov et al. 1999). This can be explained primarily by increased satiety and diet-
induced thermogenesis (Jequier 2002). Energy expenditure has also been 
demonstrated to be significantly greater when a diet high in carbohydrate was 
exchanged for a high protein diet (Mikkelsen, Toubro & Astrup 2000). The increase 
in diet-induced thermogenesis may explain why the lean participants managed to 
increase lean mass and lose percentage body fat by consuming higher amounts of 
protein than their Ov/Ob counterparts, whose body composition remained unaltered. 
In addition, it may also explain the trend towards a lower energy balance during the 
later stages of the exercise intervention through an increase in energy expenditure by 
diet-induced thermogenesis. 
 
The 4 week circuit training intervention had no effect on leptin concentrations in 
either of the exercise groups; however this is not surprising as fat mass remained 
unaltered by the intervention also. It is well established that leptin concentrations are 
linked to adiposity (Yannakoulia et al. 2003) and higher leptin levels are known to be 
associated with the prevalence of obesity (Hellstrom et al. 2004, Hagobian et al. 
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2009). Additionally, it has previously been reported that leptin concentrations remain 
unchanged without weight loss (Martins, Robertson & Morgan 2008, Christiansen et 
al. 2010, Perusse et al. 1997). Moreover, small decreases in leptin as a result of 
changes to energy balance have been seen to increase fat mass in obese subjects, in an 
attempt to restore levels to some ‘set point’ (Farooqi et al. 2001). The above not only 
explain why leptin levels were higher in Ov/Ob individuals but it may also offer an 
explanation why participants did not lose weight during the exercise intervention, 
even under changes in energy balance through increased energy expenditure, leptin 
forms part of a homeostatic mechanism that  tightly regulates body weight and 
adiposity, maintaining an inherent set point. 
 
Following the same trend as leptin, adiponectin levels were not significantly altered 
by the exercise intervention, however levels were significantly different between lean 
and Ov/Ob participants. In line with previous investigations plasma adiponectin was 
lower in Ov/Ob subjects compared their lean counterparts (Arita et al. 1999). 
Adiponectin has also been shown to be positively associated with weight loss; 
individuals with the greatest weight loss have been identified with greater 
concentrations of circulating adiponectin (Christiansen et al. 2010). Furthermore, it 
has been previously been demonstrated that after exercise training where weight loss 
did not occur, adiponectin levels remained unchanged (Hulver et al. 2002). This 
association with weight loss is most likely due to the fact that adiponectin reportedly 
stimulates mitochondrial biogenesis and henceforth if individuals are low in 
adiponectin their ability to make more mitochondria, reduce fatty acid oxidation and 
increase carbohydrate metabolism is impaired (Borer 2008, Civitarese et al. 2006). 
 
A positive outcome of the study in terms of adaptation to exercise was the significant 
shift in energy expenditure of the Ov/Ob group at the early onset of exercise, Ov/Ob 
subjects had significantly lower energy expenditure pre intervention but after the 
intervention no significant difference was seen. Energy expenditure has previously 
been reported to be higher in obese individuals because of their increased mass 
(Westerterp 1998) however, as this was not the case in our energy expenditure data 
based on oxygen consumption; it would seem that these participants obtain energy 
through other mechanisms/pathways. It has previously been found that due to their 
reduced mitochondrial capacity and physical inactivity, obese individuals tend to 
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depend more on anaerobic glycolysis during exercise and a glycolytic pathway that 
may not function optimally, this is likely caused by an increase in phosphomonesters 
(PME) that impair normal glycolytic function (Hunter et al. 2006). This suggests that 
the participants in the Ov/Ob group of the present study were dependent on anaerobic 
metabolism during the early stages of exercise pre intervention but through an 
exercise induced improvement in oxidative capacity this was no longer the case post 
intervention. 
 
Additionally, because of the potential increase in anaerobic glycolysis of the Ov/Ob 
women in this study it is likely that blood lactate levels were also increased (Gladden 
2004), this has previously been seen in overweight diabetic individuals (Metz et al. 
2005). Furthermore, when lactate levels are increased, some of the lactate may be 
buffered by bicarbonate which can release more CO2 into the blood and raise RER 
(Steffan et al. 1999). This was likely the case in our Ov/Ob group as RER did tend to 
be higher in these individuals. Moreover, although only seen in animal studies, due to 
the increased levels of lactate in the blood, some of the lactate may be converted to 
fatty acid stores in the liver (Shreeve et al. 1967). This suggests the increased lactate 
metabolism in Ov/Ob individuals may contribute to the higher rates of carbohydrate 
oxidation seen in this population and increased fatty acid storage. 
 
In the present study, the initial difference in energy expenditure, during exercise at 
low intensity, between lean and Ov/Ob subjects was no longer apparent after the 
exercise intervention, suggesting that the increase in physical activity reduced the 
Ov/Ob participants dependence on anaerobic metabolism. Previously, a reduction in 
monocarboxylate transporter 1 (MCT1) expression has been associated with a 
decreased capacity to oxidise exogenous lactate in oxidative muscle fibres (Crawford 
et al. 2010) and alterations in MCT1 expression have been linked with obesity (Py et 
al. 2001). In support of this explanation, endurance training has previously been 
demonstrated to decrease lactate levels by an increase in lactate clearance, through 
increased MCT1 and MCT4 expression of sarcolemmal and mitochondrial 
membranes, in turn promoting the action of the oxidative enzyme citrate synthase 
(Dubouchaud et al. 2000). In the present study, it is possible the exercise training 
increased oxidative capacity of the Ov/Ob individuals, by an exercise induced 
increase in lactate clearance. 
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To conclude, whilst participants were naive to the true purpose of the study, the 4 
weeks exercise training intervention did not lead to weight/fat loss in Ov/Ob subjects 
but was enough to reduce percentage body fat and increase lean mass in lean subjects. 
This suggests that a body weight set point may exist in both groups but on different 
weight levels. It is suggested that leptin may form part of a homeostatic mechanism 
that tightly regulates body weight and adiposity, maintaining an inherent set point. 
Protein intake may also play an important role in the response to exercise and control 
of energy balance, regulating body weight. Finally, the results of the present study do 
indicate that 4 weeks circuit training at a moderate intensity can improve aerobic 
metabolism, of Ov/Ob individuals during exercise by enhancing the oxidative 
capacity of skeletal muscle. 
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CHAPTER IV 
 
EFFECTS OF 8 WEEKS HIGH AND LOW INTENSITY EXERCISE ON 
BODY COMPOSITION, METABOLISM AND ENERGY BALANCE OF 
LEAN AND OVERWEIGHT/OBESE SEDENTARY WOMEN 
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Introduction 
 
At present, intervention studies have investigated how either restricting energy intake, 
manipulating energy expenditure or both simultaneously affect weight loss and so far 
have produced no clear intervention that has been able to achieve long-term 
sustainable weight loss, more research needs to focus on the dysregulation of 
homeostatic mechanisms regulating energy balance (Hafekost et al. 2013). In Jakicic 
et al. (2008) study after 6 months of lifestyle alteration and weight loss, an 18 month 
follow up was conducted, 72% had regained weight and a further 31% regained 
weight over and above their previous baseline. Stubbs et al. (2002) described the issue 
with intervention studies so far, that they do not take into account compensatory 
mechanisms that may exist and assume that energy intake and expenditure can be 
altered independently from one another (Stubbs et al. 2002).  
 
Both the regulatory processes of leptin and insulin in the regulation of energy balance 
have been well documented. They are both known to decrease appetite and increase 
energy expenditure (Porte, Baskin & Schwartz 2005). Insulin concentrations are also 
known to be higher in obese individuals (Moore, Cooper 1991), often leading to 
insulin resistance. Moreover, suppression of insulin has been shown to reduce leptin 
resistance (Blaak, Saris & van Baak 1993), combined with the associated 
hyperglycaemia and hyperlipidaemia, this suggests that hyperinsulinaemia may be 
one of the key causes of leptin resistance (Lustig 2006). Both, insulin and leptin are 
controlled by the CNS in similar ways and they share signalling pathways that 
regulate adiposity and energy homeostasis (Niswender, Schwartz 2003) but more 
research is needed to further understand how they interact to regulate a compensatory 
mechanism in obese individuals. 
 
Amylin which is co-secreted with insulin could form part of a compensatory 
mechanism is obese individuals. Amylin concentrations are also typically elevated in 
obese individuals (Moore, Cooper 1991). Moreover, amylin receptor agonism has 
been found to suppress appetite (Pullman, Darsow & Frias 2006), slow gastric 
emptying (Smith et al. 2008) and reduce postprandial glucagon release (Roth et al. 
2008), together slowing the release of glucose into the blood to improve the 
effectiveness of insulin. Furthermore, when amylin antagonist AC187 was centrally 
88 
 
administered to rats it increased food intake, glucagon concentrations, gastric 
emptying, and glycaemia after glucose ingestion (Riediger et al. 2004, Gedulin et al. 
2006).  
 
There is strong evidence to suggest that insulin resistance is one of the major factors 
contributing to the development of leptin resistance (Lustig 2006). Therefore, it seems 
logical that amylin may be important in this mechanism, as it is co-secreted with 
insulin and they both are known to regulate energy homeostasis. Furthermore, obese 
leptin resistant rats administered amylin, reduced food intake, bodyweight and body 
fat (Roth et al. 2006) and obese humans that were administered amylin and leptin 
together for a 20 week period, were compared to amylin alone and leptin alone 
treatment groups (Roth et al. 2008). The combined amylin and leptin treatment 
induced a 12.7% loss in bodyweight, compared to the amylin and leptin groups where 
an 8% loss was observed. Although the mechanisms for this change are not fully 
understood it is clear amylin is very important in mediating leptin sensitivity and 
therefore any potential weight loss in obese individuals.  
 
At present, there are few studies which have investigated the effect of exercise on 
amylin response. In a study with progressive intermittent exercise from moderate to 
maximal intensities (60%, 75%, 90% and 100% ?̇?O2MAX), no change at the moderate 
intensities was seen but at 90 and 100% amylin was elevated with the highest at 100% 
(Kraemer, Chu & Castracane 2002). Additionally, in a further study with resistance 
exercise no significant increase was seen in amylin concentrations but insulin was 
significantly elevated (Kraemer et al. 2004) and in a final study, a reduction in amylin 
was seen during prolonged moderate intensity exercise for 90 minutes (Kraemer et al. 
2011). What is more, the effects of chronic exercise on amylin are so far unknown as 
no studies have investigated this but 2 weeks of exercise and diet restriction have been 
seen to reduce amylin concentrations by 36% (Izadpanah et al. 2012). Although, the 
effects of a chronic exercise are likely to be similar to those observed in insulin and in 
support of this, the findings after acute exercise in amylin concentrations follow those 
seen in insulin (Kraemer, Chu & Castracane 2002, Kraemer et al. 2004, Kreisman et 
al. 2000). However, it is evident more research is needed to understand the role of 
amylin in the regulation of energy balance during chronic exercise.  
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Taking into consideration chapter 3 and expanding on its findings, in this chapter an 8 
week high (80-90% ?̇?O2MAX) and low (50-60% ?̇?O2MAX) intensity exercise 
intervention (60-90 min/day, 3 days/week) was prescribed to lean and Ov/Ob 
sedentary individuals, to analyse the effects of chronic exercise with ad libitum 
energy intake on body composition, metabolism and energy balance. The aim of this 
study was to improve the understanding of regulatory mechanisms controlling energy 
homeostasis and response to exercise of both lean and Ov/Ob populations. As with the 
4 week study, participants were recruited with no intention to lose weight and kept 
unaware of the objectives of the study throughout the intervention. Participants were 
notified that the aim of the study was to investigate the effects of exercise on 
cardiovascular health and cognitive function. Once agreeing to take part, subjects 
were randomly assigned to either a high or low intensity exercise group, both groups 
exercised together in a circuit training fashion and a telemetric heart monitoring 
system was used to set intensity and match energy expenditure between groups. To 
analyse the effects of exercise, pre and post intervention body composition was 
assessed by dual-energy x-ray absorptiometry (DXA). Metabolism, cardiovascular 
function and response to exercise were assessed between and within groups by 
indirect calorimetry during incremental exercise to exhaustion and at rest in a fasted 
state. Furthermore, venous blood was collected before and after a test meal also and 
lipid profile, glucose, insulin, leptin and amylin plasma concentrations were measured 
to gain a comprehensive view of participants’ metabolic profile. Finally, diet records 
were collected from all participants to measure energy and macronutrient intake 
before, during and after the 8 week exercise intervention. 
 
It was hypothesised that during the exercise intervention Ov/Ob participants would 
display compensatory tendencies in response to the exercise induced energy 
expenditure, adapting energy and macronutrient intake, thus preventing any weight or 
fat loss. This was expected to be facilitated by a reduction in amylin concentrations, 
explained by reduced insulin and leptin sensitivity in this population. However, this 
was not anticipated in the lean participants with normal metabolic function, because 
of this it was expected lean participants would demonstrate a stronger response to 
exercise, primarily seen in significant changes to body composition. 
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Methods 
 
Ethical approval 
 
The study design was approved by the School of Sport, Health and Exercise Sciences, 
Bangor University ethics committee and the North Wales Research Ethics Committee 
– West (Ysbyty Gwynedd Hospital, Betsi Cadwaladr University Health Board). 
Before taking part in the study all participants were given an information sheet 
describing all procedures and any potential risks involved in experiments. As well as 
this all procedures were explained verbally and once satisfied all participants provided 
written informed consent. 
 
Participants and study design 
 
Thirty-five healthy and sedentary women were recruited for this study through an 
advertising campaign which included emails and posters placed around Bangor 
University and the surrounding area. During the recruitment process and throughout 
testing participants were informed that the aim of the study was to investigate the 
effects of exercise on cardiovascular health and cognitive function, they were not 
aware that weight loss was being investigated. Additionally, only participants who 
had expressed no desire to lose weight in the screening process were recruited to take 
part in the study. This was necessary to prevent participants from consciously altering 
their diet in any way. Upon completion of the study participants were debriefed and 
informed the true purpose of the study. As an extra incentive participants were offered 
a pair of trainers up to the value of £100 at the end of the study. 
 
Following initial interest potential participants were selected to take part in the study 
based on their responses to a pre-screening questionnaire. All subjects were; aged 
between 18 and 40; BMI between 18 and 24.9 kg/m2 (lean) or 25 and 39.9 kg/m2 
(overweight/obese); in good health; sedentary; not pregnant or breast feeding; and not 
consuming any type of specialised diet. In good health was defined as having no 
chronic health complaints, currently not receiving any medication other than the oral 
contraceptive pill, and non-smoking (Martins et al. 2010). Sedentary lifestyle was 
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defined as not engaged in regular strenuous physical activity more than once a week 
or light exercise more than 20 minutes a day on 3 days per week (Martins et al. 2010).  
 
All participants completed an 8 week supervised exercise intervention and both lean 
and overweight/obese participants were randomly allocated to either a high intensity 
exercise or a low intensity exercise programme, giving rise to four experimental 
conditions; lean high intensity exercise (LH; n=6), overweight/obese high intensity 
exercise (OH; n=11), lean low intensity exercise (LL; n=6) and overweight/obese low 
intensity exercise (OL; n=12). Baseline anthropometric characteristics for each group 
are presented in table 4.1. During the week before the training intervention and the 
week following participants came into the laboratory on three separate occasions for 
pre and post testing. Participants completed anthropometric measures on day 1, 
metabolic measures and blood sampling on day 2, and maximal oxygen uptake 
assessment on day 3.  
 
Parameter (units) 
 
Lean high 
intensity (n=6) 
Lean low 
intensity (n=6) 
Overweight high 
intensity (n=11) 
Overweight low 
intensity (n=12) 
Age (yr) 25.0 ± 7.54 23.5 ± 6.35 24.0 ± 6.62 22.8 ± 4.95 
Weight (kg) 65.39 ± 6.91 62.99 ± 4.20 86.16 ± 12.99 79.70 ± 10.37 
BMI (kg/m2) 23.34 ± 1.24 21.67 ± 2.50 30.72 ± 4.56 29.87 ± 2.76 
Fat mass (kg) 19.28 ± 3.35 18.62 ± 3.75 34.13 ± 8.73 30.85 ± 6.86 
Lean mass (kg) 43.84 ± 6.17 42.44 ± 3.09 50.88 ± 5.40 47.54 ± 5.20 
Fat Percentage (%) 29.77 ± 5.52 29.40 ± 4.84 39.15 ± 5.06 38.38 ± 4.91 
VO2PEAK (ml/kg/min) 44.80 ± 7.84 46.43 ± 5.71 31.17 ± 6.5 33.87 ± 6.06 
RMR (kcal/d) 1386.42 ± 
247.23 
1404.31 ± 
182.21 
1761.92 ± 344.23 1488.28 ± 237.80 
RER 0.79 ± 0.06 0.79 ± 0.08 0.77 ± 0.07 0.78 ± 0.05 
 
Table 4.1. Anthropometric, oxygen uptake, and metabolic data of participants in all conditions pre 
intervention. Data are presented as means ± standard deviation.  
 
Study intervention 
 
Participants were randomly assigned to either a high intensity (80-90% ?̇?O2MAX) or a 
low intensity (50-60% ?̇?O2MAX) 8 week exercise training intervention. Exercise 
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sessions were circuit based and completed 3 times a week, length of sessions was 
dependent on the intensity of exercise. Energy expenditure during exercise sessions 
was matched between groups. All sessions were completed in groups and supervised 
by at least 3 members of the research team. Training intensity was controlled by a 
telemetric monitoring system (Activio, Activio Sport System, Sweden) and projector, 
used to display the live heart rates of each participant. Participants were asked to 
increase or decrease their effort where necessary to remain in the correct zones, 
corresponding to %?̇?O2MAX. 
 
Anthropometry 
 
Body mass was measured to using a beam balance scale (Seca, Hamberg, Germany), 
participants were instructed to wear minimal clothing. Height was measured using a 
wall mounted stadiometer (Bodycare products, Southam, United Kingdom). Body 
composition (lean mass, fat mass and percentage body fat) bone mineral density were 
measured using dual-energy x-ray absorptiometry (DEXA; QDR 4500, Hologic, 
Bedford, MA, USA). 
 
Resting metabolic measurements 
 
Participants were instructed to arrive at the laboratory after a 12 hour overnight fast 
and well rested, having refrained from any exercise for 48 hours prior to 
measurement. Resting metabolic rate (kcal.min-1) and respiratory exchange ratio 
(RER; ?̇?CO2/?̇?O2) were measured by indirect calorimetry (Oxycon Pro, Erich Jaegar, 
Germany) as participants lay awake in a supine position for 30 minutes, temperature 
of the room was kept constant (19oC) and to drown out ambient noise subjects 
listened to classical music through headphones. Heart rate (Polar RS800CX, Polar 
Electro Oy, Kempele, Finland) was also recorded during resting metabolic rate 
measurement and electro-cardiography (ECG) was monitored for pre-screening 
purposes. 
 
Test meal 
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Following an overnight fast participants were given a liquid test meal (Resource® 
Energy Vanilla 200ml, Nestle, Switzerland), providing 300kcal of which 55% was 
carbohydrate, 30% fat and 15% protein. Blood samples were taken prior to the test 
meal and precisely 1 hour after consumption. Fasting and postprandial blood samples 
were then analysed to measure the response of various hormones to the test meal. 
 
Maximal oxygen consumption 
 
To determine maximal oxygen uptake (?̇?O2MAX; ml.kg-1.min-1) a progressive exercise 
test was performed on an electronically braked cycle ergometer (Corival 400, Lode, 
Groningen, Netherlands). After a 3 minute seated measurement, participants began a 
graded exercise test with 1 minute stages, starting at 25 watts (w), then increasing to 
50w and plus 20w every minute following, until the point of volitional exhaustion. 
Expired gas fractions of oxygen and carbon dioxide were measured breath by breath 
with a metabolic cart (Oxycon Pro, Erich Jaegar, Germany). RER and energy 
expenditure (kcal.min-1) were also obtained by metabolic cart. Energy expenditure 
was calculated using the Weir equation. Heart rate (Polar RS800CX, Polar Electro 
Oy, Kempele, Finland) and ratings of perceived exertion (RPE; Borg, 1973) were 
collected at the end of every stage and at the point of exhaustion. As a plateau in ?̇?O2 
was not reached for many of the participants ?̇?O2PEAK will be used henceforth. 
?̇?O2PEAK was achieved when one of three criteria was met: RER greater than 1.1, RPE 
of 20 or cadence less than 60rpm.  
 
Energy and macronutrient intake 
 
During the 10 week duration of the study (1 week pre-testing period, 8 weeks training 
intervention and 1 week post-testing period) all participants were asked to maintain 
their normal diet and report 3 days (2 week days and 1 weekend day, chosen at 
random) diet each week using food record sheets. Participants were instructed to 
complete the diet diaries using standardised instructions (Gibson 1993) and the 
importance of accuracy and precision when reporting was emphasised. Each 
participant was provided with a set of cup measures to improve the estimation of 
portion sizes. The United States Department of Agriculture, National Nutrient 
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Database for Standard Reference (http://ndb.nal.usda.gov/) and the Tesco 
Supermarket online database (http://www.tesco.com/groceries/) were used to assess 
macronutrient composition. Energy balance (EB), energy expenditure (EE) and 
energy intake (EI) were calculated based on body composition data obtained by 
DEXA scan according to methods previously outlined (Thomas et al. 2010). 
 
Blood sampling and analysis 
 
Under both fasting and postprandial conditions 12ml (2 x 6ml vacutainers™ 
containing ethylenediaminetetraacetic acid) of venous blood was collected from the 
forearm of participants. Glucose was measured by the Accu-Chek Aviva glucose 
meter (Accu-Chek® Aviva, Mannheim, Germany), and total cholesterol, 
triglycerides, and high-density lipoproteins were measured using the Reflotron Plus 
system (Reflotron® Plus, Roche, Germany). Low-density lipoproteins were 
calculated using the formula LDL = TC – HDL - (TG/5) (Friedewald, Levy & 
Fredrickson 1972). For further hormone measurements, whole blood was centrifuged 
at 3000rpm for 10 minutes at 4oC, plasma was then separated, aliquoted and stored at 
-80oC for later analysis. Hormone measurement was carried out by enzyme-linked 
immunosorbent assay (ELISA) and plate reader (Fluostar Omega, BMG Labtech, 
Germany). ELISA’s were carried out to measure amylin (Millipore, St. Charles, MO, 
USA), insulin (Mercodia, Uppsala, Sweden), and leptin (BioVendor Research and 
Diagnostic Products, BioVendor – Laboratorni medicina a.s., Czech Republic). The 
Homeostasis Model Assessment version 2 (HOMA2) 
(www.dtu.ox.ac.uk/homacalculator/) was used to calculate beta cell function (%B), 
insulin resistance (IR) and insulin sensitivity (%S) from fasting plasma insulin and 
glucose (Wallace, Levy & Matthews 2004). All samples were batch analysed and 
assayed in duplicate. 
 
Statistical analysis 
 
All statistical analyses were performed using IBM SPSS Statistics 20. All 
anthropometry, metabolic, exercise and blood data were analysed by three-factor 
mixed model ANOVA, with one within factor (pre versus post intervention) and two 
between factors (high intensity versus low intensity and lean versus obese), after all 
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relevant assumptions had been met and outliers removed. Pearson’s correlations were 
used to analyse relationships between variables. All data are reported as means 
± SD. Statistical significance was set at P<0.05.  
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Results  
 
In the present study, an 8 week high and low intensity exercise intervention was 
prescribed to lean and overweight/obese (Ov/Ob) sedentary individuals, to analyse the 
effects of chronic exercise with ad libitum energy intake on body composition, 
metabolism and energy balance. The aim of this study was to improve the 
understanding of regulatory mechanisms controlling energy homeostasis and response 
to exercise of both lean and Ov/Ob populations. Participants were recruited and 
completed the intervention in 3 phases, the 8 week exercise and recruitment process 
was conducted twice with Ov/Ob participants and once again with lean participants. It 
was not intended to run the intervention twice with Ov/Ob participants but because of 
a high attrition rate it was necessary to do so. All participants expressed no desire to 
lose weight via qualitative questionnaire and during the course of the study, 
participants were not made aware we were investigating weight loss, to prevent them 
from knowingly altering energy intake. Pre and post intervention, body composition 
was assessed by dual-energy x-ray absorptiometry (DXA), along with peak oxygen 
uptake (?̇?O2PEAK), resting metabolic rate (RMR) and fasting and postprandial blood 
sampling to gain a comprehensive view of participants’ metabolic profile before and 
after the 8 week intervention. Diet diaries were also collected throughout the study to 
monitor participants’ energy and macronutrient intake. 
 
Anthropometry 
 
Three factor mixed model ANOVA with two between group factors (Intensity: high 
versus low and body type: lean versus Ov/Ob) and one repeated measures factor (pre 
versus post 8 week training intervention), revealed no significant differences in 
weight, BMI, lean mass and fat mass pre to post 8 week training intervention (Table 
4.2, all P’s > 0.05). However a significant effect for time (P = 0.011) was seen in 
percentage body fat, along with significant interactions between time and intensity (P 
= 0.041) and time and body type (P = 0.03). Both lean groups decreased in percentage 
body fat with LH decreasing considerably more than LL (Table 4.2), compared to OH 
and OL which were unaltered. Body fat was also separated into two different 
categories, trunk fat and limb fat and although there was no significant change in 
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either of these after the training, a trend towards an interaction between time and body 
type was observed. Both trunk fat and limb fat decreased slightly in lean participants 
and this was not seen in the Ov/Ob subjects (Table 4.2, all P’s < 0.1). Significant 
differences were also reported between lean and Ov/Ob participants for weight, BMI, 
lean mass, fat mass, percentage body fat, trunk fat and limb fat (All P’s < 0.05).  
 
Metabolic, aerobic and exercise tolerance measures 
 
Absolute ?̇?O2PEAK was unaffected by the training intervention and no group 
differences were observed between groups (Table 4.2, all P’s > 0.05). Relative 
?̇?O2PEAK was also unaffected by the intervention but a significant difference was 
observed between lean and Ov/Ob participants, with lean participants reporting 
significantly greater levels (Table 4.2, P = 0.000). RMR, RER and resting HR were 
also unchanged by the 8 weeks exercise training but a significant difference was seen 
between body types once again with Ov/Ob participants showing a significantly 
higher RMR.  
 
Heart rate (HR), ratings of perceived exertion (RPE), respiratory exchange ratio 
(RER) and energy expenditure (EE) were all monitored and recorded during every 
watt stage of ?̇?O2PEAK assessment. After conducting three factor mixed model 
ANOVA’s of HR at each stage no main effects were seen for any of the three factors, 
although significant interactions for intensity and body type were observed at every 
stage from rest to 130 watts, it seems that the LH group had the greatest response to 
exercise, lowering HR post intervention at every stage, LL had a reduced response but 
HR was still lower at all stages, OH had little to no response during stages and OL 
actually increased HR in most stages of assessment (Table 4.3, all P’s < 0.05 where 
significant).  
 
RPE data did not display normal distribution between groups; therefore a log 
transformation was used to achieve this. A significant effect of time was observed in 
RPE at 25 watts, with all groups rating the first stage lower. Significant interactions 
were also illustrated for time and intensity at 50, 70 and 110 and also time, intensity 
and body type, a trend was also seen in these at 90 watts, both high intensity groups 
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displayed greater reductions in RPE post intervention than low intensity groups, with 
lean participants showing the biggest reductions (Table 4.3, all P’s < 0.05 except 
trend where P < 0.1).  
 
RER showed no alterations post intervention and no group effects or interactions were 
seen either (Table 4.4, all P’s > 0.05). Also, EE did not display any significant main 
effects but a significant interaction was reported between time and body type at the 
onset of exercise (25 watts). Ov/Ob participants displayed significantly lower EE than 
lean participants at 25 watts pre intervention but following exercise this difference 
was no longer visible, meaning Ov/Ob participants energy expenditure normalised 
during exercise towards that seen in lean participants. A significant interaction was 
also observed between time and intensity for EE at 90 and 110 watts, including a 
trend at 70 watts, where high intensity groups increased EE and low intensity was 
unaffected (Table 4.4, all P’s < 0.05 except trend where P < 0.1). 
 
Blood parameters 
 
Analysis of lipid profile showed no change in total cholesterol after the training 
intervention and no effect of intensity or body type was reported (Table 4, all P’s > 
0.05). HDL showed no significant differences but LDL did show a significant effect 
of time and body type, with a significant interaction between intensity and body type 
also. LDL increased over the intervention in all groups apart from in the LH group 
and Ov/Ob levels were significantly greater than their lean counterparts (Table 4.2, all 
P’s < 0.05).  
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 Lean High Lean Low Ov/Ob High Ov/Ob Low 
 Pre Post Pre Post Pre Post Pre Post 
         
Weight (kg) 65.39±6.91* 64.42±6.75 62.99±4.20* 63.36±4.36 86.16±12.99 86.72±12.99 79.70±10.37 80.01±10.68 
BMI (kg/m2) 23.34±1.24* 23.00±1.44 21.67±2.50* 21.78±2.46 30.72±4.56 30.92±4.52 29.87±2.76 29.99±2.93 
Lean mass (kg) 43.84±6.17* 46.20±5.24 42.44±3.09* 42.79±3.13 50.88±5.40 51.38±5.78 47.54±5.20 47.36±5.21 
Fat mass (kg) 19.28±3.35* 17.23±4.33 18.62±3.75* 18.27±3.90 34.13±8.73 34.18±8.53 30.85±6.86 31.33±7.14 
Fat percentage (%) 29.77±5.52* 26.12±5.96† 29.40±4.84* 28.70±5.17† 39.15±5.06 39.01±5.02 38.38±4.91 38.80±5.16 
Trunk fat (kg) 8.24±1.99* 7.15±2.54# 8.16±2.40* 8.02±2.73# 17.26±5.07 17.45±5.02 14.73±3.95 14.94±4.22 
Limb fat (kg) 10.17±1.62* 9.21±1.84# 9.57±1.50* 9.37±1.34# 15.93±4.29 15.79±3.79 15.19±3.36 15.45±3.27 
VO2PEAK (L/min) 2.91±0.60 2.80±0.62 2.94±0.52 2.65±0.58 2.61±0.46 2.70±0.43 2.66±0.53 2.68±0.51 
VO2PEAK (ml/kg/min) 44.80±7.84* 43.08±9.34 46.43±5.71* 42.32±7.38 31.17±6.50 32.15±4.53 33.87±6.04 34.15±5.48 
RMR (kcal/d) 1386±247* 1441±144 1404±182* 1542±267 1762±344 1763±305 1488±238 1574±285 
RER (VCO2/VO2) 0.79±0.08 0.83±0.06 0.79±0.08 0.80±0.13 0.77±0.07 0.81±0.05 0.78±0.05 0.80±0.07 
Tchol (mmol/L) 3.38±0.60 3.36±0.53 3.80±0.40 4.13±0.82 3.90±0.79 4.13±0.70 3.81±0.90 4.12±0.69 
HDL (mmol/L) 1.70±0.47 1.80±0.55 1.67±0.34 1.64±0.38 1.24±0.26 1.23±0.23 1.75±0.50 1.56±0.34 
LDL (mmol/L) 1.52±0.58* 1.40±0.37 1.97±0.58* 2.31±0.69† 2.42±0.74 2.64±0.63† 2.05±0.65 2.34±0.63† 
         
Table 4.2. Physiological characteristics pre and post intervention of all groups, including anthropometric, metabolic and lipid data. Data are presented as means ± SD. * P < 
0.05 for differences between body type. † P < 0.05 for differences pre and post intervention. # P < 0.1 for interaction between time and body type. 
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 Lean High Lean Low Ov/Ob High Ov/Ob Low 
 Pre Post Pre Post Pre Post Pre Post 
         
HR (bpm)         
25 w 126.00±17.23 121.67±9.67 103.83±10.17 103.33±12.66 112.27±13.39 112.00±11.39 116.58±14.96 121.17±9.12 
50 w 133.33±17.42 128.33±10.75 113.17±10.78 109.17±12.29 119.00±12.97 119.82±12.32 125.42±14.64 127.25±12.02 
70 w 144.83±16.55 141.33±8.41 127.33±14.09 123.33±14.31 127.45±13.36 128.45±15.12 135.42±13.24 136.50±11.07 
90 w 155.67±13.71 151.67±10.88 139.17±13.96 136.17±16.61 137.82±14.79 139.00±15.09 146.42±13.03 146.75±11.99 
110 w 165.00±13.15 161.33±12.29 149.00±13.99 148.83±16.08 147.27±13.61 149.00±16.22 156.00±14.02 155.67±11.71 
130 w 174.50±11.04 169.50±12.80 159.83±12.35 159.67±14.49 155.70±12.01 158.18±16.02 165.42±12.68 164.42±11.78 
RPE         
25 w 7.67±1.21 6.33±0.52† 7.17±1.17 7.00±0.63† 7.09±1.64 6.82±1.25† 7.25±1.08 6.92±0.67† 
50 w 9.83±2.23 8.33±2.25* 7.50±1.38 9.00±1.41 8.36±1.80 7.64±1.29* 8.75±2.01 8.58±1.68 
70 w 11.75±2.52 10.17±3.06* 9.17±2.32 11.33±1.97 9.82±2.09 9.36±1.80* 10.38±2.48 10.00±1.91 
90 w 13.17±2.56 12.83±2.86 10.67±1.37 13.00±2.19 11.18±1.78 11.27±1.62 11.54±2.19 11.58±2.11 
110 w 15.33±2.25 14.17±2.93* 13.00±0.89 14.83±2.23 12.64±1.12 12.82±1.60 13.42±2.11 13.50±2.11 
130 w 17.17±2.14 16.67±3.20 14.83±1.33 16.50±2.59 14.10±1.52 14.59±1.69 14.92±2.15 15.17±2.21 
         
Table 4.3. Heart rate (HR) and ratings of perceived exertion (RPE) during each watt (w) stage of ?̇?O2PEAK assessment. Data are presented as means ± SD. * P < 0.05 for 
differences between time and intensity. † P < 0.05 for differences pre and post intervention. 
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 Lean High Lean Low Ov/Ob High Ov/Ob Low 
 Pre Post Pre Post Pre Post Pre Post 
         
RER (VCO2/VO2)         
25 w 0.84±0.09 0.81±0.08 0.80±0.05 0.82±0.11 0.82±0.08 0.83±0.09 0.84±0.13 0.83±0.10 
50 w 0.77±0.11 0.77±0.10 0.76±0.03 0.76±0.09 0.75±0.09 0.77±0.08 0.76±0.11 0.78±0.09 
70 w 0.79±0.14 0.81±0.13 0.78±0.03 0.80±0.10 0.77±0.12 0.76±0.08 0.76±0.11 0.79±0.10 
90 w 0.86±0.15 0.85±0.13 0.87±0.06 0.88±0.12 0.83±0.13 0.81±0.09 0.82±0.11 0.86±0.11 
110 w 0.92±0.17 0.91±0.15 0.94±0.08 0.97±0.13 0.90±0.15 0.87±0.10 0.90±0.13 0.93±0.12 
130 w 1.00±0.18 0.97±0.18 1.01±0.11 1.04±0.16 0.96±0.18 0.93±0.10 0.96±0.15 0.99±0.14 
EE (kcal.min-1)         
25 w 2.06±0.81 2.07±0.67 2.79±0.89 1.93±1.08 1.97±0.69 2.31±0.76* 1.81±0.60 2.12±0.66* 
50 w 2.70±1.04 3.46±0.73 3.62±1.39 3.31±0.73 3.41±0.66 3.61±0.81 3.26±0.55 3.43±0.91 
70 w 4.11±0.94 4.48±0.73 4.89±1.45 4.37±0.69 4.53±0.52 4.78±0.66 4.47±0.72 4.52±0.78 
90 w 5.14±0.66 5.38±0.78† 5.92±1.08 5.37±0.89 5.43±0.55 5.83±0.58† 5.32±0.64 5.39±0.77 
110 w 5.95±0.67 6.57±0.66† 6.83±1.03 6.42±0.74 6.35±0.53 6.67±0.44† 6.21±0.62 6.33±0.54 
130 w 7.02±0.72 7.44±0.81 7.96±1.14 7.71±1.17 7.58±0.46 7.89±0.63 7.23±0.57 7.36±0.50 
         
Table 4.4. Respiratory exchange ratio (RER) and energy expenditure (EE) during each watt (w) stage of ?̇?O2PEAK assessment. Data are presented as means ± SD. * P 
< 0.05 for differences between time and body type. † P < 0.05 for differences between time and intensity. 
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 Lean High Lean Low Ov/Ob High Ov/Ob Low 
 Pre Post Pre Post Pre Post Pre Post 
         
Fasting Glucose (mmol/l) 4.68±0.42 4.83±0.27 4.37±0.41 4.73±0.19* 4.78±0.34 4.66±0.26 4.37±0.41 4.63±0.31* 
Postprandial Glucose (mmol/l) 4.03±0.55 3.93±1.09 5.58±0.57 5.22±0.96 4.78±0.82 4.78±0.85 4.33±0.90 4.20±0.67 
Fasting Insulin (mU/L) 4.36±1.67† 4.55±2.15 3.33±2.52† 4.45±3.03 8.02±3.53 8.43±3.85 7.07±2.92 7.48±3.66 
Postprandial Insulin (mU/L) 22.25±6.84 26.68±10.98# 38.61±20.12 47.60±27.35# 41.01±22.48 52.01±17.30# 40.97±17.20 43.32±21.10# 
Beta Cell Function (%B) 73.52±19.26† 69.95±17.06 73.48±31.69† 71.28±32.82 105.46±29.54 114.10±33.14 116.73±32.86 106.07±28.51 
Insulin Sensitivity (%S) 201.82±74.05† 191.62±58.02 284.88±163.03† 236.88±117.68 114.70±47.48 112.47±53.21 134.80±62.32 123.43±46.23 
Insulin Resistance (IR) 0.56±0.22† 0.59±0.28 0.48±0.32† 0.57±0.38 1.03±0.46 1.07±0.50 0.89±0.37 0.97±0.48 
         
Table 4.5. Glucose and insulin levels both in fasting and postprandial conditions, with HOMA 2 calculations for beta cell function, insulin sensitivity and insulin 
resistance. Data are presented as means ± SD. * P < 0.05 for differences between time and intensity. † P < 0.05 for differences between body types. # P < 0.1 for 
differences pre to post intervention. 
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Fasting glucose also proved to be significantly affected by the intervention, a 
significant effect of intensity was also reported, along with a significant interaction 
between time and intensity, fasting glucose increased in all groups apart from OH 
(Table 4.4, all P’s < 0.05). Postprandial glucose revealed no effects of time on 
circulating levels, one hour after a test meal but a significant interaction was observed 
between intensity and body type (P = 0.000), as levels seemed to decrease in all 
groups except from OH once again.  
 
Fasting insulin demonstrated no significant effects of time, intensity or interactions 
although a significant difference was measured between body types with Ov/Ob 
participants displaying greater concentrations than lean participants (Table 4.4, P = 
0.002). Postprandial insulin showed no significant differences but a trend towards 
increased levels post intervention did occur and Ov/Ob tended to display significantly 
higher levels than lean participants (Table 4.4, all P’s < 0.1). When fasting values 
were subtracted from postprandial values to reflect the response to the test meal, 
Ov/Ob participants showed significantly greater differences than lean participants but 
no training effects were observed. 
 
HOMA 2 calculations, combining fasting measurements of glucose and insulin, were 
used estimate insulin sensitivity (%S), resistance (IR) and beta cell function (%B). %S 
data was not normally distributed and to resolve this data was transformed using a 
logarithm. Post intervention no differences were observed in %S, %B, or IR, no effect 
of intensity or any interactions were seen either but differences between body types 
were present, Ov/Ob participants displayed significantly greater %B and IR, while 
lean participants showed significantly greater %S (Table 4.4, all P’s < 0.05). 
 
Leptin and amylin concentrations were also measured in plasma samples before and 
after the 8 week exercise programme. Leptin was only measured in fasting samples as 
this was not expected to alter with a food challenge but amylin was measured both in 
a fasting and postprandial state, as with glucose and insulin. Leptin showed no 
significant differences when pre and post intervention levels were compared or 
between intensities (Fig. 4.1, all P’s > 0.05). However, a significant effect of body 
type as expected was observed, with Ov/Ob showing significantly greater amounts 
than lean subjects (Fig. 4.1, P = 0.000).  
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When fasting amylin values were compared significant main effects for body type and 
intensity were both seen, a trend was also observed for time as well as a significant 
interaction between time and body type (Fig. 4.2, all P’s < 0.05, trend P < 0.1). Figure 
4.2 illustrates a significant decrease in both Ov/Ob groups post intervention, with a 
greater reduction in the high intensity group, compared to no reduction in the lean 
participants. Postprandial amylin also showed a significant effect of intensity as well 
as, significant interactions between time and body type, intensity and body type (Fig. 
4.2, all P’s < 0.05), no main effects of time or body type were observed though. As 
with fasting amylin, postprandial amylin is reduced post intervention in Ov/Ob 
compared to lean which increased over time. Amylin response to test meal, where 
fasting levels were subtracted from postprandial concentrations, revealed no 
significant training effects or group differences (All P’s > 0.05).  
 
Moreover, pre intervention fasting amylin levels were significantly correlated with pre 
leptin levels (r = 0.435, P = 0.013), showing individuals with higher leptin 
concentrations also displayed higher amylin concentrations. When pre intervention 
concentrations were subtracted from post intervention concentrations (∆) of fasting 
amylin, this was negatively correlated with pre leptin also (r = -0.567, P = .001), 
demonstrating participants with higher leptin concentrations also showed the greatest 
reductions in amylin. Furthermore, leptin concentrations were significantly correlated 
with ∆ bodyweight (r = 0.4, 0.017), showing individuals with the greatest weight gain 
displayed higher leptin levels and those with the greatest weight loss tended to have 
lower leptin levels. 
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Fig. 4.1. Plasma leptin concentrations after an overnight fast, pre and post 8 week 
training intervention. Data are presented as means ± SEM. * P < 0.05 for differences 
between body types.  
 
 
Fig. 4.2. Plasma amylin concentrations after an overnight fast and one hour following 
a test meal. Data are presented as means ± SEM. * P < 0.05 for differences between 
body types. # P < 0.1 for differences pre to post intervention. † P < 0.05 between 
intensities. 
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Energy intake, expenditure and balance 
 
Total energy expenditure for the exercise training intervention was calculated using a 
telemetric heart rate monitoring system, as described in the methods section, to keep 
energy expenditure equal between groups. To test this assumption a one way ANOVA 
was used and no significant difference was found between groups (OH, 3317.09 ± 
1217.83 kcal, OL, 3331.60 ± 948.90 kcal, LH, 2747.42 ± 554.68 kcal, LL, 3453.90 ± 
1799.12 kcal, P = 0.712). Average training intensity in wattage was also calculated in 
the same way, from the telemetric system during training (OH, 121.56 ± 22.77 w, OL, 
60.96 ± 14.96 w, LH, 86.82 ± 15.75 w, LL, 68.48 ± 19.81 w). Both total energy 
expenditure from exercise and average training intensity were shown to be positively 
correlated with changes in lean mass (r = 0.344, P = 0.046; r = 0.370, P = 0.031, 
respectively), meaning participants with the highest expenditure and training load 
showed the greatest gains in lean mass.  
 
Total energy expenditure (kcal/d), total energy intake (kcal/d) and energy balance 
(kcal/d) were calculated for the duration of the 8 week training intervention based on 
DEXA data, as described in the methods section, and groups were compared with a 
one way ANOVA. Total energy expenditure showed a significant difference between 
groups (P = 0.044) and Tukey’s post hoc test only revealed a significant trend 
between OH and LH groups (OH, 2173.92 ± 345.80 kcal/d, OL, 1896.67 ± 293.52 
kcal/d, LH, 1745.60 ± 210.96 kcal/d, LL, 1829.65 ± 249.95 kcal/d, P = 0.098). Total 
energy intake also proved to be significantly different between groups (P = 0.022) and 
post hoc analysis showed a significant difference between OH and LH groups only 
(OH, 2192.98 ± 363.25 kcal/d, OL, 1973.55 ± 501.97 kcal/d, LH, 1508.35 ± 201.00 
kcal/d, LL, 1778.29 ± 340.60 kcal/d, P = 0.018). Finally, energy balance was also 
significantly different between groups (Fig. 4.3, P = 0.045) but only between OL and 
LH (P = 0.031), OH and LH showed a trend towards being significantly different (P = 
0.092).  
 
Percentage macronutrient intake of protein, carbohydrate, sugar and fat were also 
calculated from the diet diaries of participants across the 8 week training intervention 
and this was not shown to be significantly different between groups (all P’s > 0.05). 
However, even though no significant differences were reported in macronutrient 
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intake, percentage carbohydrate, sugar and fat intake were all significantly correlated 
with changes in lean mass (r = -0.541, P = 0.002; r = -0.451, P 0.014; r = 0.499, P = 
0.006, respectively), demonstrating high carbohydrate and sugar intake was associated 
with low lean mass and conversely, higher fat intake was associated with higher lean 
mass. 
 
 
Fig. 4.3. Energy Balance (kcal/d) during the 8 week training intervention, calculated 
from DEXA scans. Data are presented as means ± SEM. * P < 0.05 and # P < 0.1 for 
differences between LH. 
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Responders versus Non-Responders 
 
Although no alterations were observed in ?̇?O2PEAK after the 8 week intervention, it 
was noted that some individuals did show shifts in some exercise related outcomes 
during the ?̇?O2PEAK assessment. Most notably, a reduction of HR in the concomitant 
stages of the test post training. These individuals who reduced heart rate during each 
stage of ?̇?O2PEAK assessment from 25 to 130 watts were separated from those who did 
not and henceforth are referred to as responders; those who did not show this response 
are referred to as non-responders. Participants were split into four groups; Ov/Ob 
responders (n = 8), lean responders (n = 5), Ov/Ob non-responders (n = 14) and lean 
non-responders (n = 7). For statistical analysis a three factor mixed model ANOVA 
with two between group factors (Response: responder versus non-responder and body 
type: lean versus Ov/Ob) and one repeated measures factor (pre versus post 8 week 
training intervention) was used to compare groups. 
 
Anthropometry 
 
When comparing the results of the DEXA scans between responders and non-
responders to exercise, no significant differences were seen between groups, for 
weight, BMI, lean mass, fat mass, body fat percentage or distribution of fat (Table 
4.5, all P’s > 0.05).. However, trends were observed for differences in body weight 
and BMI when looking at the interaction between responders and non-responders over 
time, responders had a trend towards decreased body weight and BMI post 
intervention, whereas non-responders show no alterations post intervention (Table 
4.5, all P’s < 0.1). 
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 Ov/Ob responders Lean responders Ov/Ob non-responders Lean non-responders 
 Pre Post Pre Post Pre Post Pre Post 
         
Weight (kg) 88.07±13.59 87.69±14.43* 63.99±6.34 63.17±6.32* 80.56±10.39 81.35±10.53 64.34±5.52 64.39±5.20 
BMI (kg/m2) 31.57±3.87 31.42±4.13* 22.96±1.42 22.68±1.62* 29.89±3.42 30.18±3.47 22.18±2.49 22.19±2.38 
Lean mass (kg) 51.39±5.76 51.25±6.40 42.22±6.28 44.30±6.01 47.95±5.25 48.20±5.48 43.80±3.63 44.36±3.71 
Fat mass (kg) 34.97±9.42 34.72±9.53 19.56±2.24 17.98±3.48 31.56±6.72 32.11±6.79 18.52±4.17 17.7±4.42 
Fat percentage (%) 39.19±5.27 39.05±5.20 30.96±4.73 27.93±5.35 38.88±4.80 39.19±5.02 28.60±5.23 27.30±5.88 
Trunk fat (kg) 16.83±5.40 16.87±5.75 8.55±1.47 7.57±2.53 15.72±4.28 16.04±4.20 7.95±2.55 7.66±2.77 
Limb fat (kg) 17.19±4.12 16.88±3.82 10.09±1.03 9.51±0.95 14.91±3.35 15.13±3.19 9.71±1.86 9.18±1.79 
VO2PEAK (L/min) 3.05±0.30 2.91±0.41 2.63±0.68 2.32±0.63 2.47±0.40 2.61±0.46 3.13±0.31 3.02±0.31 
VO2PEAK (ml/kg/min) 35.86±6.33 33.89±4.22 40.72±7.23 36.04±6.68 31.26±5.64 32.99±5.69 49.11±3.26 47.46±5.02 
RMR (kcal/d) 1721±375 1758±319 1412±300 1473±228 1539±275 1642±284 1383±135 1505±216 
RER (VCO2/VO2) 0.76±0.05 0.78±0.06 0.76±0.05 0.82±0.09 0.78±0.07 0.82±0.07 0.81±0.07 0.81±0.11 
         
Table 4.6. Physiological characteristics pre and post intervention of responders and non-responders, separated into Ov/Ob and lean groups. Data are 
presented as means ± SD. * P < 0.1 for differences between pre and post intervention.  
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 Ov/Ob responders Lean responders Ov/Ob non-responders Lean non-responders 
 Pre Post Pre Post Pre Post Pre Post 
HR (bpm)         
Rest 79.83±11.13 74.83±10.7* 69.00±19.4 67.4.0±14.94* 63.83±4.96 70.00±4.69 67.5.0±4.32 67.83±5.98 
25 w 128.38±11.24 121.25±10.55* 121.40±23.91 111.20±18.98* 107.13±8.96 114.40±10.93 110.29±11.74 113.43±11.70 
50 w 136.38±9.87 125.50±12.11* 131.80±20.46 117.60±17.59* 114.87±9.19 122.73±12.98 117.14±13.02 119.57±14.06 
70 w 144.25±9.41 134.75±12.23* 146.60±16.32 133.00±13.29* 124.87±10.34 131.53±14.40 128.57±14.54 131.86±16.53 
90 w 154.13±9.43 143.75±12.51* 156.00±13.64 144.60±10.45* 136.00±12.37 142.67±14.88 141.29±15.03 143.43±19.36 
110 w 161.25±11.82 151.63±11.69* 165.40±13.50 155.40±9.13* 146.80±13.05 152.93±15.65 151.00±14.58 154.86±19.07 
130 w 168.75±11.59 161.25±11.51* 173.60±11.06 165.80±9.44* 156.57±12.05 160.50±15.60 162.57±13.99 163.71±17.70 
         
Table 4.7. Heart rate (HR) during each watt (w) stage of ?̇?O2PEAK assessment. Data are presented as means ± SD. * P < 0.05 for differences pre and post 
intervention. 
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Metabolic measures 
 
As stated above, no significant changes in ?̇?O2PEAK were seen as a result of 
completing the 8 week exercise intervention and no significant differences were seen 
between the responders or non-responders either; this was the case for both absolute 
and relative ?̇?O2PEAK (Table 4.5, all P’s > 0.05). RMR and RER did not reveal any 
significant differences either but resting heart rate did prove to be significantly 
different, as responders demonstrated a significant reduction in HR post training and 
non-responders showed no change, this alteration was also repeated in all stages of 
?̇?O2PEAK assessment from 25 watts through to 130 watts (Table 4.6, all P’s < 0.05). 
 
Blood parameters 
 
Blood analyses were also compared between responders and non-responders and no 
differences were found in cholesterol, glucose, insulin, HOMA 2 results or leptin (All 
P’s > 0.05), this was also taking into account fasting and postprandial levels of 
parameters. However, analysis of fasting amylin levels did reveal significant 
differences between groups (Fig. 4.4, P = 0.034), it seems that Ov/Ob participants 
reduced amylin levels and lean participants increased, as previously described but 
when comparing responders against non-responders, Ov/Ob non-responders decreased 
more so than Ov/Ob responders and lean responders increased in contrast to lean non-
responders which decreased post intervention.  
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Fig. 4.4. Plasma amylin concentrations after an overnight fast in Ov/Ob responders 
(OR), lean responders (LR), Ov/Ob non-responders (ON) and lean non-responders 
(LN). Data are presented as means ± SEM. * P < 0.05 for significant interaction 
between response to exercise and time. 
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Fig. 4.5. Energy Balance (kcal/d) during the 8 week training intervention, calculated 
from DEXA scans, for Ov/Ob responders (OR), lean responders (LR), Ov/Ob non-
responders (ON) and lean non-responders (LN). Data are presented as means ± SEM.  
Energy intake, expenditure and macronutrient composition 
 
Energy intake, expenditure, balance and macronutrient composition after the 8 week 
training intervention were compared between groups (Ov/Ob responders, lean 
responders, Ov/Ob non-responders and lean responders) by one-way ANOVA. No 
differences were seen between responders and non-responders for total energy 
expenditure or energy intake (All P’s > 0.05), however a significant trend was seen 
for energy balance (Fig. 4.5, P = 0.063), although not significant lean responders 
showed a greater negative energy balance than the lean non responders, Ov/Ob also 
displayed a lesser negative energy balance and the Ov/Ob non responders were the 
only group to show a positive energy balance. Analysis of macronutrient composition 
showed no significant differences in percentage protein, carbohydrate, sugar or fat 
intake (All P’s > 0.05). 
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Discussion 
 
The main findings of the current study are that an 8 week exercise training 
intervention, with ad libitum energy intake, did not induce weight or fat loss in Ov/Ob 
individuals, independent of exercise intensity. This is all the more meaningful as 
participants were not looking to lose weight and they were informed we were not 
looking to induce weight loss either. This is the first study to investigate the effects of 
chronic exercise on ad libitum energy intake in this manner, in an effort to better 
understand the compensatory mechanisms regulating energy balance. Our results 
suggest that body weight is part of a homeostatic mechanism closely regulated around 
a set point, which may exist in both lean and Ov/Ob populations but simply Ov/Ob 
individuals’ set point is upregulated. The significant reduction of amylin in Ov/Ob 
participants indicates that it may play a key role in regulating energy balance of these 
individuals. Although, no weight loss was observed post intervention, metabolic 
alterations to exercise were seen. Additionally, some individuals demonstrated far 
greater response to exercise than others and how these differ and why is discussed. 
 
The main aim of this study was to investigate the effects of an 8 week exercise 
intervention with ad libitum energy intake, on the regulation of energy balance in lean 
and Ov/Ob individuals and to analyse the potential mechanisms which may prevent 
weight or fat loss from increased energy expenditure through exercise. As stated 
above the training intervention at either intensity did not result in any weight or fat 
loss of Ov/Ob participants even though the on average participants expended 3220.53 
± 1167.62 kcal through exercise during the intervention, this should have been 
sufficient enough to bring about weight loss if participants kept to the same habitual 
diet as before training. As this was not the case it is evident that a compensatory 
mechanism promoting energy intake post exercise must exist in these individuals. No 
weight loss was achieved in lean participants either however, a significant reduction 
in percentage body fat was observed, suggesting that a compensatory mechanism 
regulating body weight exists in these participants also but this is inherently different 
from that of Ov/Ob individuals (Lustig 2006). In support of this, energy intake was 
seen to be lower in these individuals resulting in a significantly different energy 
balance also and this is likely responsible for the significant reduction in percentage 
body fat. In addition, the ability for the lean individuals to reduce body fat as a result 
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of the increases in physical activity may be a consequence of differences in absolute 
intensity. Despite the intensity being matched between groups through percentage of 
VO2PEAK due to the large differences in body weight, and body fat limiting their 
cardio-respiratory capacity, the lean participants were able to work at a higher 
absolute intensity enabling them to produce an exercise induced adaptation and drop 
in percentage body fat. As previously demonstrated long term high intensity exercise 
intervention combining ad libitum energy intake have been able to elicit greater 
changes in fat mass than lower intensity interventions (Tremblay, Drapeau 1999, 
Trapp et al. 2008).Finally, in line with previous investigations no significant 
alterations were identified in macronutrient composition following the 8 week training 
intervention (Martins, Robertson & Morgan 2008, Donnelly et al. 2003, Tremblay, 
Drapeau 1999). No significant changes were reported in carbohydrate, sugar, fat or 
protein intake of either of the lean or Ov/Ob participants, no differences were seen 
between groups either.  
 
Analysis of blood samples, more specifically parameters controlling glucose 
homeostasis were largely unaffected by the exercise intervention, this is unsurprising 
as the intervention did not alter macronutrient composition in either lean or Ov/Ob 
individuals. However, Ov/Ob participants were seen to have significantly higher 
fasting insulin levels and from HOMA 2 comparisons, scores of insulin resistance and 
beta cell function were significantly higher, with insulin sensitivity reportedly lower 
in these participants also, demonstrating a movement towards impaired glucose 
homeostasis in this population as previously well documented (Olefsky, Reaven & 
Farquhar 1974, Ferrannini et al. 1997).  
 
A further observation from the blood samples of the present study was the expected 
and significantly greater plasma leptin levels of the Ov/Ob subjects. The greater 
prevalence of high leptin concentrations in obesity is well established in the previous 
literature (Hellstrom et al. 2004, Hagobian et al. 2009). Additionally, also as 
previously seen no significant alterations were observed post intervention in any of 
the exercise groups (Martins, Robertson & Morgan 2008, Christiansen et al. 2010, 
Perusse et al. 1997). This was still the case even though participants in the lean 
exercise groups saw a reduction in percentage body fat, indicating that changes in 
both are not synonymous in lean participants at least. Moreover, in the present study 
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significant correlations were observed between insulin resistance and leptin (r = 
0.621) as previously described (Lustig 2006) indicating a potential leptin resistance 
mechanism which may prevent weight/fat loss in obesity and support a theory of body 
weight set point regulation. However, more research is needed into leptin resistance to 
greater understand these pathways (Kalra 2008).  
 
In the present study, both fasting and postprandial amylin concentrations were 
significantly reduced post training in Ov/Ob individuals, compared to no alteration in 
lean participants. This is the first study to document a significant reduction in both 
fasting and postprandial amylin concentrations after a long term exercise intervention. 
Previously, a significant reduction in amylin concentrations has been seen after a 14 
day diet and exercise intervention (Izadpanah et al. 2012) but mechanisms behind the 
reduction were not discussed and hence still very little is known about the effect of 
exercise on amylin levels. However, weight lowering effects in obese individuals 
have been associated with the amylin-analogue pramlintide, after 6 weeks of 
administration before meals in obese subjects; participants reduced body weight, daily 
food intake, portion size and binge eating tendencies (Smith et al. 2007). These 
findings suggest that a reduction in amylin would result in increased energy intake, as 
seen in the current study in the Ov/Ob participants, and that amylin may be part of a 
homeostatic mechanism protecting against a negative energy balance and therefore 
weight loss in obese individuals. It is possible that Ov/Ob participants in a 
hyperinsulinaemia and hyperleptinaemia state may have developed an over-reliance 
on amylin for satiety signalling, in turn increasing energy intake after exercise and 
overcompensating for an exercise induced energy deficit. 
 
In addition to the lack of weight loss after the 8 week exercise intervention, no 
exercise adaptations were observed in ?̇?O2PEAK, RMR or RER. Although, at the 
beginning of the exercise intervention there were also some underlying differences in 
characteristics of lean and Ov/Ob individuals, lean participants had a significantly 
higher relative ?̇?O2PEAK and lower RMR than their Ov/Ob counterparts but this was 
much as expected and as previously stated neither was altered by the intervention. 
From the data collected during the ?̇?O2PEAK measurement, it seems that the lean high 
intensity group had the biggest response to exercise as a significant reduction in HR 
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was seen for each of the workloads prescribed. This group also showed the greatest 
changes in RPE, suggesting that their exercise tolerance was improved by the 8 week 
training intervention. This seems to support the earlier discussions that the lean 
participants were able to achieve the highest absolute intensity during training and 
therefore demonstrated the largest training adaptations. Moreover, these findings also 
offer some support for previous research which state that high intensity exercise 
interventions are more effective than the low intensity equivalent (Trapp et al. 2008, 
Tremblay, Simoneau & Bouchard 1994). Energy expenditure during low intensity 
exercise was another factor measured during the ?̇?O2PEAK assessment that seemed to 
reveal some possible adaptations to the exercise intervention. Following the 
alterations seen in chapter 3 of the Ov/Ob participants during the 25 watts stage, 
energy expenditure was significantly lower in Ov/Ob participants prior to the 8 week 
training programme but post training no significant difference were seen when 
compared to the lean participants. This finding strengthens the argument in chapter 3, 
that Ov/Ob individuals tend to rely more heavily on anaerobic metabolism during low 
intensity exercise (Hunter et al. 2006). Furthermore, it also indicates that an exercise 
intervention can alter this metabolic condition and improve the oxidative capacity of 
obese individuals, this most likely achieved through improved lactate metabolism by 
promoting monocarboxylate transporter activity (Dubouchaud et al. 2000) .  
 
From the exercise data of the present study is it evident that participants varied 
substantially in their response to exercise, and there is a need to try and further 
understand why some individuals seem to respond to exercise more so than others 
(Booth, Laye 2010). A large number of factors have been identified to vary in 
responsiveness to exercise (Bouchard, Rankinen 2001) and exactly why these differ is 
likely largely due to genetic factors, as much as 48% (Bouchard et al. 1999). In the 
present study, participants were separated between those that demonstrated clear 
training adaptations and those that did not. Heart rate (HR) as previously seen to vary 
adaptive responses to exercise (An et al. 2003), was chosen as a mediator and 
participants who illustrated an improvement in this parameter during ?̇?O2PEAK 
assessment were grouped and referred to as responders, those that did not are referred 
to as non-responders. When grouped the responders showed a significant reduction in 
heart at all stages of the ?̇?O2PEAK test between 25 and 130 watts post intervention, 
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resting heart rate was also significantly reduced. Responders and non-responders were 
also split into lean and Ov/Ob groups (Ov/Ob responders (n = 8), lean responders (n = 
5), Ov/Ob non-responders (n = 14) and lean non-responders (n = 7)), signifying that 
response to exercise seems to be independent of body type. From anthropometric data 
responders displayed a trend towards a decrease in BMI and body weight although 
this was not significant; non-responders showed no significant differences post 
intervention. This was in conjunction with a significant difference in energy balance, 
both lean and Ov/Ob responders displayed a negative energy balance which tended to 
be lower than lean and Ov/Ob non-responders. Finally, when comparing amylin 
concentrations, lean responders displayed the lowest amylin levels and increased after 
the intervention compared to the Ov/Ob non-responders which showed the highest 
levels and decreased the most. Lean-non responders reduced but to a lesser degree and 
Ov/Ob responders decreased but also to a lesser extent. In summary, responders 
showed a trend towards greater weight loss and a more negative energy balance; 
moreover, responders demonstrated reduced effects of exercise on amylin 
concentrations. These findings seem to suggest that some individuals, irrespective of 
body weight or fat mass, are able to respond to exercise and achieve weight loss, this 
may be because they have not developed the postulated leptin resistance hypothesised 
earlier, meaning they do not develop the over reliance on amylin for satiety signalling. 
Without an accurate measure of leptin resistance it is not possible to test this 
assumption, highlighting the need for further research in this area.   
 
To conclude, the present study provides further evidence that a body weight set point 
may exist in lean and obese individuals but the regulation of this set point may be 
controlled by different mechanisms in both populations. It is apparent that in obesity, 
leptin resistance may lead to the promotion of amylin as a key regulator in a 
homeostatic mechanism that protects against any potential weight or fat loss through 
an increase in exercise induced energy expenditure. However, even though weight 
loss is not achieved in this population there are still positive metabolic alterations 
associated with exercise in obese participants. Finally, it is suggested that some 
individuals may be more susceptible to these training adaptations than others, and this 
may also influence a leptin-amylin mechanism regulating body weight. 
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CHAPTER V 
 
GENERAL DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 120 
 
Summary of the main findings 
 
The aim of chapter 2 was to investigate the associated metabolic alterations of high 
glucose availability on skeletal muscle; both in vivo and in vitro studies were 
designed to analyse the periodic and chronic effects. A 4 week sugar-sweetened 
beverage (SSB) intervention was prescribed to healthy, lightly active, normal weight 
individuals, with very little or no history of previous soft drink consumption to 
analyse the in vivo effects of periodic high glucose availability and to analyse the 
chronic effects in vitro, primary human muscle cell cultures were exposed to 
hyperglycaemia for 7 days and compared to control conditions. Western blotting and 
real time reverse-transcriptase polymerase chain reaction (RT-PCR) were conducted 
to analyse protein and gene expression of several metabolic markers. It was 
hypothesised that both in vivo and in vitro conditions would display elevated 
glycolytic and lipogenic activity, reduced oxidative activity and increased glucose 
sensing mechanisms, in response to the high glucose availability. 
 
From the results of chapter 2, the impact of high glucose availability on metabolism is 
clear to see. After only 4 weeks of exposure to high periodic glucose levels through 
SSB consumption, otherwise young healthy normal weight individuals with low 
physical activity demonstrated considerable alterations in metabolism of skeletal 
muscle comparable to those found in muscle cell cultures under hyperglycaemic 
conditions and type 2 diabetes mellitus patients. Our in vivo study showed that after 
only 4 weeks of SSB consumption on top of their normal habitual diet, fasting glucose 
and insulin levels were heightened, reducing insulin sensitivity. Moreover, fat mass 
was increased along with an altered substrate preference towards increased 
carbohydrate oxidation during fasting conditions, all demonstrating considerable 
changes to glucose homeostasis, metabolism and possible shifts in glycogen storage. 
These are among the more preliminary findings and further in depth analysis of 
fundamental changes to metabolic markers and glucose signalling systems on a 
protein and gene expression level were seen.  
 
Both our in vivo and in vitro studies demonstrated a shift towards increased glycolytic 
activity and reduced oxidative activity similar to that found in type 2 diabetes mellitus 
patients (He, Kelley 2004, Simoneau, Kelley 1997), after the high glucose availability 
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interventions. In addition, it is hypothesised that this alteration in metabolic 
phenotype may be influenced by changes to glucose dependent signalling and it is 
suggested that the MondoA-TXNIP relationship may play a key role in this 
adaptation. In both the in vitro and in vivo studies an increase in MondoA expression 
was observed and in the in vitro cell cultures TXNIP expression was also increased 
but this wasn’t seen under in vivo conditions. As TXNIP was not significantly altered 
in vivo it is possible that the SSB intervention was not long enough to promote 
MondoA activity sufficiently to bring about significant change to TXNIP expression 
but with a longer period of SSB consumption this is likely to change.  
 
The fact that the findings from in vivo study are comparable to those from the in vitro 
study, demonstrates the potency of high glucose availability in skeletal muscle. Cells 
in the in vitro study were under similar conditions to those reported postprandially in 
type 2 diabetes mellitus patients (Matsuda, DeFronzo 1999, Monnier et al. 2006) for 7 
days and under in vivo conditions participants were given on average 2 bottle of soft 
drink per day for 4 weeks, this was similar to average consumption in the UK (BSDA 
2011). The results are all the more alarming as the participants were young healthy 
individuals, not overweight or obese and with very little previous history of SSB 
consumption, highlighting just how damaging the effects of SSBs can be and the 
significant role they play in the development of obesity and type 2 diabetes mellitus. 
 
In chapter 3, 4 weeks moderate intensity exercise training was used to investigate the 
effects of chronic exercise with ad libitum energy intake on body composition, 
metabolism and mechanisms regulating energy balance. Both sedentary lean and 
Ov/Ob women, naïve to the true purpose of the study and no desire to lose weight 
underwent various assessments to measure the above factors. It was anticipated that 
Ov/Ob participants would respond to the increase in energy expenditure from exercise 
by adapting energy intake and therefore compensating for any possible weight loss 
from exercise induced energy expenditure. Furthermore, it was expected the lean 
exercise group would not display this mechanism and significant differences in the 
regulatory hormones and metabolic data of lean and Ov/Ob participants would offer 
further support for this argument. 
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The main outcomes from chapter 3 seem to suggest that exercise with ad libitum 
energy intake does not seem to induce weight or fat loss in Ov/Ob individuals. 
Importantly, as stated previously participants were not made aware that the true aim 
of the study was to investigate the effects of exercise on energy balance regulation, so 
that participants would not try to consciously alter their diet in anyway. However, 
even though Ov/Ob participants did not alter their body weight or fat mass, lean 
exercisers did show a trend towards reduced body fat and increased lean mass after 
the 4 week exercise intervention. These findings seem to suggest that both lean and 
Ov/Ob individuals have a body weight set point that is tightly regulated and not 
influenced by an increase in energy expenditure through physical activity. The fact 
that lean individuals were able to respond to exercise with altered body composition 
may be the explained by their ability to exercise at a higher absolute intensity, 
promoting more pronounced physiological adaptations to exercise. Furthermore, it is 
suggested that the lack of weight loss can be explained by an over-compensatory 
mechanism present in non-exercisers, however the trend towards a more tightly 
coupled energy intake and expenditure later in the exercise intervention does show 
that exercise can improve eating sensitivity of individuals with previously low levels 
of physical activity (Martins, Robertson & Morgan 2008, Martins, Truby & Morgan 
2007). Additionally, a further explanation for the differences seen here in lean and 
Ov/Ob individuals may be the observed differences in protein intake. It is suggested 
that the lean participants reported greater consumption of protein intake may have led 
to their increase in lean mass and subsequent reduction in percentage body fat. 
Finally, significant differences were seen in the leptin concentrations of the two 
different body types as expected (Hellstrom et al. 2004, Hagobian et al. 2009) and it is 
implied that this difference may be important in regulating a body weight set point 
(Farooqi et al. 2001). 
 
Importantly, a further finding of the 4 week exercise intervention in chapter 3 is the 
shift in anaerobic metabolism of the Ov/Ob participants during low intensity exercise 
towards aerobic metabolism at the same intensity post intervention. This was seen in 
the normalisation of energy expenditure in these individuals towards those of their 
lean counterparts. It is postulated that this exercise induced metabolic alteration is 
associated with improved lactate metabolism resulting in increased oxidative capacity 
of skeletal muscle and hence improved efficiency (Dubouchaud et al. 2000). 
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The 8 week exercise intervention in chapter 4 was an expansion on the findings from 
chapter 3 and the 4 week exercise intervention. The intervention still kept the ad 
libitum design and participants were still naïve to the true purpose of the study but the 
intervention and data collection was more overreaching, building on the observations 
of the 4 week intervention. Not only was the intervention twice as long but greater 
analysis was carried out on the blood samples, collected pre and post intervention, 
including the addition of a test meal and postprandial sampling. In addition, the effect 
of both high and low intensity exercise was investigated and greater control of heart 
rate and energy expenditure was upheld, with the use of a heart rate telemetric 
monitoring system. Finally, resting metabolic rate was also measured to gain a more 
complete view of the participants’ metabolic profiles. Similar to chapter 3 it was 
hypothesised that Ov/Ob participants would display compensatory tendencies in 
response to the exercise induced energy expenditure, adapting energy and 
macronutrient intake, thus preventing any weight or fat loss. Importantly, this was 
expected to be facilitated by a reduction in amylin concentrations, explained by 
reduced insulin and leptin sensitivity in this population. This was not anticipated in 
the lean participants with normal metabolic function, because of this it was expected 
lean participants would demonstrate a stronger response to exercise. 
 
To summarise the findings of the 8 week training intervention, no significant weight 
loss was observed as per the 4 week intervention. Neither Ov/Ob nor lean participants 
reported a reduction in body weight; however lean participants did show a significant 
decrease in percentage body fat. This finding reaffirms the notion that with an 
increase in exercise induced energy expenditure, Ov/Ob individuals demonstrate a 
tendency to over-compensate this deficit with increased energy intake, negating any 
possible weight or fat loss and possibly even promote weight gain. On the contrary 
lean individuals do not display the same over-compensation to the increased energy 
expenditure and there energy intake is unchanged. As previously described in relation 
to the 4 week exercise study, it is hypothesised that the lean participants were able to 
display a reduction in body fat through the ability to exercise at a higher absolute 
intensity.  
 
 124 
 
As greater analysis of blood samples was carried in the 8 week exercise intervention it 
was possible to further investigate and identify possible regulators and relationships 
that may control a body weight set point or homeostatic mechanism, preventing or 
protecting against weight/fat loss in obese individuals. Following 8 weeks exercise 
training a significant drop in amylin concentrations was observed in the Ov/Ob 
participants, compared to no change in the lean subjects. In light of this finding, it was 
proposed that Ov/Ob individuals, who also displayed heightened insulin resistance 
and hyperleptinemia, have developed an overreliance on amylin for satiety signalling. 
Moreover, in conjunction with the inability to achieve an absolute intensity high 
enough to induce adaptive responses to exercise, OvOb individuals with reduced 
amylin secretion, increase energy intake after exercise and prevent any possible 
weight or fat loss. 
 
Furthermore, it’s not all bad news as adaptive responses to exercise were seen in line 
with the 4 week exercise study, the Ov/Ob individuals in the 8 week exercise study 
also displayed a positive movement away from a preference to rely on anaerobic 
metabolism at low exercise intensity pre-intervention, towards more anaerobic 
metabolism post-intervention. It was suggested, that this metabolic alteration was as a 
result of improved lactate metabolism, facilitating an improvement of the oxidative 
capacity of skeletal muscle (Dubouchaud et al. 2000). 
 
In addition, following the 8 week exercise intervention, the inter-individual variability 
in response to exercise was investigated. As previously described individuals seem to 
vary greatly in their response to exercise (Bouchard et al. 1999) and in this study 
participants were separated based on their heart rate response, which individuals have 
previously been identified to vary in magnitude of response (An et al. 2003). After 
separation into responders and non-responders, it was revealed that those who clearly 
demonstrated adaptations, also tended to lose more weight, maintain a negative 
energy balance, and avoid the maladaptive decrease in amylin concentrations. 
Suggesting these individuals do not develop the hypothesised leptin resistance, and 
overreliance on amylin signal, meaning they do not overcompensate for increased 
exercise induced energy expenditure and can lose weight. 
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Strengths and weaknesses of the research design 
 
The major strength of the studies in chapter 2 are their generalizability, the conditions 
are similar to those seen in a ‘real world’ situation. Although, energy intake was not 
controlled and may be considered a confounding factor, participants were asked to 
keep to their normal habitual diet and diet records were kept to see how the SSB 
intervention may influence this. Furthermore, glucose load was prescribed based on 
average consumption values, as reported by the British soft drinks association, 
making the findings generalizable to a large proportion of the UK population or 
western society. This study was also the first to attempt to measure MondoA 
responses in vivo and the first to demonstrate that MondoA protein and gene 
expression can be influenced by chronic hyperglycaemia in vitro and further elevated 
by periodic high glucose availability in vivo.  
 
One of the main strengths of the exercise interventions in chapter 3 and 4 is also the 
more realistic approach to the design of the intervention. Many exercise studies in the 
past has employed very demanding high intensity exercise interventions, in a lab 
based environment with a large time commitment. In contrast, these studies were 
undertaken in a gym environment with a group circuit training based intervention, 3 
days a week, for an hour. This is more typical and achievable for a subject that is not 
used to taking part in physical activity and hence, the results are more generalizable to 
what an individual may be able to undertake in a free living environment. A further 
strength of the study design was the naivety of the participants to the true nature of 
experiments; this meant participants were unlikely to modify their energy intake 
purposefully and the sensitivity of data was improved. Finally, both of these studies 
are the first of their kind to investigate the differing responses of Ov/Ob and lean 
individuals to chronic exercise with ad libitum energy intake, and the 8 week exercise 
intervention was the first study to identify amylin’s key role in mediating weight loss 
through exercise. 
 
A possible limitation of the in vivo study into SSB consumption may be the choice of 
SSB itself, participants in this study were prescribed a glucose syrup based soft drink 
and therefore careful consideration must be taken when generalising the findings to all 
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soft drinks. More frequently high fructose corn syrups are used to sweeten soft drinks 
and fructose may vary in its effects on metabolism. Sample size may be considered a 
further limitation of this study, eleven subjects were recruited and took part in the 
study, but only ten participants were able to provide a blood sample and muscle 
biopsy post intervention. It is possible that the findings in this sample may not be 
representative of the population, participants were chosen to take part in the study 
after completing a questionnaire based on their soft drink habits and it was difficult to 
find participants with a very little previous history of SSB consumption that met the 
inclusion criteria. 
 
One of the limitations of the 4 week exercise study was the lack of an accurate resting 
metabolic rate (RMR) measurement. In this study resting energy expenditure was 
estimated based on the indirect calorimetry of the 3 minutes of rest before ?̇?O2PEAK 
assessment. However, this limitation was reconciled in the 8 week exercise study, 
resting metabolic rate was measured following previously published guidelines 
(Compher et al. 2006). A limitation of the 8 week study may be the use of the 
telemetric heart rate monitoring system in estimating energy expenditure. High 
variability in heart rate during exercise has previously been demonstrated (Elia, 
Stratton & Stubbs 2003) but for an intervention of this nature and size, more accurate 
means of measurement would not be justifiable. A further limitation of both of these 
studies is the use of self-reported diet diaries in analysing energy intake. Previous 
literature demonstrates that the mere introduction of dietary intake methodology can 
alter dietary habits (Bingham 1991, Stallone et al. 1997) and obese individuals have 
previously been known to under report food intake by as much as 30 % (Lichtman et 
al. 1992). However taking these considerations into account there is realistic 
alternative to replace this measure in this study design. 
 
Recommendations for future research 
 
Taking into account the findings of chapter 2 and the possible limitations to the study 
design, larger and broader studies need to be conducted to further develop the 
understanding of the role MondoA and TXNIP play in the regulation of metabolic 
adaptations to high glucose availability. Future studies would be well placed to 
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investigate the counterbalancing effects of exercise in protecting against the effects of 
high glucose availability.  
 
Outcomes from both exercise studies seem to agree that Ov/Ob individuals 
counterbalance the increased energy expenditure from physical exercise interventions 
with increased energy intake, when no emphasis is placed on adjusting dietary intake. 
It has been suggested that amylin may play an important role in regulating this 
homeostatic mechanism. As already discussed this is the first study to observe this 
finding and therefore more research is required to investigate this mechanism and 
reaffirm these findings. Additionally, the current study was carried out using only 
female participants; logically further research needs to be carried out to investigate 
whether the mechanisms suggested here are gender specific. Previous literature has 
led to the suggestion that exercise training programs may be less effective with female 
populations, than with their lean counterparts (Donnelly et al. 2003, Potteiger et al. 
2003). Men and women have also previously been shown to vary leptin 
concentrations in response to exercise (Hickey et al. 1997).  
 
Furthermore, exercise modality is an important consideration in prescribing exercise, 
in this thesis circuit training was chosen as it was assumed this would be the most 
effective group based training intervention and combined both resistance and aerobic 
elements of exercise. To date there is conflicting research investigating the most 
appropriate training modality to induce weight loss and bring about training 
adaptations in the Ov/Ob. Prior literature employing an 8 month intervention 
comparing aerobic training (AT), resistance training (RT) and combined aerobic and 
resistance training (AT/RT), demonstrated reduced energy intake and body mass in all 
groups but the combined approach also increased lean mass (Bales et al. 2012). 
Similarly, a further study also observed significantly reduced body mass, BMI and 
body fat in AT and AT/RT after 12 months but the AT/RT group saw an additional 
increase in lean mass also (Carnier et al. 2013). In a shorter duration study of 3 
months, a combined approach to training yielded significantly greater improvements 
in body mass, fat mass and cardiorespiratory fitness, more so than AT or RT alone 
(Ho et al. 2012). Greater responses to combined training have also been seen in 
participants with metabolic syndrome (Dutheil et al. 2013) and insulin resistance 
(Davidson et al. 2009). In contrast, no differences have also been reported when 
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comparing modalities after a 48 week training intervention (Wadden et al. 1998). 
Wadden et al. (1998) observed no differences in AT, RT or AT/RT, only a smaller 
reduction in REE of the AT group compared to RT. Further studies only comparing 
AT and RT have also measured no differences in response, however exercise capacity 
was still improved in both cases (Sale et al. 1995, Sarsan et al. 2006). Consequently it 
has been argued that because an AT/RT intervention did not produce significantly 
greater reductions in body mass or fat mass, with the additional time commitments, 
AT alone may be the optimal modality for many where lean mass is not of a concern 
(Willis et al. 2012). Interestingly, the findings from this thesis clearly demonstrate 
that lean individuals were able to achieve greater adaptive response to exercise than 
their Ov/Ob counterparts; possibly through an ability to exercise at a greater absolute 
intensity. Future exercise studies with obese individuals would likely benefit more 
from combined AT/RT training which may increase lean mass and stimulate greater 
metabolic alterations, preventing the maladaptive leptin-amylin response and 
facilitating weight loss. 
 
Finally, in these studies, there was a considerable pressure and lack of funding which 
has limited the scope of these investigations. Future research would benefit from 
larger scale studies, with greater and more representative sampling which would 
improve the generalizability of findings. Taking into account all of the studies 
employed in this thesis, subsequent studies would inevitably need to investigate the 
effectiveness of diet and exercise interventions. A randomised pre-test post-test 
design with control, diet, and diet-exercise groups would be a logical progression. Pre 
and post-test measures would involve both blood and muscle biopsy sampling, to 
analyse both of the key mechanisms put forth in this thesis, controlling metabolic 
alterations of skeletal muscle to high glucose availability and response to exercise. 
 
Conclusions 
 
From the overwhelming evidence provided in chapter 2, the contribution of SSBs to 
the current obesity and type 2 diabetes epidemic is all too apparent. Through the 
constant exposure of periodic high glucose availability for just 4 weeks, otherwise 
lean healthy individuals with low physical activity and very little previous usage of 
SSB consumption demonstrated a clear alteration in metabolic phenotype and 
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substrate preference which could lead to shifts in metabolism of skeletal muscle 
similar to those in type 2 diabetes mellitus. The fact that it was possible to observe 
these changes in this population highlights the potency of regular SSB consumption 
and as the findings were comparable to those seen in primary muscle cell cultures 
under chronic hyperglycaemic conditions, the role of chronic and periodic high 
glucose availability in skeletal muscle contributing to obesity is undeniable. It is 
hypothesised that increases in MondoA and TXNIP contribute to the development of 
this metabolic alteration and movement towards a pre-diabetic state and this is where 
future treatment of type 2 diabetes mellitus might lead.  
 
Additionally, in combating obesity, many health professionals look to and recommend 
promoting physical activity in obese populations and this is what led to the exercise 
intervention studies in chapter 3 and 4. In order to truly test the effectiveness of 
exercise as a cure for obesity, a more ecologically valid methodological approach was 
employed, with ad libitum energy intake and a more realistic and typical exercise 
programme that previously sedentary individuals would be capable to sustain. From 
these exercise interventions it was concluded that Ov/Ob individuals are not capable 
to achieve the desired weight or fat loss normally associated with exercise. Instead, 
Ov/Ob subjects respond to exercise by increasing their energy intake and over-
compensating the induced energy deficit, resulting in no weight loss and possibly 
even weight gain. This is not to say that obese populations consciously alter their 
intake but alternatively, through an already impaired metabolism, likely caused by a 
poor diet high in refined carbohydrate and sugars, they have developed a metabolic 
phenotype controlled by leptin resistance and maladaptive amylin satiety mechanism, 
where they are incapable to achieve weight loss through exercise alone.  
 
The previous statements may not show exercise prescription, for obese populations, in 
a positive light but this does not mean it should not be recommended in this 
population, as there are still positive outcomes through promoting physical activity in 
the obese. Even without weight loss Ov/Ob participants in both exercise interventions 
demonstrated positive training adaptations, in the form of improved oxidative 
capacity of skeletal muscle. Bearing this in mind and taking into account all of the 
considerations outlined above, moving forward in the treatment of obesity it is clear 
that an exercise only or a one size fits all approach is not the answer. A more multi-
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dimensional approach is necessary and in order to reduce many of the associated 
lifestyle disease markers, both diet and levels of physical activity must be addressed 
in the obese. Recommendations for future intervention studies must address this and 
combine a diet low in refined carbohydrates and sugars, with high intensity interval 
training and resistance exercise. 
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APPENDIX A.1 
Participant information sheet for sugar-sweetened beverage study 
 
Study Title: Effects of a 4 week sugar-sweetened beverage (SSB) intervention on 
psychophysiological factors  
 
You are being invited to take part in a research study. This information sheet is 
designed to help you decide whether or not you would like to participate. 
 
Please ask at any time if you feel anything is unclear or contact: 
Francesco Sartor                          pep421@bangor.ac.uk          tel: 01248 388254 
 
What is the background of the study? 
With this study we want to look at the effects of sugar-sweetened beverage (SSB) 
consumption on several systems of the human body. We will analyse how the 
metabolism is affected, whether taste is affected, whether there is an effect on mental 
task performance.   
 
Do I have to take part?  
It is up to you to decide whether or not to take part. If you decide to take part you will 
be given this information sheet to keep and be asked to sign a consent form. If you 
decide to take part you are free to withdraw at any time and without giving a reason. 
 
 If you are a student this will not affect the marks you receive, the outcome of your 
period of study at SSHES or your standing with your supervisor, other staff or with 
the School. After completion of this study your expenses and time commitment will 
be reimbursed by £100.  
 
So that the results of this study will answer our research question we need to be sure 
that the people who take part have similar sort of physiques. Because of this we have 
a strict list of who can and cannot take part in the study. We will ask you a list of 
questions to make sure that you have the sort of physique we are looking for.   
 
What will happen to me if I take part?  
SUMMARY  
First of all we will ask you to keep a diet diary where you will write precisely what 
you eat and drink for two weeks. Then several tests will be carried out. These tests 
will include a muscle biopsy, a blood sample, a taste test and a mental task. They are 
described in detail below. Once you have done all these tests you will start taking the 
SSB supplement. You will be asked to keep taking the supplements every day for 4 
weeks. During this period you will be asked to keep a diet diary to make sure that 
your eating habits stay the same. The amount of drink you will be asked to take each 
day will depend on your weight.  If your body weight is around 70 kg (11 stones) you 
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will be asked to drink two one bottles (380ml a bottle) of Lucozade a day, if your 
weight is around 90 kg (14 stones) you will be asked to drink three bottles of 
Lucozade per day, if your body weight is greater than 90 kg (more than 14 stones) we 
will give you three bottles and a half per day. When the four week period has finished 
we will repeat all the tests we did at the beginning. Finally, you will be asked to keep 
a diet diary for the two weeks following the end of the study.    
 
Details of Study 
The details of the study are set out in the flow chart.  
 
DIET DIARY 
We will give you a Food Record Sheet (FRS) where you should describe with 
accuracy and precision your daily food and beverage intake. You will be asked to 
keep a record of your diet before, during and after the supplementation. The FRS will 
include 7 days food record. Those 7 days will be randomly chosen over a period of 
two weeks concerning the pre-tests and post-tests periods. A 14 day food record (two 
FRS) will be used for the 4 weeks of the supplementation period. How to describe 
foods and drinks will be fully explained in the Food Record Form.  
 
Tests: Day 1 (55 minutes) 
 
MENTAL TASK  
We will ask you to undergo a computerised way of measuring the speed with which 
you respond to the pictures of different objects. This will allow us to asses your 
reaction times and whether they might be changed by drinking SSBs. This test 
requires about 10 minutes at the computer. 
 
TASTE TEST 
You will be asked to refrain from 1) drinking alcohol the day before this test, 2) 
caffeine on the day of testing. In this test we are looking at how you respond to sweet 
and salty tastes. We will prepare sweet or salty solutions at different strengths. You 
will be asked to wash your mouth with each solution for about 5 seconds, spit the 
solution out and then rate how strong and how pleasant the taste is. We will tell you 
whether the solution is meant to be sweet or salty, but we will not tell you anything 
about its concentration. Between each taste you should rinse your mouth with a glass 
of demineralised water for 20 seconds. The total time of this test will be around 30 
minutes.  
 
DEXA SCAN 
A whole body low radiation (DXA) scan will be performed to assess how much bone, 
fat and muscle mass you have. For this procedure you need to wear shorts, socks, 
underwear (no bra) and t-shirt. The scan will last 15 minutes. This procedure is 
painless, and it is not more than lying down on a bed. Although there are small risks 
involved in radiation exposure, the amount of exposure during a DXA scan is minimal 
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and is lower than the amount of background radiation that we are exposed to during 
the course of two weeks in North Wales. 
 
Tests: Day 2 (1h 10 min) 
You will be asked to come to our labs in a fasting state (without eating anything since 
the night before).  
 
RESPIRATORY QUOTIENT  
You will be asked to lie on a bed for about 30 minutes while we will measure how 
much oxygen you uptake and carbon dioxide you produce. We will use a breath by 
breath gas analyser which does not involve you inhaling gas of any sort. The analyser 
just collects the air that you normally breathe in and out. This test is necessary to find 
out more details about your metabolism.   
 
BLOOD SAMPLING 
We will take only two blood samples, from a vein of your forearm. A small amount (8 
ml) of blood will be collected (0.2% of the total blood volume). We will use sterile 
needles to draw the blood samples. It is very important that you have fasted overnight. 
The first blood sample will be used to measure the fasting glucose and insulin levels 
in your blood. Afterwards, we will give you a very sweet drink (75 g sugar). One hour 
after you drank it we will take the second and last blood sample. This will give us 
precious information about your metabolic response to a sugar load.    
 
NEEDLE MUSCLE BIOPSY 
After one hour you drank the sweet drink, mention above, we shall take one small 
piece of muscle from one of your thighs. The procedure to remove the specimens will 
be performed by Dr Verena Matschke, Rheumatology research fellow, from SSHES 
experienced in taking muscle specimens. First of all the skin of the thigh is numbed 
with local anaesthetic and then a special sterile needle is inserted in to the muscle to 
take the sample. This is done twice. The procedure is usually painless. At the most, it 
will feel as you have been given a light punch in the thigh. No more than 40 mg of 
muscle tissue will be taken. There are usually no side effects but sometimes a bruise 
may form in the muscle. If this happens, the leg muscle will feel a bit stiff and sore for 
the next few days. It is possible that infection could be introduced. This is most 
unusual because the procedure is done under sterile conditions. If it does occur you 
will be given an antibiotic which should resolve things quickly. This procedure takes 
about 30 minutes. If any problems do arise you can contact us (details below).  
 
Experiment  
4 WEEKS SSB SUPPLEMENTATION  
Once you have completed the baseline measures, we will provide a SSB 
supplementation on top of your habitual diet. It will be important that you do not 
change your usual diet. The supplementation will consist of two bottles (380ml a 
bottle) of Lucozade if your body weight is around 70 kg (11 stones) or three bottles (1 
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litre) of Lucozade if your weight is around 90 kg (14 stones) and three bottles and if 
you body weight is greater than 90 kg (more than 14 stones) per day. {Lucozade 
contains only 0.012 % caffeine. You will not be consuming more than about 92 mg of 
caffeine/day, which means much less than a cup of coffee (100-240 mg per cup)}. 
During the whole duration of the supplementation we randomly will ask you to collect 
a sample of urine for us. This will help us to control your adherence to the 
supplementation. 
NB Moreover, we advice on having a good dental care throughout the 
supplementation period, for this reason we suggest cleaning well your mouth and 
teeth after each meal and Lucozade ingestion.  
 
Post-tests in the lab 
At the end of the supplementation period all the tests will be repeated in order to find 
differences between baseline and post supplementation.  
 
Timetable  
Including the two weeks of baseline where you will be asked to keep only a diet diary 
of what you eat, this study lasts 6 weeks. For 4 weeks what you are asked to do is 
only to keep a diet diary and drink the SSBs provided. 
 
Possible risks of taking part: 
You might experience some discomfort associated with the muscle biopsy. Muscle 
biopsy might cause some bleeding. We will give you a special plaster which reduces 
the risk of bruises. Although, we have never seen this to occur, there is a slight 
possibility of infection related to the muscle biopsy. In this case antibiotic should 
resolve things quickly. You also might experience discomfort during blood sampling. 
The blood sampling might be stressful for people who do not like needles or seeing 
blood. However, one blood sample is often as stressful as being stung by a thorn of a 
rose. High consumption of SSBs may provoke slight weight gain (0.5 kg; 1.1 pounds 
in 4 weeks). All these effects are reversible when the supplementation is stopped and 
when a normal diet and physical activity are reintroduced. 
 
Possible benefits of taking part: 
An economic benefit of £100 will be provided in case you carry out the study. By 
taking part in this study you will have the possibility to find out valuable information 
about your health.  
Your participation in this study will provide us with valuable insights into how the 
human body and mind adapts to drinking SSBs. It will add to our understanding of 
why some people develop common conditions like diabetes and obesity which are 
major health problems in this day and age. 
 
Confidentiality  
All information which is collected about you during the course of the research will be 
kept strictly confidential. Any information which leaves the School will have your 
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name and address removed so that you cannot be recognised from it. It will not be 
possible to identify you in any report or publication of the study.  
 
Who is organising or funding the research?  
This study has been organised by Mr Francesco Sartor and Dr Hans-Peter Kubis from 
the SSHES of Bangor University, in collaboration with Dr David Markland from 
SSHES and Dr Verena Matschke, Rheumatology research fellow, from SSHES too, 
and in collaboration with Dr John Parkinson from the School of Psychology of 
Bangor University and Prof Lucy Donaldson from the Department of Physiology and 
Psychopharmacology Unit of the University of Bristol.  
 
Who has reviewed the study?  
This study has been approved by the SSHES Ethics Committee. 
 
Any Questions? 
Please ask us if you have any questions.  
 
Principal investigator: Francesco Sartor, pep421@bangor.ac.uk ,  (01248) 388 254. 
Chief investigator: Dr Hans-Peter Kubis, pes203@bangor.ac.uk, (01248) 388 261.   
 
For any complaints please contact Prof Michael Khan m.khan@bangor.ac.uk, (01248) 
38 8275 
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I will take part 
in the study 
 
Sign informed 
consent 
 
Keep diet 
diary for 2 
weeks 
PRE-TESTS DAY 2 
 
- Overnight fasting  
- Respiratory quotient (30 min) 
- One blood sample (10 min)  
- Needle muscle biopsy (30 min)  
 
1h 10 min 
 
 
Total duration 40 minutes  Payment £10 
PRE-TESTS DAY 1 
 
- Mental task (10 min) 
- Taste test (30 min)  
- DXA scan (15 min) 
 
Total duration 55 minutes  
EXPERIMENT  
 
4 weeks of SSB supplementation 
 
For example, one and a half bottles (750ml) of 
Lucozade if your body weight is around 70 kg (11 
stones) or two bottles (1 litre) of Lucozade if your 
weight is around 90 kg (14 stones)  per day 
 
End of the study and 
Payment of  £100 
 PRE-TESTS DAY 2 
 
- Overnight fasting  
- Respiratory quotient (30 min) 
- One blood sample (10 min)  
- Needle muscle biopsy (30 min)  
 
1h 10 min 
 
 PRE-TESTS DAY 1 
 
- Mental task (10 min) 
- Taste test (30 min)  
- DXA scan (15 min) 
 
Total duration 55 minutes  
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APPENDIX A.II 
Participant information sheet for 4 week study 
1. Title 
 
The effect of a 4 week training programme on metabolism and cognitive 
reactions (Reaction Time) in lean and overweight inactive women. 
 
2. What is the purpose of the study? 
 
The aim of this study is to find out the effects of 4 weeks of circuit training on 
metabolism and cognitive reactions (reaction time) in lean inactive women. 
This study will hopefully bring a greater knowledge of the effect exercise has 
on metabolism and cognitive reactions (reaction time) in inactive lean and 
overweight women. 
 
3. Why have I been chosen? 
 
You have been chosen because of the information you gave us in the pre-
screening questionnaire matches that required for participation in this study. 
 
4. Do I have to take part? 
 
Your taking part in this study is entirely voluntary. It is up to you to decide 
whether or not to take part. If you decide to take part you will be given this 
information sheet to keep and be asked to sign a consent form. If you decide to 
take part you are still free to withdraw at any time and without giving reason. 
 
5. What do I have to do? 
 
As a participant, you will be asked to complete a food diary 3 days a week for 
8-weeks.  
 
Pre-testing will consist of a cognitive (reaction time) test, a body composition 
analysis (DEXA scan), a resting capillary blood sample from the earlobe, and 
maximal exercise (?̇?O2max) test. These tests in total will take between 60 and 
90 minutes.  
 
Half of the participants will be asked to take part in a 4 week circuit training 
intervention, working at 70% individual ?̇?O2max 3 times a week for one hour 
and continue to complete food diaries on the same 3 days each week for 8-
weeks. The other half of the participants will only complete the food diaries.  
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After those 4 weeks all participants will re-take the cognitive (reaction time) 
test, DEXA scan and ?̇?O2max. The results will be compared with the initial 
test results.  
 
Although your results will be used within the final report, the information you 
provide will remain anonymous. Results, therefore, will not be attributed to a 
specific individual. 
 
 
6. Benefits of taking part? 
 
You will complete two ?̇?O2max tests, this fitness assessment cost £200-250 if 
assessed privately. Your body composition will be assessed using a DEXA 
scan. This is the most accurate measurement of body fat, muscle and bone 
mass currently available and is not available as a measure of body composition 
to the general public. 
 
Food diaries are routinely used to assess current dietary habits and can identify 
any areas for improvement. A 7-day diet analysis can cost around £40. 
 
Participants taking part in circuit training will receive 3 supervised training 
sessions each week for 4-weeks. These sessions can cost £2.50 - £5 at local 
leisure centres. 
 
7. Who is organising the Study? 
 
This project is being organised by Kirstie Tew and Kholoud Alabduljader at 
the School of Sport Health and Exercise Science, Bangor University. 
 
8. Contacts for further information 
 
Kirstie Tew    pepa14@bangor.ac.uk 07849229997 
(MSc student) 
Kholoud Alabduljader  elpaab@bangor.ac.uk  07759893217 
(MSc student) 
 
Supervised by: 
Dr. Hans-Peter Kubis  pes203@bangor.ac.uk (01248) 388261 
(Senior lecturer) 
Dr. David Markland  d.a.markland@bangor.ac.uk (01248) 383487 
(Senior lecturer) 
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APPENDIX A.III 
Participant information sheet for 8 week study 
 
Study Title: Effects of exercise intensity on substrate utilisation and cognitive 
function. 
You are being invited to take part in a research study. Before you agree to take part it 
is important for you to understand why the research is being done and what it will 
involve. Please read the following information carefully and take time to decide 
whether you wish to take part, or not. 
 
Please contact the researchers if anything is unclear or you would like more 
information. 
 
Matthew Jackson        pepa2f@bangor.ac.uk        Tel: 01248388254 
 
Fardin Fatahi              pepc09@bangor.ac.uk        Tel: 01248388254 
 
What is the background of the study? 
 
The main aim of this study is to investigate the effects of exercise intensity on 
substrate utilisation and cognitive function in inactive women, with a range in BMI. 
Specifically, we will analyse how exercise of high and low intensity affects the body’s 
metabolism and how quick you can recognise visual cues and perform simple 
cognitive tasks. Substrate utilisation is the composition of fuel we use, both when 
exercising and at rest, this fuel can be derived from either carbohydrate, protein or fat 
and the amount of each can alter based on;- energy requirements, energy balance, 
dietary composition, body composition and aerobic capacity. It is known that regular 
exercise is beneficial for cardiovascular fitness and enhances cognitive performance. 
The effects of exercise on substrate utilisation may be one of the underlying 
mechanisms responsible for these beneficial outcomes. An 8 week exercise 
intervention will be used to test these assumptions. A further aim of the study is to 
investigate the influence of different exercise intensities on cognitive function e.g. 
reaction times in a task combining pictures and words in a computer based test. 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are free to withdraw at any time and without giving a 
reason.  
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What will happen to me if I take part? 
 
Summary 
 
You will be asked to keep a diet diary for one week before the study begins, in which 
you will need to write down precisely and accurately what you have had to eat and 
drink each day. After this the first bout of testing will take place;- these tests will 
include a dual-energy x-ray absorptiometry (DEXA) scan to assess your body 
composition, a VO2 max test to measure your aerobic/endurance fitness, analysis of 
resting metabolic rate, blood sampling before and after a test meal, and a cognitive 
function task. The tests will be completed over three visits to the lab. Each of these 
tests are discussed in greater depth below. Once the preliminary testing has been 
carried out the exercise intervention begins. You will be asked to attend exercise 
sessions 3 times a week for an hour or so on each occasion. These exercise classes 
will be conducted in a group format, and exercise will be done in a circuit training 
fashion. The exercise programme will last for 8 weeks in total, during this time you 
will also need to fill out a diet diary for two days of each week. Once the 8 week 
training period is finished, a second bout of testing will take place, in exactly the same 
format as the first with all the same tests. You will then be asked to fill out a diet diary 
once again as before. In the case, you are in the control group; you will carry out all 
testing before and after the training period but you will not take part in the exercise 
programme. 
 
Diet Diary 
 
We will give you a Food Record Sheet (FRS) where you should describe with 
accuracy and precision your daily food and beverage intake. You will be asked to 
keep a record of your diet for 7 days pre-intervention, 7 days post-intervention, and 2 
days per week during the intervention. The 2 days of each week during the 
intervention randomly chosen. How to describe foods and drinks will be fully 
explained in the Food Record Sheet. The analysis of your food composition is 
necessary to exclude influence of certain foodstuff on measures we take. It is fine to 
eat whatever you wish, but be sure to note everything that you eat on your food record 
sheet. 
 
Cognitive Function Task 
 
You will be asked to undergo a computerised test of the speed with which you 
respond to pictures of different objects. This will allow us to assess your cognitive 
function and whether it is affected by exercise. The test will last for approximately 20 
minutes. 
 
DEXA Scan 
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A whole body low radiation (DEXA) scan will be performed to assess how much 
bone, fat and muscle mass you have. For this procedure you need to wear shorts, 
socks, underwear (no bra) and t-shirt. The scan will last 15 minutes. This procedure is 
painless, and it is not more than lying down on a bed. Although there are small risks 
involved in radiation exposure, the amount of exposure during a DEXA scan is 
minimal and is lower than the amount of background radiation that we are exposed to 
during the course of two weeks outside in North Wales. 
 
VO2 Max Assessment 
 
VO2 max is a measure of your aerobic capacity and it is achieved with an incremental 
exercise test. You will begin by cycling at a fixed speed and a low resistance, and 
with every minute of the test the resistance will be increased slightly so the exercise 
becomes harder. The resistance will be increased until you have reached maximal 
exertion and can carry on no longer. During the test will be monitoring your heart 
rate, oxygen uptake and carbon dioxide production, The latter two will be measured 
with a breath by breath gas analyser, which collects the air you breath in and out. This 
is necessary so we can gain an accurate measure of your cardiovascular fitness. The 
test will normally last no longer than 30 minutes. 
 
Resting Metabolic rate 
 
You will be asked to arrive at the laboratory in an overnight fasted state and then to 
lie on a bed for about 30 minutes. As with the VO2 max test we will measure your 
oxygen uptake and carbon dioxide production with a breath by breath gas analyser. 
This test is necessary to find out more about your metabolism.   
 
Blood Sampling and Test Meal 
 
We will take two blood samples (i.e. pre and post-meal) from a vein of your forearm, 
on two separate occasions (i.e. pre and post exercise intervention). A small amount (8 
ml) of blood will be collected (0.2% of the total blood volume). We will use sterile 
needles to draw the blood samples. It is very important that you have fasted overnight. 
Afterwards, we will give you a test meal which will be in the form a milk shake. Then 
one hour after the test meal we will take the second blood sample. The blood samples 
will be use to measure hormone levels in your blood, which will give us important 
information about how exercise alters the way foodstuff is consumed in your body.    
 
Exercise Intervention 
 
Once you have completed all the baseline measures, we will begin the exercise 
intervention. As stated above, the exercise programme will last for 8 weeks and you 
will be asked to attend 3 exercise sessions per week, each exercise session will last for 
an hour or so and participants will train as a group. There will be 3 groups in this 
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study, a high intensity exercise group, a low intensity exercise group and a control. 
Each participant will be randomly allocated to one of these groups for the entire 
duration of the study. Exercise sessions will be in a circuit training format, this is 
where a series of exercise stations are completed one after another until a whole 
circuit is completed. During exercise sessions you will also be required to where chest 
belts so that we can monitor your heart rate. Finally, exercise sessions will take place 
at Normal Site Sports Hall, you will need to make your own way there. 
 
Timeline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agree to take 
part in study 
 
Keep diet diary 
for 1 week 
Pre-test visit 1 
Cognitive Performance Task 
DEXA scan 
Total time: 40 mins 
Pre-test visit 2 
Resting metabolic rate 
Blood sample 1 
Test meal 
Blood sample 2 
Total time: 2 hrs 
Exercise Intervention 
8 weeks training 3 times a 
week for approx. 1 hour. 
Total time: 24 hrs 
Pre-test visit 3 
VO2 max test 
Total Time: 30 mins 
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Post-test visit 1 
Cognitive Performance Task 
DEXA scan 
Total time: 40 mins 
Post-test visit 2 
Resting metabolic rate 
Blood sample 1 
Test meal 
Blood sample 2 
Total time: 2 hrs 
Keep diet diary 
for 1 week 
End of study 
Post-test visit 3 
VO2 max test 
Total Time: 30 mins 
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What are the possible disadvantages and risks of taking part? 
 
You may experience some discomfort during blood sampling. The blood sampling 
might be stressful for people who do not like needles or seeing blood. You may also 
find the VO2 max testing somewhat uncomfortable as you are required to exercise up 
to maximal exertion. There is a relatively large time commitment for this study, pre-
testing and post-testing will last for just over 3 hours each and you will need to 
exercise for approximately 3 hours per week for 8 weeks. 
 
What are the possible benefits of taking part? 
 
By taking part in this study you have the opportunity to join in a comprehensive 8 
week exercise intervention with a team of sport scientists who are passionate about 
the benefits of exercise to health and who have many years of combined experience in 
fitness training. You have a chance of reducing the possible risks of lifestyle related 
diseases associated with low physical activity and improving your overall health. 
Other benefits of exercise include improved cardiovascular fitness and metabolism, 
and possibly cognitive performance. Your participation in this study will also provide 
us with valuable insights into how the human body and mind adapts to exercise and 
will add to our understanding of how exercise positively influences health. In addition 
to the above, upon completion of the study you will be eligible for a free pair of 
trainers of your choice up to the value of £100 (these will be chosen from 
wiggle.co.uk) as a reimbursement for your effort and time commitment.  
 
Confidentiality 
 
All information which is collected about you during the course of the research will be 
kept strictly confidential. Any data which is to leave the school, for possible 
publications or reports, will have your name and any other personal information 
removed so that you cannot be recognised from it. It will not be possible to identify 
you in any of these reports or publications.  
 
Who is organising or funding the research? 
 
This study has been organised by Matthew Jackson (PhD student), Fardin Fatahi (PhD 
student), Dr Hans-Peter Kubis (Senior lecturer) and Dr David Markland (Senior 
lecturer) from the School of Sport, Health and Exercise Sciences (SSHES) of Bangor 
University.  
 
Who has reviewed the study? 
 
This study has been reviewed by the SSHES Ethics Committee and North Wales 
Research Ethics Committee – West.  
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Feedback and conduct of research 
 
SSHES is always keen to hear the views of research participants about their 
experience. If you would like to give feedback, please ask your researcher to provide 
you with Form 6 – Participant Feedback Form – from the Ethics Guidelines 
Handbook. Completion of this form is optional and can be done anonymously. The 
completed form should be returned to Dr Andrew Lemmey, Chair, SSHES Ethics 
Committee, SSHES, Bangor University, Bangor LL57 2PZ. All information will be 
treated in a strictly confidential manner. 
 
Complaints 
 
If during the course of this study you feel the need to complain about how the 
research has been carried out, for any reason, then please contact the Head of School, 
Dr Tim Woodman, SSHES, Bangor University, Bangor LL57 2PZ. 
 
Any questions? 
 
Please ask us if you have any questions. Here are the contact details of all 
investigators in this study: 
 
Matthew Jackson (PhD student)               pepa2f@bangor.ac.uk             Tel: 01248 38 
8254 
Fardin Fatahi (PhD student)                     pepc09@bangor.ac.uk             Tel: 01248 38 
8254 
Dr Hans-Peter Kubis (Senior Lecturer)    pes203@bangor.ac.uk             Tel: 01248 38 
8261 
Dr David Markland  (Senior Lecturer)     d.a.markland@bangor.ac.uk    Tel: 01248 38 
3487 
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APPENDIX B.I 
Lifestyle questionnaire for sugar-sweetened beverage study 
 
Please take a few minutes to read the following introduction:  
 
This questionnaire has been designed to recruit new participants for our nutrition related 
Research Study. Once you have filled in this questionnaire we will be able to see 
whether you are eligible as a possible participant. In case you are eligible we would like 
to get in touch with you. So please leave contact details at the end of this questionnaire. 
It is up to you to decide whether or not to take part. If you decide to take part you will 
be given an information sheet to keep and be asked to sign a consent from. If you decide 
to take part you are free to withdraw at any time and without giving a reason. This will 
not affect the marks you receive, the outcome of your period of study at SSHES or your 
standing with your supervisor, other staff or with the School. The outcome of this 
questionnaire will be held confidential by the researcher.  
 
In case you complete the entire study you will be reimbursed with £ 100.  
 
Please ask at any time if you feel anything is unclear or contact: 
Francesco Sartor                         pep421@bangor.ac.uk               tel: 01248 388254 
 
How many cigarettes do you smoke per day? 
 
1) none 
2) less than a pack  
3) a pack  
4) more than a pack  
 
How much physically active are you?  
 
1) physically inactive (little or no exercise)  
2) lightly active (light exercise or sports 1-3 days a week)  
3) moderately active (moderate exercise or sports 3-5 days a week) 
4) very active (hard exercise or sports  6-7 days a week)  
 
How many steps do you think you walk on average per day? 
 
1) less than 5000 
2) between 5000 and 7000 
3) between 7000 and 10000 
4) more than 10000 
 
How often do you drink soft drinks?  
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1. more than 4 pints (or 2 litre) a week 
2. 1 to 2 pints a week 
3. less then 1 pint (or a can) a week 
4. none 
 
How much water do you drink per day?  
 
1) about 4 pints (about 2 litres)  
2) more than 4 pints (more than 2 litres) 
3) less than 4 pint 
4) less than 1 pint 
 
How many times do you eat fish per week?  
 
1) More than 3 
2) 2-3 
3) 1 
4) 0 
 
How much alcohol do you drink per week?  
NB (500 ml, a can  of lager 4% alcohol is 2 units; 160 ml, a glass of wine 12.5% 
alcohol is 2 units; 125 ml,  party cocktail 40% is 5 units)  
 
1) more than 30 units 
2) 10 to 30 units  
3) 2 to 10 units  
4) less then 2 or none  
 
What sport/s do you practice? 
 
1 ………………………………………… 
2 ………………………………………… 
3 ………………………………………… 
 
Do you drink sports drinks, if yes how often?  
 
1) once in a while  
2) once a week 
3) more than once a week 
4) every day  
 
 
 
Do you eat vegetables, if yes how often? 
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1) every day  
2) once in a while  
3) more than once a week 
4) once a week 
 
If you train: how long does it take on average each training session?   
 
……….min 
 
 
When you go upstairs do you use the lift? 
 
1) always  
2) 50%-50% 
3) I prefer the stairs (70%-30%) 
4) never   
 
Do you eat red meat? How often?  
 
1) every day  
2) never 
3) once or twice a week 
4) every other week 
 
Do you eat potatoes and/or pasta? How often? 
 
1) never 
2) every day  
3) every day twice a day 
4) sometimes 
 
How much fruit do you eat?  
 
1) none 
2) one piece a day  
3) 1 to 3 pieces a day 
4) more than 3 pieces a day 
 
 
 
 
How often do you drink fruit juices? 
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1) more than 4 pints (or 2 litre) a week 
2) 1 to 2 pints a week 
3) less then 1 pint (or a can) a week 
4) none 
 
 
Please, if interested remember to leave a contact telephone/mobile number or e-
mail address:  
 
THANK YOU 
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APPENDIX B.II 
Pre-screening questionnaire for exercise studies 
 
 
Name of Participant: ……..………………  Date of Birth: 
..................................... 
 
Height: ………………………..                         
Email:………………………………... 
 
Weight: .....................................                                 Contact 
No:…………………………. 
 
Nationality:……………………………….. 
 
HEALTH: 
 
1. Are you in good health?     YES  NO 
 
If no, please explain: 
 
 
 
2. Have you suffered from a serious illness or accident?  YES  NO 
 
If yes, please provide details: 
 
 
 
3. Do you suffer or have you ever suffered from:   
 
 YES NO 
Asthma   
Bronchitis   
Diabetes   
Epilepsy   
Heart Condition   
High Blood Pressure   
Bone or Joint Problem   
 
4. Are you currently taking medication?              YES  NO 
 
If yes, please provide details: 
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5. Are you currently attending your GP for any condition or have you consulted 
your doctor in the last three months?                         YES              
NO 
 
If yes, please provide details: 
 
 
 
6. Do you have any allergies?                                                   YES                  NO 
 
If yes, please provide details: 
 
 
 
 
7. Menstruation: 
a. Please indicate your current menstrual status: 
 
  No menstruation 
  
  Irregular menstruation 
 
  Regular menstruation 
 
 
b. How many days since your last menstruation? ............................ 
 
c. Do you currently take an oral contraceptive?           YES           NO 
 
 
 
PHYSICAL ACTIVITY: 
 
How would you describe your present level of activity?  
Tick intensity level and indicate approximate duration. 
Vigorous  Moderate  Low intensity  
 
Duration (minutes)……………………………………………………………………. 
 
How often?  
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< once per month   2  times per week  
once per month  3-4 times per week  
2  times per month  > 5 times per week  
1 times per week    
 
NUTRITION: 
 
1. How would you describe your current diet: 
 
Westernised   
 
Traditional    
 
 
2. Are you currently: 
 
Vegetarian        YES NO 
 
 
 
 
Vegan       YES NO 
 
 
 
 
3. Are you currently attempting to lose weight?              YES              NO 
 
 
 
Have you, or are you presently taking part in any other laboratory experiment? 
          
                                                                                                            YES  NO
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PLEASE READ THE FOLLOWING CAREFULLY 
 
Persons will be considered unfit to do the experimental exercise task if they: 
 
 have a fever, cough or cold, or suffer from fainting spells or dizziness; 
 have suspended training due to a joint or muscle injury; 
 have a known history of medical disorders, i.e. high blood pressure, heart or lung 
disease; 
 have had hyper/hypothermia, heat exhaustion, or any other heat or cold disorder; 
 have anaphylactic shock symptoms to needles, probes or other medical-type 
equipment; 
 have chronic or acute symptoms of gastrointestinal bacterial infections (e.g. 
Dysentery, Salmonella); 
 have a history of infectious diseases (e.g. HIV, Hepatitis B); and if appropriate to the 
study design, have a known history of rectal bleeding, anal fissures, haemorrhoids, or 
any other condition of the rectum. 
 
 
DECLARATION 
 
I agree that I have none of the above conditions and I hereby volunteer to be a 
participant in experiments/investigations during the period of ……………… 
 
 
My replies to the above questions are correct to the best of my belief and I understand 
that they will be treated with the strictest confidence. The experimenter has explained 
to my satisfaction the purpose of the experiment and possible risks involved. 
 
I understand that I may withdraw from the experiment at any time and that I am under 
no obligation to give reasons for withdrawal or to attend again for experimentation. 
 
Furthermore, if I am a student, I am aware that taking part or not taking part in this 
experiment, will neither be detrimental to, or further, my position as a student. 
 
I undertake to obey the laboratory/study regulations and the instructions of the 
experimenter regarding safety, subject only to my right to withdraw declared above. 
 
 
Signature ………………………………….  Date ………………………………….. 
Participant 
 
Signature ………………………………….  Date ………………………………….. 
Experimenter           
 193 
 
APPENDIX C.I 
Example circuit training session 
WARM-UP (10mins): 
 
Moving in a circle around the sports hall, progress through: 
 Walk  
 Mobilisation while walking 
o Arm swings forwards 
o Arm swings backwards 
o Pass the rugby ball body rotation 
o “Opening the gate” legs 
o “Closing the gate” legs  
 Jog 
 High knees  
 Butt kicks 
 Jog 
 
 
SPRINTS: 
 
Put the exercisers into 2 equal sized teams for races. During the race, those not 
running should do the exercise in brackets. 
 
1. Shuttle runs (star jumps) 
2. Side shuffle (squats) 
 
 
CIRCUIT: 
 
 12 stations in a circuit around the sports hall 
o Squat jumps 
o Leg raises 
o Triceps dips 
o Toe touches 
o Abdominal bike 
o Press-ups 
o Step-ups 
o Dorsal raises 
o Star jumps 
o Ladder climb 
o Lunges 
o Plank 
 
 Circuit 1: 45-seconds exercise/15-seconds rest 
 Circuit 2: 30-seconds exercise/15-seconds rest 
 3-minutes rest between circuit 1 and 2. 
 
COOL-DOWN (5-10minutes): 
Moving in a circle around the sports hall, progress through: 
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 Jog 
 Walk 
 Mobilisation while walking 
o Arm swings forwards 
o Arm swings backwards 
o Pass the rugby ball body rotation 
o “Opening the gate” legs 
o “Closing the gate” legs  
 Stretches 
o Neck 
o Cross-chest shoulder stretch 
o Triceps stretch 
o Side stretch 
o Quadriceps 
o Hamstrings 
o Glutes 
 
